COVER
COVER - shares | 3 Months Ended | |
Mar. 31, 2020 | May 05, 2020 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2020 | |
Document Transition Report | false | |
Entity File Number | 001-38469 | |
Entity Registrant Name | Equitable Holdings, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 90-0226248 | |
Entity Address, Address Line One | 1290 Avenue of the Americas | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10104 | |
City Area Code | 212 | |
Local Phone Number | 554-1234 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 450,549,631 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2020 | |
Amendment Flag | false | |
Entity Central Index Key | 0001333986 | |
Current Fiscal Year End Date | --12-31 | |
Common Stock | New York Stock Exchange | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | Common Stock | |
Trading Symbol | EQH | |
Security Exchange Name | NYSE | |
Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A | New York Stock Exchange | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series A | |
Trading Symbol | EQH PR A | |
Security Exchange Name | NYSE |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 | |
Investments: | |||
Fixed maturities available-for-sale, at fair value (amortized cost of $65,044 and $62,937) (allowance for credit losses of $2 at March 31, 2020) | $ 70,321 | $ 66,343 | |
Mortgage loans on real estate (net of allowance for credit losses of $46 at March 31, 2020) | 12,123 | 12,107 | |
Policy loans | 3,720 | 3,735 | |
Other equity investments | [1] | 1,406 | 1,344 |
Trading securities, at fair value | 6,534 | 7,031 | |
Other invested assets | [1] | 2,112 | 2,780 |
Total investments | 96,216 | 93,340 | |
Cash and cash equivalents | [1] | 10,315 | 4,405 |
Cash and securities segregated, at fair value | 2,013 | 1,095 | |
Broker-dealer related receivables | 2,436 | 1,987 | |
Deferred policy acquisition costs | 4,809 | 5,890 | |
Goodwill and other intangible assets, net | 4,760 | 4,751 | |
Amounts due from reinsurers (allowance for credit losses of $6 at March 31, 2020) | 4,614 | 4,592 | |
GMIB reinsurance contract asset, at fair value | 2,823 | 2,139 | |
Other assets | [1] | 5,824 | 3,799 |
Assets held-for-sale | 843 | 962 | |
Separate Accounts assets | 106,128 | 126,910 | |
Total Assets | 240,781 | 249,870 | |
LIABILITIES | |||
Policyholders’ account balances | 55,810 | 58,879 | |
Future policy benefits and other policyholders' liabilities | 37,968 | 34,587 | |
Broker-dealer related payables | 1,001 | 722 | |
Customer related payables | 3,630 | 2,523 | |
Amounts due to reinsurers | 1,380 | 1,404 | |
Short-term and long-term debt | 4,217 | 4,111 | |
Current and deferred income taxes | 2,355 | 549 | |
Other liabilities | [1] | 5,716 | 3,970 |
Liabilities held-for-sale | 679 | 724 | |
Separate Accounts liabilities | 106,128 | 126,910 | |
Total Liabilities | 218,884 | 234,379 | |
Redeemable noncontrolling interest | [1],[2] | 257 | 365 |
Commitments and contingent liabilities (Note 14) | |||
Equity attributable to Holdings: | |||
Preferred stock and additional paid-in capital, $1 par value, 32 million shares authorized, issued and outstanding; $25,000 liquidation preference | 775 | 775 | |
Common stock, $0.01 par value, 2,000,000,000 shares authorized; 552,896,328 and 552,896,328 shares issued, respectively; 450,584,788 and 463,711,392 shares outstanding, respectively | 5 | 5 | |
Additional paid-in capital | 1,930 | 1,920 | |
Treasury stock, at cost, 102,311,540 and 89,184,936 shares, respectively | (2,025) | (1,832) | |
Retained earnings | 17,112 | 11,827 | |
Accumulated other comprehensive income (loss) | 2,289 | 840 | |
Total equity attributable to Holdings | 20,086 | 13,535 | |
Noncontrolling interest | 1,554 | 1,591 | |
Total Equity | 21,640 | 15,126 | |
Total Liabilities, Redeemable Noncontrolling Interest and Equity | $ 240,781 | $ 249,870 | |
[1] | See Note 2 for details of balances with variable interest entities. | ||
[2] | See Note 13 for details of Redeemable noncontrolling interest. |
CONSOLIDATED BALANCE SHEETS (PA
CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) | Mar. 31, 2020 | Dec. 31, 2019 |
Fixed maturities available-for-sale, amortized cost | $ 65,042,000,000 | |
Fixed maturities available-for-sale, allowance for credit losses | (2,000,000) | $ 0 |
Mortgage loans on real estate, allowance for credit losses | 46,000,000 | |
Reinsurance recoverable, allowance for credit loss | $ 6,000,000 | |
Preferred stock par value (in dollars per share) | $ 1 | $ 1 |
Preferred stock, shares authorized (in shares) | 32,000,000 | 32,000,000 |
Preferred stock, shares outstanding (in shares) | 32,000,000 | 32,000,000 |
Preferred stock, liquidation preference | $ 25,000 | $ 25,000 |
Common stock par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock authorized (in shares) | 2,000,000,000 | 2,000,000,000 |
Common stock issued (in shares) | 552,896,328 | 552,896,328 |
Common stock outstanding (in shares) | 450,584,788 | 463,711,392 |
Treasury stock (in shares) | 102,311,540 | 89,184,936 |
Fixed maturities | ||
Fixed maturities available-for-sale, amortized cost | $ 65,044,000,000 | $ 62,937,000,000 |
Fixed maturities available-for-sale, allowance for credit losses | $ 2,000,000 | $ 0 |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Thousands, shares in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
REVENUES | ||
Policy charges and fee income | $ 991,000 | $ 931,000 |
Premiums | 289,000 | 283,000 |
Net derivative gains (losses) | 9,401,000 | (1,630,000) |
Net investment income (loss) | 616,000 | 1,015,000 |
Investment gains (losses), net: | ||
Credit losses on AFS debt securities and loans | (12,000) | 0 |
Other investment gains (losses), net | 16,000 | (11,000) |
Total investment gains (losses), net | 4,000 | (11,000) |
Investment management and service fees | 1,136,000 | 999,000 |
Other income | 156,000 | 127,000 |
Total revenues | 12,593,000 | 1,714,000 |
BENEFITS AND OTHER DEDUCTIONS | ||
Policyholders’ benefits | 2,788,000 | 880,000 |
Interest credited to policyholders’ account balances | 317,000 | 304,000 |
Compensation and benefits | 526,000 | 509,000 |
Commissions and distribution-related payments | 338,000 | 281,000 |
Interest expense | 52,000 | 56,000 |
Amortization of deferred policy acquisition costs | 1,248,000 | 198,000 |
Other operating costs and expenses | 437,000 | 410,000 |
Total benefits and other deductions | 5,706,000 | 2,638,000 |
Income (loss) from continuing operations, before income taxes | 6,887,000 | (924,000) |
Income tax (expense) benefit | (1,440,000) | 215,000 |
Net income (loss) | 5,447,000 | (709,000) |
Less: Net income (loss) attributable to the noncontrolling interest | 37,000 | 66,000 |
Net income (loss) attributable to Holdings | 5,410,000 | (775,000) |
Less: Preferred stock dividends | 13,000 | 0 |
Net income (loss) available to Holdings’ common shareholders | $ 5,397,000 | $ (775,000) |
Net income (loss) applicable to Holdings’ common shareholders per common share: | ||
Basic (in usd per share) | $ 11.71 | $ (1.50) |
Diluted (in usd per share) | $ 11.65 | $ (1.50) |
Weighted average common shares outstanding (in millions): | ||
Basic (in shares) | 461 | 518 |
Diluted (in shares) | 463.5 | 518 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Statement of Comprehensive Income [Abstract] | ||
Net income (loss) | $ 5,447 | $ (709) |
Other comprehensive income (loss) net of income taxes: | ||
Change in unrealized gains (losses), net of reclassification adjustment | 1,434 | 834 |
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment | 28 | 49 |
Foreign currency translation adjustment | (21) | (1) |
Total other comprehensive income (loss), net of income taxes | 1,441 | 882 |
Comprehensive income (loss) | 6,888 | 173 |
Less: Comprehensive income (loss) attributable to the noncontrolling interest | 29 | 65 |
Comprehensive income (loss) attributable to Holdings | $ 6,859 | $ 108 |
CONSOLIDATED STATEMENTS OF EQUI
CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions | Total | Parent | Preferred Stock and Additional Paid-In Capital | Common Stock | Additional Paid-in Capital | Treasury Stock | Retained Earnings | AOCI Attributable to Parent | Non-controlling Interest |
Beginning of year at Dec. 31, 2016 | $ 16,518 | $ 13,421 | $ 5 | $ 1,299 | $ 0 | $ 12,225 | $ (108) | $ 3,097 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Repurchase of AB Holding units | (95) | (95) | |||||||
Dividends paid to noncontrolling interest | (346) | (346) | |||||||
Net income (loss) | 2,136 | 1,820 | 1,820 | 316 | |||||
Other comprehensive income (loss) | (1,177) | (1,192) | (1,192) | 15 | |||||
Other | (18) | (103) | 85 | ||||||
End of year at Dec. 31, 2017 | 17,018 | 13,946 | 5 | 1,196 | 0 | 14,045 | (1,300) | 3,072 | |
Beginning of year at Dec. 31, 2018 | 15,432 | 13,866 | 5 | 1,908 | (640) | 13,989 | (1,396) | 1,566 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Stock compensation | (10) | (19) | (19) | 9 | |||||
Purchase of treasury stock | (594) | (594) | (594) | ||||||
Retirement of common stock | (142) | (142) | (142) | ||||||
Repurchase of AB Holding units | (21) | (21) | |||||||
Dividends paid to noncontrolling interest | (68) | (68) | |||||||
Dividends | (68) | (68) | (68) | ||||||
Net income (loss) | (721) | (775) | (775) | 54 | |||||
Other comprehensive income (loss) | 882 | 883 | 883 | (1) | |||||
Other | (8) | (8) | (8) | ||||||
End of year at Mar. 31, 2019 | 14,682 | 13,143 | 5 | 1,881 | (1,234) | 13,004 | (513) | 1,539 | |
Beginning of year at Dec. 31, 2019 | 15,126 | 13,535 | $ 775 | 5 | 1,920 | (1,832) | 11,827 | 840 | 1,591 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Stock compensation | 30 | 27 | 14 | 13 | 3 | ||||
Purchase of treasury stock | (206) | (206) | (206) | ||||||
Reissuance of treasury stock | (13) | (13) | (13) | ||||||
Repurchase of AB Holding units | 0 | 6 | 6 | (6) | |||||
Dividends paid to noncontrolling interest | (93) | (93) | |||||||
Dividends | (69) | (69) | (69) | ||||||
Dividends on preferred stock | (13) | (13) | (13) | ||||||
Net income (loss) | 5,477 | 5,410 | 5,410 | 67 | |||||
Other comprehensive income (loss) | 1,441 | 1,449 | 1,449 | (8) | |||||
Other | (10) | (10) | (10) | ||||||
End of year at Mar. 31, 2020 | $ 21,640 | $ 20,086 | $ 775 | $ 5 | $ 1,930 | $ (2,025) | $ 17,112 | $ 2,289 | $ 1,554 |
CONSOLIDATED STATEMENTS OF EQ_2
CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Cash dividends declared per common share (in usd per share) | $ 0.15 | $ 0.13 |
Retained Earnings | ||
Cash dividends declared per common share (in usd per share) | $ 0.15 | $ 0.13 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Statement of Cash Flows [Abstract] | ||
Net income (loss) | $ 5,447 | $ (709) |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
Interest credited to policyholders’ account balances | 317 | 304 |
Policy charges and fee income | (991) | (931) |
Net derivative (gains) losses | (9,401) | 1,630 |
Credit losses on AFS debt securities and loans | 12 | 0 |
Investment (gains) losses, net | (65) | 11 |
Loss on businesses held for sale | 49 | 0 |
Realized and unrealized (gains) losses on trading securities | 170 | (294) |
Non-cash long term incentive compensation expense | 5 | 42 |
Amortization and depreciation | 1,275 | 239 |
Equity (income) loss from limited partnerships | 22 | (13) |
Changes in: | ||
Net broker-dealer and customer related receivables/payables | 881 | (221) |
Reinsurance recoverable | (113) | (18) |
Segregated cash and securities, net | (918) | (93) |
Capitalization of deferred policy acquisition costs | (185) | (173) |
Future policy benefits | 1,936 | 22 |
Current and deferred income taxes | 1,425 | 183 |
Other, net | (448) | (88) |
Net cash provided by (used in) operating activities | (582) | (109) |
Proceeds from the sale/maturity/prepayment of: | ||
Fixed maturities, available for sale | 2,762 | 2,900 |
Mortgage loans on real estate | 120 | 216 |
Trading account securities | 510 | 3,843 |
Real estate joint ventures | 0 | 1 |
Short term investments | 718 | 794 |
Other | 147 | 48 |
Payment for the purchase/origination of: | ||
Fixed maturities, available-for-sale | (4,993) | (5,187) |
Mortgage loans on real estate | (181) | (517) |
Trading account securities | (166) | (536) |
Short term investments | (359) | (685) |
Other | (194) | (74) |
Cash settlements related to derivative instruments | 5,581 | (1,005) |
Investment in capitalized software, leasehold improvements and EDP equipment | (14) | (16) |
Other, net | 216 | 148 |
Net cash provided by (used in) investing activities | 4,147 | (70) |
Cash flows from financing activities: | ||
Deposits | 2,507 | 2,430 |
Withdrawals | (1,099) | (1,067) |
Transfers (to) from Separate Accounts | 513 | 424 |
Change in short-term financings | 105 | (6) |
Change in collateralized pledged assets | 44 | (6) |
Change in collateralized pledged liabilities | 657 | 631 |
(Decrease) increase in overdrafts payable | 85 | (65) |
Shareholder dividends paid | (69) | (68) |
Dividends paid on preferred stock | (13) | 0 |
Purchases of AB Holding Units to fund long-term incentive compensation plan awards | (18) | 0 |
Purchase of treasury shares | (205) | (744) |
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds | (74) | 0 |
Distribution to noncontrolling interest of consolidated subsidiaries | (93) | (68) |
Increase (decrease) in securities sold under agreement to repurchase | 0 | (573) |
Other, net | (6) | (50) |
Net cash provided by (used in) financing activities | 2,334 | 838 |
Effect of exchange rate changes on cash and cash equivalents | (13) | 1 |
Change in cash and cash equivalents | 5,886 | 660 |
Cash and cash equivalents, beginning of year | 4,405 | 4,469 |
Change in cash of businesses held for sale | 24 | 0 |
Cash and cash equivalents, end of year | 10,315 | 5,129 |
Non-cash transactions: | ||
Right-of-use assets obtained in exchange for lease obligations | $ 14 | $ 3 |
ORGANIZATION
ORGANIZATION | 3 Months Ended |
Mar. 31, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION | ORGANIZATION Equitable Holdings, Inc. (which removed “AXA” from its name on January 13, 2020, “Holdings” and, with its consolidated subsidiaries, the “Company”) is the holding company for a diversified financial services organization. The Company conducts operations in four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Company’s management evaluates the performance of each of these segments independently. • The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income. • The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses. • The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth Management - and distributes its institutional research products and solutions through Bernstein Research Services. The Investment Management and Research segment reflects the business of AllianceBernstein Holding L.P. (“AB Holding”), AllianceBernstein L.P. (“ABLP”) and their subsidiaries (collectively, “AB”). • The Protection Solutions segment includes the Company’s life insurance and group employee benefits businesses. The life insurance business offers a variety of variable universal life, indexed universal life and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of life, short- and long-term disability, dental and vision insurance products to small and medium-size businesses across the United States. The Company reports certain activities and items that are not included in our segments in Corporate and Other. Corporate and Other includes certain of our financing and investment expenses. It also includes: AXA Advisors, LLC (“Equitable Advisors”) broker-dealer business, closed block of life insurance (the “Closed Block”), run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Investment Management and Research segment. Accordingly, Corporate and Other does not include any items applicable to AB. At March 31, 2020 and December 31, 2019 , the Company’s economic interest in AB was approximately 65% and 65% , respectively. The general partner of AB, AllianceBernstein Corporation (the “General Partner”), is a wholly-owned subsidiary of the Company. Because the General Partner has the authority to manage and control the business of AB, AB is consolidated in the Company’s financial statements for all periods. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES | SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature, with the exception of the Company’s update of its interest rate assumption as further described in Assumption Updates and Model Changes. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . The accompanying consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. All significant intercompany transactions and balances have been eliminated in consolidation. The terms “ first quarter 2020 ” and “ first quarter 2019 ” refer to the three months ended March 31, 2020 and 2019 , respectively. Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2016-13 : Financial Instruments—Credit Losses (Topic 326), as clarified and amended by ASU 2018-19: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, ASU 2019-04: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU 2019-05: Financial Instruments—Credit Losses (Topic 326) Targeted Transition Relief, ASU 2019-11: Codification Improvements to Topic 326, Financial Instruments—Credit Losses ASU 2016-13 contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. ASU 2019-05 provides entities that have instruments within the scope of Subtopic 326-20 an option to irrevocably elect the fair value option on an instrument-by instrument basis upon adoption of Topic 326. ASU 2018-19, ASU 2019-04 and ASU 2019-11 clarified the codification guidance and did not materially change the standard. On January 1, 2020, the Company adopted the new standard and completed implementation of its updated expected credit loss models, processes and controls related to the identified financial assets that fall within the scope of the new standard. Upon adoption, the Company recorded a cumulative effect adjustment to reduce the opening retained earnings balance by approximately $40 million, on a pre-tax and pre-DAC basis. The adjustment is primarily attributable to an increase in the allowance for credit losses associated with the Company’s commercial and agricultural mortgage loan portfolios and reinsurance. Results for reporting periods beginning after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported in accordance with previously applicable GAAP. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. The Company elected to early adopt during 2019 the removed disclosures relating to transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and valuation processes for Level 3 fair value measurements. The Company adopted the additional disclosures related to Level 3 fair value information on January 1, 2020. ASU 2018-17 : Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The Company adopted this new standard effective for January 1, 2020. Adoption of this standard did not materially impact the Company’s financial position or results of operations. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944); ASU 2019-09: Financial Services - Insurance (Topic 944): Effective Date This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: In November 2019, ASU 2019-09 was issued which modified ASU 2018-12 to be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on the Company’s consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary, update cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in Accumulated other comprehensive income (“AOCI”) or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred policy acquisition costs. For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. For deferred policy acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, as well as clarifying and amending existing guidance. Effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact adopting the guidance will have on the Company’s consolidated financial statements, however the adoption is not expected to materially impact the Company’s financial position, results of operation, or cash flows. ASU2020-04 : Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting The amendments in this ASU provide optional expedients and exceptions to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective as of March 12, 2020 through December 31, 2022. The Company will determine the applicability of the optional expedients and exceptions provided under the ASU as reference rate reform continues to develop. Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in other comprehensive income (“OCI”), net of allowance for credit losses, policy related amounts and deferred income taxes. With the adoption of the new Financial Instruments-Credit Losses standard, changes in credit losses are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, evaluates AFS debt securities that experienced a decline in fair value below amortized cost for credit losses which are evaluated in accordance with the new financial instruments credit losses guidance effective January 1, 2020. Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security has experienced a credit loss. This assessment includes, but is not limited to, consideration of the severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity and continued viability of the issuer. The Company recognizes an allowance for credit losses on AFS debt securities with a corresponding adjustment to earnings rather than a direct write down that reduces the cost basis of the investment, and credit losses are limited to the amount by which the security’s amortized cost basis exceeds its fair value. Any improvements in estimated credit losses on AFS debt securities are recognized immediately in earnings. Management does not use the length of time a security has been in an unrealized loss position as a factor, either by itself or in combination with other factors, to conclude that a credit loss does not exist, as they were permitted to do prior to January 1, 2020. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting allowance is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. Write-offs of AFS debt securities are recorded when all or a portion of a financial asset is deemed uncollectible. Full or partial write-offs are recorded as reductions to the amortized cost basis of the AFS debt security and deducted from the allowance in the period in which the financial assets are deemed uncollectible. The Company elected to reverse accrued interest deemed uncollectible as a reversal of interest income. In instances where the Company collects cash that it has previously written off, the recovery will be recognized through earnings or as a reduction of the amortized cost basis for interest and principal, respectively. Real estate held for the production of income is stated at depreciated cost less allowance for credit losses.Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies, and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag. Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the consolidated statements of income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At March 31, 2020 and December 31, 2019 , the carrying value of COLI was $872 million and $944 million , respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. Cash and securities segregated primarily includes U.S. Treasury Bills segregated by AB in a special reserve bank custody account for the exclusive benefit of its brokerage customers under Rule 15c3-3 of the Exchange Act. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis. Commercial and Agricultural Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and the allowance for credit losses. The Company calculates the allowance for credit losses in accordance with the current expected credit losses (“CECL”) model in order to provide for the risk of credit losses in the lending process. Expected credit losses for loans with similar risk characteristics are estimated on a collective (i.e., pool) basis in order to meet CECL’s risk of loss concept which requires the Company to consider possibilities of loss, even if remote. For collectively evaluated mortgages, the Company estimates the allowance for credit losses based on the amortized cost basis of its mortgages over their expected life using a probability of default (“PD”) / loss given default (“LGD”) model. The PD/LGD model incorporates the Company’s reasonable and supportable forecast of macroeconomic information over a specified period. For periods beyond the reasonable and supportable forecast period, the model reverts to historical loss information. The CECL model is configured to the Company’s specifications and takes into consideration the detailed risk attributes of each discrete loan in the mortgage portfolio which include, but are not limited to the following: • Loan-to-value (“LTV”) ratio - Derived from current loan balance divided by the fair market value of the property. An LTV ratio in excess of 100% indicates an underwater mortgage. • Debt service coverage (“DSC”) ratio - Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0x, then the income from the property does not support the debt. • Occupancy - Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations - The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Other - Any other factors such as maturity, borrower/tenant related issues, payment status, property condition, or current economic conditions may call into question the performance of the loan. For individually evaluated mortgages, the Company continues to recognize an allowance on the present value of expected future cash flows discounted at the loan’s original effective interest rate or on its collateral value. Mortgage loans that do not share similar risk characteristics with other loans in the portfolio are individually evaluated quarterly by the Company’s IUS Committee. The allowance for credit losses on these individually evaluated mortgages is a loan-specific reserve as a result of the loan review process that is recorded based on the present value of expected future cash flows discounted at the loan’s effective interest rate or based on the fair value of the collateral. The individually assessed allowance for mortgage loans can increase or decrease from period to period based on such factors. Individually assessed loans may include, but are not limited to, mortgages that have deteriorated in credit quality such as troubled debt restructurings (“TDR”) and reasonably expected TDRs, mortgages for which foreclosure is probable, and mortgages which have been classified as “potential problem” or “problem” loans within the Company’s IUS Committee processes as described below. Within the IUS process, Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problem mortgages but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being modified. The decision whether to classify a performing mortgage loan as a potential problem involves judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. Individually assessed mortgage loans without provision for losses are mortgage loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on mortgage loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on mortgage loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Mortgage loans are placed on nonaccrual status once management believes the collection of accrued interest is not probable. Once mortgage loans are classified as nonaccrual mortgage loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan has been restructured to where the collection of interest is considered likely. The Company charges off loan balances and accrued interest that are deemed uncollectible. Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses) Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the allowance for credit losses are included in Investment gains (losses), net. Realized and unrealized holding gains (losses) on trading and equity securities are reflected in Net investment income (loss). Unrealized investment gains (losses) on fixed maturities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, as are amounts attributable to certain pension operations, Closed Block’s policyholders’ dividend obligation, insurance liability loss recognition, DAC related to UL policies, investment-type products and participating traditional life policies. Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities classified as AFS and do not reflect any change in fair value of policyholders’ account balances and future policy benefits. Accounting and Consolidation of VIEs For all new investment products and entities developed by the Company (other than Collateralized Debt Obligations (“CDOs”)), the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, the Company then identifies the primary beneficiary of the VIE. If the Company is deemed to be the primary beneficiary of the VIE, then the Company consolidates the entity. Management of the Company reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client assets under management (“AUM”) to determine the entities that the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships. The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate. Consolidated VIEs At March 31, 2020 and December 31, 2019 , the Company consolidated one real estate joint venture for which it was identified as the primary beneficiary under the VIE model. The consolidated entity is jointly owned by Equitable Life and AXA France and holds an investment in a real estate venture. Included in Other invested assets in the Company’s consolidated balance sheets at March 31, 2020 and December 31, 2019 are total assets of $32 million and $32 million , respectively, related to this VIE, primarily resulting from the consolidated presentation of this real estate joint venture as real estate held for sale. Consolidated AB-Sponsored Investment Funds Included in the Company’s consolidated balance sheet at March 31, 2020 and December 31, 2019 are assets of $377 million and $424 million , liabilities of $73 million and $12 million , and redeemable noncontrolling interests of $179 million and $273 million , respectively, associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets at March 31, 2020 and December 31, 2019 are assets of $193 million and $188 million , liabilities of $32 million and $19 million , and redeemable noncontrolling interests of $46 million and $52 million , respectively, from consolidation of AB-sponsored investment funds under the VOE model. The assets of these consolidated funds are presented within Other invested assets and Cash and cash equivalents, and liabilities of these consolidated funds are presented with Other liabilities in the Company’s consolidated balance sheets; ownership interests not held by the Company relating to consolidated VIEs and VOEs are presented either as redeemable or non-redeemable noncontrolling interests, as appropriate. Redeemable noncontrolling interests are presented in mezzanine equity and non-redeemable noncontrolling interests are presented within permanent equity. The Company is not required to provide financial support to these Company-sponsored investment funds, and only the assets of such funds are available to settle each fund’s own liabilities. Non-Consolidated VIEs At March 31, 2020 and December 31, 2019 , respectively, the Company held approximately $1.2 billion and $1.2 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $151.4 billion and $160.2 billion at March 31, 2020 and December 31, 2019 , respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.2 billion and $1.2 billion and approximately $1.1 billion and $1.1 billion of unfunded commitments at March 31, 2020 and December 31, 2019 , respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. In addition, at March 31, 2020 and December 31, 2019 , Other invested assets includes real estate held for sale of $(5) million and $(5) million , respectively, as related to one non-consolidated real estate joint venture. Non-Consolidated AB-Sponsored Investment Products As of March 31, 2020 and December 31, 2019 , the net assets of investment products sponsored by AB that are non-consolidated VIEs are approximately $80.5 billion and $79.3 billion , respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is its investment of $7 million and $8 million at March 31, 2020 and December 31, 2019 , respectively. The Company has no further commitments to or economic interest in these VIEs. Assumption Updates and Model Changes The Company conducts its annual review of its assumptions and models during the third quarter of each year. The annual review encompasses assumptions underlying the valuation of unearned revenue liabilities, embedded derivatives for our insurance business, liabilities for future policyholder benefits, DAC and deferred sales inducement assets (“DSI”). However, the Company updates its assumptions as needed in the event it becomes aware of economic conditions or events that could require a change in assumptions that it believes may have a significant impact to the carrying value of product liabilities and assets and consequently materially impact its earnings in the period of the change. Due to the extraordinary economic conditions driven by the COVID-19 pandemic in the first quarter of 2020, the Company updated its interest rate assumption to grade from the current interest rate environment to an ultimate five-year historical average over a 10-year period. As such, the 10-year U.S. Treasury yield grades from the current level to an ultimate 5-year average of 2.25% . The low interest rates environment and subsequent update to the interest rate assumption caused a loss recognition event for the Company’s life interest-sensitive products, as well as to certain run-off business. This loss recognition event caused an acceleration of DAC amortization on the life interest-sensitive products and an increase in the premium deficiency reserve on the run-off business in the first quarter of 2020. The net impact of the economic assumption update in the first quarter of 2020 increased Policyholders’ benefits by $1.4 billion , increased Amortization of DAC by $1.1 billion , increased Policy charges and fee income by $46 million and decreased Interest credited to policyholders’ account balances by $6 million . This resulted in a decrease in Income (loss) from |
INVESTMENTS
INVESTMENTS | 3 Months Ended |
Mar. 31, 2020 | |
Investments, Debt and Equity Securities [Abstract] | |
INVESTMENTS | INVESTMENTS Fixed Maturities Available-for-Sale Accounting for impairments of fixed maturities classified as AFS has changed from a direct write-down, or other-than-temporary impairment (“OTTI”) approach, to an allowance for credit loss model starting in 2020 upon adoption of the new credit impairment guidance (see Note 2, Significant Accounting Policies — Investments). The components of fair value and amortized cost for fixed maturities classified as AFS on the consolidated balance sheets excludes accrued interest receivable because the Company elected to present accrued interest receivable within Other assets. Accrued interest receivable on AFS fixed maturities at March 31, 2020 was $498 million . When the Company determines that there is more than 50% likelihood that it is not going to recover the principal and interest cash flows related to an AFS debt security, the security is placed on nonaccrual status and the Company reverses Accrued interest receivable against Interest income. Since the nonaccrual policy results in a timely reversal of Accrued interest receivable, the Company does not record an allowance for credit losses on Accrued interest receivable. The total amount of accrued interest written off for the three months ended March 31, 2020 for AFS fixed maturities was $1 million . Comparative tables as of December 31, 2019 include OTTI, reported net of tax in OCI and in AOCI until realized. The following tables provide information relating to the Company’s fixed maturities classified as AFS. AFS Fixed Maturities by Classification Amortized Cost Allowance for Credit Losses (4) Gross Unrealized Gains Gross Unrealized Losses Fair Value (in millions) March 31, 2020 (5): Fixed Maturities: Corporate (1) $ 47,408 $ 2 $ 1,760 $ 844 $ 48,322 U.S. Treasury, government and agency 14,226 — 4,407 — 18,633 States and political subdivisions 661 — 71 7 725 Foreign governments 483 — 27 12 498 Residential mortgage-backed (2) 170 — 14 — 184 Asset-backed (3) 1,514 — 6 124 1,396 Commercial mortgage-backed 37 — 2 — 39 Redeemable preferred stock 545 — 10 31 524 Total at March 31, 2020 $ 65,044 $ 2 $ 6,297 $ 1,018 $ 70,321 December 31, 2019 (5): Fixed Maturities: Corporate (1) $ 45,900 $ — $ 2,361 $ 62 $ 48,199 U.S. Treasury, government and agency 14,410 — 1,289 305 15,394 States and political subdivisions 638 — 70 3 705 Foreign governments 462 — 35 5 492 Residential mortgage-backed (2) 178 — 13 — 191 Asset-backed (3) 848 — 4 3 849 Redeemable preferred stock 501 — 17 5 513 Total at December 31, 2019 $ 62,937 $ — $ 3,789 $ 383 $ 66,343 ______________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent the allowance for credit losses for 2020 (see Note 2 Significant Accounting Policies – Investments) (5) Excludes amounts reclassified as Held-for-Sale. The contractual maturities of AFS fixed maturities at March 31, 2020 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of AFS Fixed Maturities Amortized Cost (Less Allowance for Credit Losses) Fair Value (in millions) March 31, 2020 (1) (2): Contractual maturities: Due in one year or less $ 4,680 $ 4,675 Due in years two through five 14,638 14,733 Due in years six through ten 18,606 19,091 Due after ten years 24,852 29,679 Subtotal 62,776 68,178 Amortized Cost (Less Allowance for Credit Losses) Fair Value Residential mortgage-backed 170 184 Asset-backed 1,514 1,396 Commercial-backed 37 39 Redeemable preferred stock 545 524 Total at March 31, 2020 $ 65,042 $ 70,321 ______________ (1) Net amortized cost is equal to amortized cost, less any allowance for credit losses to the extent applicable. (2) Excludes amounts reclassified as Held-for-Sale. The following table shows proceeds from sales, gross gains (losses) from sales and credit losses for AFS fixed maturities for the three months ended March 31, 2020 and 2019 : Proceeds from Sales, Gross Gains (Losses) from Sales and Credit Losses for AFS Fixed Maturities Three Months Ended March 31, 2020 2019 (in millions) Proceeds from sales $ 1,820 $ 1,450 Gross gains on sales $ 70 $ 8 Gross losses on sales $ (6 ) $ (18 ) Credit losses (1) $ (2 ) $ — ______________ (1) Commencing with the Company’s adoption of ASU 2016-13 on January 1, 2020 , credit losses on AFS debt securities were recognized as an allowance for credit losses. In 2019 and prior, credit losses on AFS fixed maturities were recognized as OTTI. The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts. AFS Fixed Maturities - Credit Loss Impairments Three Months Ended March 31, 2020 2019 (in millions) Balance at January 1, $ (21 ) $ (58 ) Previously recognized impairments on securities that matured, paid, prepaid or sold — 32 Recognized impairments on securities impaired to fair value this period (1) — — Credit losses recognized this period on securities for which credit losses were not previously recognized (2 ) — Additional credit losses this period on securities previously impaired — — Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows (for OTTI securities 2019 and prior) — — Balance at March 31, $ (23 ) $ (26 ) ______________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. Net unrealized investment gains (losses) on AFS fixed maturities are included in the consolidated balance sheets as a component of AOCI. Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net income (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which a credit loss has been recognized, and all other: Net Unrealized Gains (Losses) on AFS Fixed Maturities Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2020 $ 3,453 $ (899 ) $ (189 ) $ (497 ) $ 1,868 Net investment gains (losses) arising during the period 1,922 — — — 1,922 Reclassification adjustment: Included in Net income (loss) (62 ) — — — (62 ) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (23 ) — — (23 ) Deferred income taxes — — — (351 ) (351 ) Policyholders’ liabilities — — (165 ) — (165 ) Net unrealized investment gains (losses) excluding credit losses 5,313 (922 ) (354 ) (848 ) 3,189 Net unrealized investment gains (losses) with credit losses (7 ) 1 — 1 (5 ) Balance, March 31, 2020 $ 5,306 $ (921 ) $ (354 ) $ (847 ) $ 3,184 Balance, January 1, 2019 $ (522 ) $ 100 $ (73 ) $ 104 $ (391 ) Net investment gains (losses) arising during the period 1,710 — — — 1,710 Reclassification adjustment: Included in Net income (loss) (1 ) — — — (1 ) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (701 ) — — (701 ) Deferred income taxes — — — (230 ) (230 ) Policyholders’ liabilities — — 85 — 85 Net unrealized investment gains (losses) excluding credit losses 1,187 (601 ) 12 (126 ) 472 Net unrealized investment gains (losses) with credit losses (1) 1 — — — 1 Balance, March 31, 2019 $ 1,188 $ (601 ) $ 12 $ (126 ) $ 473 _____________ (1) Credit losses for 2019 were OTTI losses. The following tables disclose the fair values and gross unrealized losses of the 1,723 issues at March 31, 2020 and the 413 issues at December 31, 2019 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) March 31, 2020 (1): Fixed Maturities: Corporate $ 14,516 $ 750 $ 265 $ 90 $ 14,781 $ 840 U.S. Treasury, government and agency — — — — — — States and political subdivisions 188 7 — — 188 7 Foreign governments 127 5 36 8 163 13 Residential mortgage-backed 17 — 10 — 27 — Asset-backed 1,202 116 61 7 1,263 123 Commercial mortgage-backed — — — — — — Redeemable preferred stock 265 25 43 6 308 31 Total at March 31, 2020 $ 16,315 $ 903 $ 415 $ 111 $ 16,730 $ 1,014 December 31, 2019 (1) (2): Fixed Maturities: Corporate $ 2,773 $ 42 $ 373 $ 20 $ 3,146 $ 62 U.S. Treasury, government and agency 4,309 305 2 — 4,311 305 States and political subdivisions 112 3 — — 112 3 Foreign governments 11 — 47 5 58 5 Residential mortgage-backed — — — — — — Asset-backed 319 1 201 2 520 3 Commercial mortgage-backed — — — — — — Redeemable preferred stock 29 — 49 5 78 5 Total at December 31, 2019 $ 7,553 $ 351 $ 672 $ 32 $ 8,225 $ 383 ______________ (1) Excludes amounts reclassified as Held-for-Sale. (2) Amounts represents fixed maturities in an unrealized loss position that are not deemed to be other-than-temporarily impaired for 2019. The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of the Company, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.6% of total corporate securities. The largest exposures to a single issuer of corporate securities held at March 31, 2020 and December 31, 2019 were $286 million and $309 million , respectively, representing 1.3% and 2.0% of the consolidated equity of the Company. Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). At March 31, 2020 and December 31, 2019 , respectively, approximately $1.7 billion and $1.4 billion , or 2.6% and 2.3% , of the $65.0 billion and $62.9 billion aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had gross unrealized losses of $217 million and $21 million at March 31, 2020 and December 31, 2019 , respectively. At March 31, 2020 and December 31, 2019 , respectively, the $111 million and $32 million of gross unrealized losses of twelve months or more were concentrated in corporate securities, as applicable. In accordance with the policy described in Note 2 , the Company concluded that an adjustment to income for OTTI (prior to January 1, 2020) nor an allowance for credit losses (after January 1, 2020) for these securities was not warranted at either March 31, 2020 or December 31, 2019 . At March 31, 2020 and December 31, 2019 , the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis. Based on the Company’s evaluation both qualitatively and quantitatively of the drivers of the decline in fair value of fixed maturity securities, the Company determined that the unrealized loss was primarily due to increases in credit spreads and changes in credit ratings due to the impact of the COVID-19 pandemic on financial markets and assessments of fundamental risks. Mortgage Loans The Company utilizes a PD/LGD model, configured in accordance with the Company’s policies that meet the concepts in the CECL framework, to estimate expected credit losses for mortgage loans as a product of PD, LGD and the exposure at default across various economic scenarios. The PD and LGD are estimated at the loan-level based on loans’ current and forecasted risk characteristics as well as macroeconomic forecasts. The PD is estimated using both macroeconomic conditions as well as individual loan risk characteristics including loan-to-value (“LTV”) ratios, debt service coverage (“DSC”) ratios, seasoning, collateral type, geography, and underlying credit. The LGD is driven primarily by the type and value of collateral, and secondarily by expected liquidation costs and time to recovery. The model also incorporates the Company’s reasonable and supportable forecasts of the macroeconomic variables deemed to be correlated to the credit risk of its loans. The length of the reasonable and supportable forecast period is reassessed on a quarterly basis and may be adjusted as appropriate over time to be consistent with macroeconomic conditions and the environment as of the reporting date. Reversion to historical loss information is performed for periods beyond the reasonable and supportable forecast period. The components of amortized cost for mortgage loans on the consolidated balance sheets excludes accrued interest amounts because the Company presents accrued interest receivables within Other assets. Accrued interest receivable on commercial and agricultural mortgage loans at March 31, 2020 and December 31, 2019 was $ 28 million and $32 million , respectively. No accrued interest was written off for the three months ended March 31, 2020 for commercial and agricultural mortgage loans. Once mortgage loans are placed on nonaccrual status, the Company reverses accrued interest receivable against interest income. Since the nonaccrual policy results in the timely reversal of accrued interest receivable, the Company does not record an allowance for credit losses on accrued interest receivable. At March 31, 2020 , the Company had no loans for which foreclosure was probable included within the individually assessed mortgage loans, and accordingly had no associated allowance for credit losses. Allowance for Credit Losses on Mortgage Loans The change in the allowance for credit losses for commercial mortgage loans and agricultural mortgage loans during the three months ended March 31, 2020 was as follows: Three Months Ended March 31, 2020 (in millions) Allowance for credit losses on mortgage loans (1): Commercial mortgages: Beginning Balance, January 1, $ (33 ) Current-period provision for expected credit losses (11 ) Write-offs charged against the allowance — Recoveries of amounts previously written off 1 Ending Balance, Net change in allowance $ (10 ) Ending Balance, March 31 $ (43 ) Three Months Ended March 31, 2020 (in millions) Agricultural mortgages: Beginning Balance, January 1, $ (3 ) Current-period provision for expected credit losses — Write-offs charged against the allowance — Recoveries of amounts previously written off — Net change in allowance — Ending Balance, March 31 $ (3 ) Total allowance for credit losses $ (46 ) _______________ (1) See Note 2 for discussion of the transition balance. The change in the allowance for credit losses is attributable to: • increases/decreases in the loan balance due to new originations, maturing mortgages, and loan amortization; • changes in credit quality; and • changes in market assumptions primarily related to COVID-19 driven economic changes. Credit Quality Information The following tables summarize the Company’s mortgage loans segregated by risk rating exposure for the three months ended March 31, 2020 . LTV Ratios (1)(3) At March 31, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: 0% - 50% $ — $ — $ 28 $ 324 $ 213 $ 637 $ 1,202 50% - 70% 119 767 1,003 1,072 2,501 2,046 7,508 70% - 90% — 85 209 10 59 391 754 90% plus — — — — — — — Total commercial $ 119 $ 852 $ 1,240 $ 1,406 $ 2,773 $ 3,074 $ 9,464 Agricultural: 0% - 50% $ 30 $ 136 $ 164 $ 171 $ 270 $ 834 $ 1,605 50% - 70% 38 165 187 126 145 420 1,081 70% - 90% — — 3 — — 16 19 90% plus — — — — — — — Total agricultural $ 68 $ 301 $ 354 $ 297 $ 415 $ 1,270 $ 2,705 Total mortgage loans: 0% - 50% $ 30 $ 136 $ 192 $ 495 $ 483 $ 1,471 $ 2,807 50% - 70% 157 932 1,190 1,198 2,646 2,466 8,589 70% - 90% — 85 212 10 59 407 773 90% plus — — — — — — — Total mortgage loans $ 187 $ 1,153 $ 1,594 $ 1,703 $ 3,188 $ 4,344 $ 12,169 Debt Service Coverage Ratios (2)(3) At March 31, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: Greater than 2.0x $ 119 $ 373 $ 680 $ 583 $ 2,242 $ 1,340 $ 5,337 1.8x to 2.0x — 184 48 379 40 451 1,102 1.5x to 1.8x — 242 223 332 491 577 1,865 1.2x to 1.5x — — 207 75 — 590 872 1.0x to 1.2x — 53 82 37 — 116 288 Less than 1.0x — — — — — — — Total commercial $ 119 $ 852 $ 1,240 $ 1,406 $ 2,773 $ 3,074 $ 9,464 Agricultural Greater than 2.0x $ 3 $ 38 $ 41 $ 37 $ 77 $ 189 $ 385 1.8x to 2.0x 7 30 15 17 22 102 193 1.5x to 1.8x 26 39 47 49 62 249 472 1.2x to 1.5x 12 127 150 121 174 413 997 1.0x to 1.2x 17 57 92 72 61 276 575 Less than 1.0x 3 10 9 1 19 41 83 Total agricultural $ 68 $ 301 $ 354 $ 297 $ 415 $ 1,270 $ 2,705 Total mortgage loans Greater than 2.0x $ 122 $ 411 $ 721 $ 620 $ 2,319 $ 1,529 $ 5,722 1.8x to 2.0x 7 214 63 396 62 553 1,295 1.5x to 1.8x 26 281 270 381 553 826 2,337 1.2x to 1.5x 12 127 357 196 174 1,003 1,869 1.0x to 1.2x 17 110 174 109 61 392 863 Less than 1.0x 3 10 9 1 19 41 83 Total mortgage loans $ 187 $ 1,153 $ 1,594 $ 1,703 $ 3,188 $ 4,344 $ 12,169 ______________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (3) Amounts presented at amortized cost basis. The following tables provide information relating to the LTV and DSC ratios for commercial and agricultural mortgage loans at March 31, 2020 and December 31, 2019 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by LTV and DSC Ratios DSC Ratio (2) (3) LTV Ratio (1) (3): Greater than 2.0x 1.8x to 1.5x to 1.2x to 1.0x to Less than Total (in millions) March 31, 2020: Mortgage loans: Commercial: 0% - 50% $ 942 $ 21 $ 214 $ 25 $ — $ — $ 1,202 50% - 70% 4,143 983 1,437 704 241 — 7,508 70% - 90% 252 98 214 143 47 — 754 90% plus — — — — — — — Total commercial $ 5,337 $ 1,102 $ 1,865 $ 872 $ 288 $ — $ 9,464 Agricultural: 0% - 50% $ 304 $ 110 $ 252 $ 558 $ 333 $ 48 $ 1,605 50% - 70% 81 83 220 420 242 35 1,081 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total agricultural $ 385 $ 193 $ 472 $ 997 $ 575 $ 83 $ 2,705 Total mortgage loans: 0% - 50% $ 1,246 $ 131 $ 466 $ 583 $ 333 $ 48 $ 2,807 50% - 70% 4,224 1,066 1,657 1,124 483 35 8,589 70% - 90% 252 98 214 162 47 — 773 90% plus — — — — — — — Total mortgage loans $ 5,722 $ 1,295 $ 2,337 $ 1,869 $ 863 $ 83 $ 12,169 December 31, 2019: Mortgage loans: Commercial: 0% - 50% $ 903 $ 38 $ 214 $ 25 $ — $ — $ 1,180 50% - 70% 4,097 1,195 1,118 795 242 — 7,447 70% - 90% 251 98 214 154 46 — 763 90% plus — — — — — — — Total commercial $ 5,251 $ 1,331 $ 1,546 $ 974 $ 288 $ — $ 9,390 Agricultural: 0% - 50% $ 322 $ 104 $ 241 $ 545 $ 321 $ 50 $ 1,583 50% - 70% 82 87 236 426 251 33 1,115 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total agricultural $ 404 $ 191 $ 477 $ 990 $ 572 $ 83 $ 2,717 Total mortgage loans: 0% - 50% $ 1,225 $ 142 $ 455 $ 570 $ 321 $ 50 $ 2,763 50% - 70% 4,179 1,282 1,354 1,221 493 33 8,562 70% - 90% 251 98 214 173 46 — 782 90% plus — — — — — — — Total mortgage loans $ 5,655 $ 1,522 $ 2,023 $ 1,964 $ 860 $ 83 $ 12,107 ______________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (3) Amounts presented at amortized cost basis. Past-Due and Nonaccrual Mortgage Loan Status The following table provides information relating to the aging analysis of past-due mortgage loans at March 31, 2020 and December 31, 2019 , respectively. Age Analysis of Past Due Mortgage Loans (1) Accruing Loans Non-accruing Loans Total Loans Non-accruing Loans with No allowance Interest Income on Non-accruing Loans Past Due Current Total 30-59 Days 60-89 Days 90 Days or More Total (in millions) March 31, 2020: Mortgage loans: Commercial $ — $ — $ — $ — $ 9,464 $ 9,464 $ — $ 9,464 $ — $ — Agricultural 7 17 63 87 2,618 2,705 — 2,705 — — Total $ 7 $ 17 $ 63 $ 87 $ 12,082 $ 12,169 $ — $ 12,169 $ — $ — December 31, 2019: Mortgage loans: Commercial $ — $ — $ — $ — $ 9,390 $ 9,390 $ — $ 9,390 $ — $ — Agricultural 57 1 66 124 2,593 2,717 — 2,717 — — Total $ 57 $ 1 $ 66 $ 124 $ 11,983 $ 12,107 $ — $ 12,107 $ — $ — _______________ (1) Amounts presented at amortized cost basis. At March 31, 2020 and December 31, 2019 , the carrying values of problem mortgage loans that had been classified as non-accrual loans were $0 million and $0 million , respectively. Trading Securities At March 31, 2020 and December 31, 2019 , respectively, the fair value of the Company’s trading securities was $6.5 billion and $7.0 billion . At March 31, 2020 and December 31, 2019 , respectively, trading securities included the General Account’s investment in Separate Accounts which had carrying values of $46 million and $58 million . Net unrealized and realized gains (losses) on trading securities are included in Net investment income (loss) in the consolidated statements of income (loss). The table below shows a breakdown of Net investment income (loss) from trading securities during the three months ended March 31, 2020 and 2019 : Net Investment Income (Loss) from Trading Securities Three Months Ended March 31, 2020 2019 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ (186 ) $ 318 Net investment gains (losses) recognized on securities sold during the period 4 (24 ) Unrealized and realized gains (losses) on trading securities (182 ) 294 Interest and dividend income from trading securities 51 92 Net investment income (loss) from trading securities $ (131 ) $ 386 |
DERIVATIVES
DERIVATIVES | 3 Months Ended |
Mar. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVES | DERIVATIVES The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of Treasury Inflation-Protected Securities (“TIPS”), which is discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (Conditional Tail Expectation, or “CTE”, is a statistical measure of tail risk which quantifies the total asset requirement to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.) Derivatives Utilized to Hedge Exposure to Variable Annuities with Guarantee Features The Company has issued and continues to offer variable annuity products with GMxB features. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features’ benefits being higher than what accumulated policyholders’ account balances would support. For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. The reinsurance of the GMIB features is accounted for as a derivative. The Company has in place an economic hedge program using interest rate swaps and U.S. Treasury futures to partially protect the overall profitability of future variable annuity sales against declining interest rates. Derivatives Utilized to Hedge Crediting Rate Exposure on SCS, SIO, MSO and IUL Products/Investment Options The Company hedges crediting rates in the Structured Capital Strategies (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST variable annuity series (“SIO”), Market Stabilizer Option (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment. In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers, thereby substantially reducing any exposure to market-related earnings volatility. Derivatives Used to Hedge Equity Market Risks Associated with the General Account’s Seed Money Investments in Retail Mutual Funds The Company’s General Account seed money investments in retail mutual funds expose us to market risk, including equity market risk which is partially hedged through equity-index futures contracts to minimize such risk. Derivatives Used to Hedge Universal Life Products with Secondary Guarantee (“ULSG”) Policy The Company implemented a hedge program using fixed income total return swaps to mitigate the interest rate exposure in the ULSG policy statutory liability. Derivatives Used for General Account Investment Portfolio The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of credit default swaps (“CDSs”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net derivative gains (losses). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDSs in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDSs. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the dollar or euro-equivalent of the derivative’s notional amount. The Standard North American CDS Contract (“SNAC”) or Standard European Corporate Contract (“STEC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative. The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond. The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category At March 31, 2020 Three Months Ended March 31, 2020 Fair Value Notional Amount Derivative Assets Derivative Liabilities Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 6,317 $ 2 $ 5 $ 220 Swaps 12,947 585 124 3,778 Options 30,050 2,547 3,086 (3,851 ) Interest rate contracts: Swaps 22,896 2,475 343 3,578 Futures 26,713 — — 1,988 Swaptions — — — 9 Credit contracts: Credit default swaps 1,507 26 22 (1 ) Other freestanding contracts: Foreign currency contracts 430 9 8 (2 ) Margin — 107 171 — Collateral — 29 3,757 — Embedded derivatives: GMIB reinsurance contracts (3) — 2,823 — 726 GMxB derivative features liability (4) — — 9,727 (1,198 ) SCS, SIO, MSO and IUL indexed features (5) — — (940 ) 4,154 Total derivative instruments $ 100,860 $ 8,603 $ 16,303 Net derivative gains (losses) $ 9,401 ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets. Derivative Instruments by Category At December 31, 2019 Three Months Ended March 31, 2019 Fair Value Notional Amount Derivative Assets Derivative Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 4,257 $ 1 $ 1 $ (762 ) Swaps 17,156 9 281 (985 ) Options 47,861 5,098 1,752 1,111 Interest rate contracts: Swaps 23,793 468 526 648 Futures 20,901 — — 56 Swaptions 3,201 16 — — Credit contracts: Credit default swaps 1,400 21 6 7 Other freestanding contracts: Foreign currency contracts 559 12 9 10 Margin — 155 — — Collateral — 74 3,016 — Embedded derivatives: GMIB reinsurance contracts (3) 2,139 — 18 GMxB derivative features liability (4) — — 8,432 (408 ) SCS, SIO, MSO and IUL indexed features (5) — — 3,268 (1,325 ) Total derivative instruments $ 119,128 $ 7,993 $ 17,291 Net derivative gains (losses) $ (1,630 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets. Equity-Based and Treasury Futures Contracts Margin All outstanding equity-based and treasury futures contracts at March 31, 2020 and December 31, 2019 are exchange-traded and net settled daily in cash. At March 31, 2020 and December 31, 2019 , respectively, the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000 and Emerging Market indices, having initial margin requirements of $466 million and $252 million , (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $651 million and $166 million , and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200 and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $159 million and $60 million . Collateral Arrangements The Company generally has executed a Credit Support Annex (“CSA”) under the International Swaps and Derivatives Association Master Agreement (“ISDA Master Agreement”) it maintains with each of its over-the-counter (“OTC”) derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. At March 31, 2020 and December 31, 2019 , respectively, the Company held $3.8 billion and $3.0 billion in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in Other invested assets. The Company posted collateral of $29 million and $74 million at March 31, 2020 and December 31, 2019 , respectively, in the normal operation of its collateral arrangements. The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at March 31, 2020 : Offsetting of Financial Assets and Liabilities and Derivative Instruments At March 31, 2020 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount (in millions) Assets: Derivative assets (1) $ 5,779 $ 5,522 $ 257 $ (162 ) $ 95 Other financial assets 1,855 — 1,855 — 1,855 Other invested assets $ 7,634 $ 5,522 $ 2,112 $ (162 ) $ 1,950 Liabilities: Derivative liabilities (2) $ 7,354 $ 5,522 $ 1,832 $ — $ 1,832 Other financial liabilities 3,884 — 3,884 — 3,884 Other liabilities $ 11,238 $ 5,522 $ 5,716 $ — $ 5,716 ______________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Primarily financial instrument sent (held). The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2019 : Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2019 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount (in millions) Assets: Derivative assets (1) $ 5,852 $ 5,466 $ 386 $ (77 ) $ 309 Other financial instruments 2,394 — 2,394 — 2,394 Other invested assets $ 8,246 $ 5,466 $ 2,780 $ (77 ) $ 2,703 Liabilities: Derivative liabilities (2) $ 5,512 $ 5,466 $ 46 $ — $ 46 Other financial liabilities 3,924 — 3,924 — 3,924 Other liabilities $ 9,436 $ 5,466 $ 3,970 $ — $ 3,970 ______________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Primarily financial instrument sent (held). |
GOODWILL
GOODWILL | 3 Months Ended |
Mar. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
GOODWILL | GOODWILL Goodwill represents the excess of purchase price over the estimated fair value of identifiable net assets acquired in a business combination. The Company tests goodwill for recoverability each annual reporting period at December 31 and at interim periods if facts or circumstances are indicative of potential impairment. The carrying value of goodwill from the Company’s Investment Management and Research segment totaled $4.6 billion at both March 31, 2020 and December 31, 2019 , resulting primarily from its investment in AB as well as direct strategic acquisitions of AB, including its purchase of Sanford C. Bernstein, Inc. For purpose of testing this goodwill for impairment, the Company applied a discounted cash flow valuation technique to measure the fair value of the reporting unit, sourcing the underlying cash flows and assumptions from AB’s current business plan projections and adjusting the result to reflect the noncontrolling interest in AB as well as incremental taxes at the Company level as related to the form and structure of its investment in AB. During the first quarter of 2020, the unit price of AB declined significantly in response to the precipitous decline in the financial markets. As such, the Company performed an interim impairment evaluation of goodwill utilizing the discounted cash flow valuation technique and considered the results along with a number of other factors (including current market conditions) and determined that the fair value of the reporting unit exceeded its carrying value at March 31, 2020 . As such, no goodwill impairment existed. The Company will continue to monitor and evaluate any events that may indicate an impairment of goodwill. |
CLOSED BLOCK
CLOSED BLOCK | 3 Months Ended |
Mar. 31, 2020 | |
Closed Block Disclosure [Abstract] | |
CLOSED BLOCK | CLOSED BLOCK As a result of demutualization, the Company’s Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders. Assets allocated to the Closed Block inure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of the Company’s General Account, any of its Separate Accounts or any affiliate of the Company without the approval of the New York State Department of Financial Services (the “NYDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account. For more information on the Closed Block, see Note 5 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2019 . Summarized financial information for the Company’s Closed Block is as follows: March 31, 2020 December 31, 2019 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,404 $ 6,478 Policyholder dividend obligation — 2 Other liabilities 76 38 Total Closed Block liabilities 6,480 6,518 Assets Designated to the Closed Block: Fixed maturities available-for-sale, at fair value, net of allowance for credit losses of $0 and $0 (amortized cost of $3,557 and $3,558) 3,684 3,754 Mortgage loans on real estate, net of allowance for credit losses of $4 and $0 1,742 1,759 Policy loans 676 706 Cash and other invested assets 112 82 Other assets 133 145 Total assets designated to the Closed Block 6,347 6,446 March 31, 2020 December 31, 2019 (in millions) Excess of Closed Block liabilities over assets designated to the Closed Block 133 72 Amounts included in accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation: $0 and $(2); and net of income tax: $27 and $41 111 164 Maximum future earnings to be recognized from Closed Block assets and liabilities $ 244 $ 236 The Company’s Closed Block revenues and expenses were as follows: Three Months Ended March 31, 2020 2019 (in millions) Revenues: Premiums and other income $ 42 $ 48 Net investment income (loss) 66 67 Investment gains (losses), net — (1 ) Total revenues 108 114 Benefits and Other Deductions: Policyholders’ benefits and dividends 103 121 Other operating costs and expenses — 1 Total benefits and other deductions 103 122 Net income (loss), before income taxes 5 (8 ) Income tax (expense) benefit — (1 ) Net income (loss) $ 5 $ (9 ) |
INSURANCE LIABILITIES
INSURANCE LIABILITIES | 3 Months Ended |
Mar. 31, 2020 | |
Insurance [Abstract] | |
INSURANCE LIABILITIES | INSURANCE LIABILITIES Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following: • Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals); • Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals); • Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages; • Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or • Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life. Liabilities for Variable Annuity Contracts with GMDB and GMIB Features without No-Lapse Guarantee Rider (“NLG”) Feature The change in the liabilities for variable annuity contracts with GMDB and GMIB features and without a NLG guarantee rider feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) and assumed contracts are reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities. The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three Months Ended March 31, 2020 and 2019 GMDB GMIB Direct Assumed Ceded Direct Assumed Ceded (in millions) Balance at January 1, 2020 4,784 76 (105 ) 4,691 187 (2,139 ) Paid guarantee benefits (111 ) (6 ) 5 (74 ) (1 ) 20 Other changes in reserve 379 2 (11 ) 1,682 33 (704 ) Balance at March 31, 2020 $ 5,052 $ 72 $ (111 ) $ 6,299 $ 219 $ (2,823 ) Balance at January 1, 2019 4,659 82 (113 ) 3,743 184 (1,732 ) Paid guarantee benefits (118 ) (6 ) 4 (56 ) (1 ) 21 Other changes in reserve 129 1 — 55 (1 ) (29 ) Balance at March 31, 2019 $ 4,670 $ 77 $ (109 ) $ 3,742 $ 182 $ (1,740 ) Liabilities for Embedded and Freestanding Insurance Related Derivatives The liability for the GMxB derivative features, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives, see Note 8 . Account Values and Net Amount at Risk Account Values and Net Amount at Risk (“NAR”) for direct and assumed variable annuity contracts in force with GMDB and GMIB features as of March 31, 2020 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive. Direct Variable Annuity Contracts with GMDB and GMIB Features at March 31, 2020 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,662 $ 92 $ 58 $ 176 $ 14,988 Separate Accounts 40,733 7,887 2,607 27,713 78,940 Total Account Values $ 55,395 $ 7,979 $ 2,665 $ 27,889 $ 93,928 Net Amount at Risk, gross $ 715 $ 877 $ 2,296 $ 22,881 $ 26,769 Net Amount at Risk, net of amounts reinsured $ 715 $ 857 $ 1,647 $ 22,881 $ 26,100 Average attained age of policyholders (in years) 51.1 67.8 74.4 69.6 55.1 Percentage of policyholders over age 70 10.7 % 46.4 % 68.7 % 51.6 % 19.5 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 18 $ 228 $ 246 Separate Accounts — — 20,724 29,476 50,200 Total Account Values $ — $ — $ 20,742 $ 29,704 $ 50,446 Net Amount at Risk, gross $ — $ — $ 1,360 $ 17,568 $ 18,928 Net Amount at Risk, net of amounts reinsured $ — $ — $ 425 $ 15,774 $ 16,199 Average attained age of policyholders (in years) N/A N/A 68.9 69.7 69.6 Weighted average years remaining until annuitization N/A N/A 1.6 0.3 0.4 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Assumed Variable Annuity Contracts with GMDB and GMIB Features at March 31, 2020 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rates) Variable annuity contracts with GMDB features Reinsured Account Values $ 776 $ 4,352 $ 225 $ 946 $ 6,299 Net Amount at Risk assumed $ 13 $ 627 $ 22 $ 263 $ 925 Average attained age of policyholders (in years) 68 73 78 76 73 Percentage of policyholders over age 70 46.3 % 65.2 % 80.7 % 75.8 % 65.0 % Range of contractually specified interest rates (1) N/A N/A 3%-10% 5%-10% 3%-10% Variable annuity contracts with GMIB features Reinsured Account Values $ 744 $ 37 $ 190 $ 956 $ 1,927 Net Amount at Risk assumed $ 2 $ 3 $ 46 $ 445 $ 496 Average attained age of policyholders (in years) 72 74 72 69 71 Percentage of policyholders over age 70 65.1 % 62.8 % 61.5 % 53.8 % 59.1 % Range of contractually specified interest rates N/A N/A 3.3%-6.5% 6%-6% 3.3%-6.5% ______________ (1) In general, for policies with the highest contractual interest rate shown (10%), the rate applied only for the first 10 years after issue, which has now elapsed. For more information about the reinsurance programs of the Company’s GMDB and GMIB exposure, see “Reinsurance” in Note 11 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2019 . Separate Accounts Investments by Investment Category Underlying Variable Annuity Contracts with GMDB and GMIB Features The total Account Values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related Account Values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds March 31, 2020 December 31, 2019 Mutual Fund Type GMDB GMIB GMDB GMIB (in millions) Equity $ 32,913 $ 13,765 $ 42,489 $ 17,941 Fixed income 5,151 2,680 5,263 2,699 Balanced 39,965 33,483 45,871 38,445 Other 911 272 865 263 Total $ 78,940 $ 50,200 $ 94,488 $ 59,348 Hedging Programs for GMDB, GMIB, GIB and Other Features The Company has a program intended to hedge certain risks associated first with the GMDB feature and with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured. These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in Net derivative gains (losses) in the period in which they occur, and may contribute to income (loss) volatility. Variable and Interest-Sensitive Life Insurance Policies – NLG The NLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The NLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements. The change in the fair value of the NLG feature, reflected in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets, is summarized in the table below. Direct Liability (1) Three Months Ended March 31, 2020 2019 (in millions) Balance at January 1, (2) 897 812 Paid guarantee benefits (13 ) (7 ) Other changes in reserves 41 20 Balance at March 31, $ 925 $ 825 ______________ (1) There were no amounts of reinsurance ceded in any period presented. (2) The beginning balance for March 31, 2020 was reduced by $22 million to reflect the balance transferred to Assets held-for-sale at December 31, 2019. |
FAIR VALUE DISCLOSURES
FAIR VALUE DISCLOSURES | 3 Months Ended |
Mar. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE DISCLOSURES | FAIR VALUE DISCLOSURES The accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value: Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness. Assets and Liabilities Measured at Fair Value on a Recurring Basis Assets and liabilities measured at fair value on a recurring basis are summarized below. At March 31, 2020 and December 31, 2019 , no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an impairment or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. Fair Value Measurements at March 31, 2020 (1) Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, AFS: Corporate (2) $ — $ 47,137 $ 1,185 $ 48,322 U.S. Treasury, government and agency — 18,633 — 18,633 States and political subdivisions — 689 36 725 Foreign governments — 498 — 498 Residential mortgage-backed (3) — 184 — 184 Asset-backed (4) — 1,356 40 1,396 Commercial mortgage-backed — 39 — 39 Redeemable preferred stock 252 272 — 524 Total fixed maturities, AFS 252 68,808 1,261 70,321 Other equity investments 12 — 87 99 Trading securities 438 6,059 37 6,534 Other invested assets: Short-term investments — 142 — 142 Assets of consolidated VIEs/VOEs 98 365 16 479 Swaps — 2,594 — 2,594 Credit default swaps — 4 — 4 Futures (3 ) — — (3 ) Options — (539 ) — (539 ) Swaptions — — — — Total other invested assets 95 2,566 16 2,677 Cash equivalents 9,026 — — 9,026 Segregated securities — 2,013 — 2,013 GMIB reinsurance contracts asset — — 2,823 2,823 Separate Accounts assets (5) 102,853 2,632 — 105,485 Total Assets $ 112,676 $ 82,078 $ 4,224 $ 198,978 Liabilities GMxB derivative features’ liability $ — $ — $ 9,727 $ 9,727 SCS, SIO, MSO and IUL indexed features’ liability — (940 ) — (940 ) Liabilities of consolidated VIEs and VOEs 1 19 — 20 Contingent payment arrangements — — 24 24 Total Liabilities $ 1 $ (921 ) $ 9,751 $ 8,831 ______________ (1) Excludes amounts reclassified as Held-for-Sale. (2) Corporate fixed maturities includes both public and private issues. (3) Includes publicly traded agency pass-through securities and collateralized obligations. (4) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (5) Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At March 31, 2020 , the fair value of such investments was $361 million . Fair Value Measurements at December 31, 2019 (1) Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, AFS: Corporate (2) $ — $ 46,942 $ 1,257 $ 48,199 U.S. Treasury, government and agency — 15,394 — 15,394 States and political subdivisions — 666 39 705 Foreign governments — 492 — 492 Residential mortgage-backed (3) — 191 — 191 Asset-backed (4) — 749 100 849 Commercial mortgage-backed (3) — — — — Redeemable preferred stock 239 274 — 513 Total fixed maturities, AFS 239 64,708 1,396 66,343 Other equity investments 13 — 97 110 Trading securities 500 6,495 36 7,031 Other invested assets: Short-term investments — 490 — 490 Assets of consolidated VIEs/VOEs 132 457 17 606 Swaps — (327 ) — (327 ) Credit default swaps — 15 — 15 Options — 3,346 — 3,346 Swaptions — 16 — 16 Total other invested assets 132 3,997 17 4,146 Cash equivalents 3,497 — — 3,497 Segregated securities — 1,095 — 1,095 GMIB reinsurance contracts asset — — 2,139 2,139 Separate Accounts assets (5) 123,432 2,892 — 126,324 Total Assets $ 127,813 $ 79,187 $ 3,685 $ 210,685 Liabilities GMxB derivative features’ liability $ — $ — $ 8,432 $ 8,432 SCS, SIO, MSO and IUL indexed features’ liability — 3,268 — 3,268 Liabilities of consolidated VIEs and VOEs 1 9 — 10 Contingent payment arrangements — — 23 23 Total Liabilities $ 1 $ 3,277 $ 8,455 $ 11,733 ______________ (1) Excludes amounts reclassified as Held-for-Sale. (2) Corporate fixed maturities includes both public and private issues. (3) Includes publicly traded agency pass-through securities and collateralized obligations. (4) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (5) Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At December 31, 2019 , the fair value of such investments was $356 million . Public Fixed Maturities The fair values of the Company’s public fixed maturities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. Private Fixed Maturities The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made. Freestanding Derivative Positions The net fair value of the Company’s freestanding derivative positions as disclosed in Note 4 are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. Level Classifications of the Company’s Financial Instruments Financial Instruments Classified as Level 1 Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less and are carried at cost as a proxy for fair value measurement due to their short-term nature. Financial Instruments Classified as Level 2 Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated by AB in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Exchange Act and for which fair values are based on quoted yields in secondary markets. Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors. Certain Company products, such as the SCS and EQUI-VEST variable annuity products, IUL and the MSO fund available in some life contracts offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected can currently have one, three, five or six year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g., holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers. Financial Instruments Classified as Level 3 The Company’s investments classified as Level 3 primarily include corporate debt securities, such as private fixed maturities and asset-backed securities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. Level 3 also includes the GMIB reinsurance contract assets, which are accounted for as derivative contracts. The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios. The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity Separate Accounts funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the swap curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset and liabilities and GMIBNLG feature to reflect the claims-paying ratings of counterparties and the Company. Equity and fixed income volatilities were modeled to reflect current market volatilities. Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations. After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $381 million and $110 million at March 31, 2020 and December 31, 2019 , respectively, to recognize incremental counterparty non-performance risk and reduced the fair value of its GMIB reinsurance contract liabilities by $74 million and $25 million at March 31, 2020 and December 31, 2019 , respectively, to recognize its own incremental non-performance risk. Lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected. The Company’s Level 3 liabilities include contingent payment arrangements associated with acquisitions in 2016 and 2019 by AB. At each reporting date, AB estimates the fair values of the contingent consideration expected to be paid based upon revenue and discount rate projections, using unobservable market data inputs, which are included in Level 3 of the valuation hierarchy. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, primarily corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities. Transfers of Financial Instruments Between Levels 2 and 3 During the three months ended March 31, 2020 , AFS fixed maturities with fair values of $126 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $0 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.6% of total equity at March 31, 2020 . During the three months ended March 31, 2019 , AFS fixed maturities with fair values of $69 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $17 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.6% of total equity at March 31, 2019 . The tables below present reconciliations for all Level 3 assets and liabilities at March 31, 2020 and 2019 , respectively: Level 3 Instruments - Fair Value Measurements Corporate State and Asset- (in millions) Balance, January 1, 2020 $ 1,257 $ 39 $ 100 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 1 — — Investment gains (losses), net (2 ) — — Subtotal (1 ) — — Other comprehensive income (loss) (61 ) (3 ) (8 ) Purchases 61 — 48 Sales (45 ) — — Transfers into Level 3 (1) — — — Transfers out of Level 3 (1) (26 ) — (100 ) Balance, March 31, 2020 $ 1,185 $ 36 $ 40 Balance, January 1, 2019 $ 1,186 $ 39 $ 519 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 1 — — Investment gains (losses), net — — — Subtotal 1 — — Other comprehensive income (loss) 9 1 4 Purchases 70 — 11 Sales (34 ) — — Transfers into Level 3 (1) 17 — — Transfers out of Level 3 (1) (69 ) — — Balance, March 31, 2019 $ 1,180 $ 40 $ 534 _____________ (1) Transfers into/out of the Level 3 classification are reflected at beginning of period fair values. Other Equity Investments GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability Contingent Payment Arrangement (in millions) Balance, January 1, 2020 $ 150 $ 2,139 $ — $ (8,432 ) $ (23 ) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net 7 — — — — Net derivative gains (losses), excluding non-performance risk — 955 — (3,884 ) — Non-performance risk (1) — (229 ) — 2,686 — Total realized and unrealized gains (losses) 7 726 — (1,198 ) — Other comprehensive income (loss) (7 ) — — — — Purchases (2) 2 10 — (111 ) — Sales (3) (11 ) (20 ) — 14 — Settlements (4) — — — — — Change in estimate (5) — (32 ) — — — Activity related to consolidated VIEs/VOEs (1 ) — — — (1 ) Transfers into Level 3 (6) — — — — — Transfers out of Level 3 (6) — — — — — Balance, March 31, 2020 $ 140 $ 2,823 $ — $ (9,727 ) $ (24 ) Balance, January 1, 2019 $ 165 $ 1,732 $ 21 $ (5,614 ) $ (7 ) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — — Net derivative gains (losses), excluding non-performance risk — (11 ) — 63 — Non-performance risk (1) — 29 — (470 ) — Total realized and unrealized gains (losses) — 18 — (407 ) — Other comprehensive income (loss) — — — — — Purchases (2) 2 11 4 (111 ) — Sales (3) — (21 ) — 6 — Settlements (4) — — (1 ) — — Change in estimate — — — — — Activity related to consolidated VIEs/VOEs (1 ) — — — — Transfers into Level 3 (6) — — — — — Transfers out of Level 3 (6) (29 ) — (1 ) — — Balance, March 31, 2019 $ 137 $ 1,740 $ 23 $ (6,126 ) $ (7 ) ______________ (1) The Company’s non-performance risk is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset, and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) For contingent payment arrangements, it represents payments under the arrangement. (5) For the GMIB reinsurance contract asset, represents a transfer from amounts due from reinsurers. (6) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. The table below details changes in unrealized gains (losses) for the three months ended March 31, 2020 and 2019 by category for Level 3 assets and liabilities still held at March 31, 2020 and 2019 , respectively. Change in Unrealized Gains (Losses) for Level 3 Instruments Net Income (Loss) Net Derivative Gains (Losses) OCI (in millions) Held at March 31, 2020: Change in unrealized gains (losses): Fixed maturities, AFS Corporate $ — $ (61 ) State and political subdivisions — (2 ) Asset-backed — (8 ) Total fixed maturities, AFS — (71 ) GMIB reinsurance contracts 726 — GMxB derivative features liability (1,198 ) — Total $ (472 ) $ (71 ) Held at March 31, 2019: Change in unrealized gains (losses): Fixed maturities, AFS Corporate $ — $ 9 State and political subdivisions — 1 Asset-backed — 4 Total fixed maturities, AFS — 14 GMIB reinsurance contracts 18 — GMxB derivative features liability (408 ) — Total $ (390 ) $ 14 Quantitative and Qualitative Information about Level 3 Fair Value Measurements The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at March 31, 2020 and December 31, 2019 , respectively. Quantitative Information about Level 3 Fair Value Measurements at March 31, 2020 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 63 Matrix pricing model Spread over Benchmark 15 - 580 bps 264 bps 1,034 Market comparable EBITDA multiples 3.2x - 31.5x 14.0x Other equity investments 37 Discounted cash flow Earnings multiple 8.0x GMIB reinsurance contract asset 2,823 Discounted cash flow Non-performance risk 144 - 293 bps 233 bps Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) Liabilities: GMIBNLG 9,308 Discounted cash flow Non-performance risk 304 bps Assumed GMIB Reinsurance Contracts 218 Discounted cash flow Non-performance risk 201 - 419 bps 357 bps GWBL/GMWB 146 Discounted cash flow Non-performance risk 304 bps GIB 38 Discounted cash flow Non-performance risk 304 bps GMAB 17 Discounted cash flow Non-performance risk 304 bps ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. (2) For Lapses, Withdrawals, and Utilizations the rates were weighted by counts, for Mortality weighted average rates are shown for all ages combined and for Withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2019 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 57 Matrix pricing model Spread over benchmark 65 - 580 bps 184 bps 1,025 Market comparable companies EBITDA multiples 3.3x - 56.7x 14.3x Other equity investments 36 Discounted cash flow Earnings multiple 8.0x GMIB reinsurance contract asset 2,139 Discounted cash flow Non-performance risk 55 - 109 bps Fair Valuation Significant Range Weighted Average Liabilities: GMIBNLG 8,128 Discounted cash flow Non-performance risk 124 bps Assumed GMIB Reinsurance Contracts 186 Discounted cash flow Non-performance risk 61 - 141 bps GWBL/GMWB 109 Discounted cash flow Non-performance risk 124 bps GIB 5 Discounted cash flow Non-performance risk 124 bps GMAB 4 Discounted cash flow Lapse rates 1.0% - 10.0% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Level 3 Financial Instruments for which Quantitative Inputs are Not Available Certain Privately Placed Debt Securities with Limited Trading Activity Excluded from the tables above at March 31, 2020 and December 31, 2019 , respectively, are approximately $267 million and $428 million of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments. • The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities. • Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above at March 31, 2020 and December 31, 2019 , there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities. • Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit tenant loans, and equipment financings. Included in the tables above at March 31, 2020 and December 31, 2019 , there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would have resulted in significantly lower (higher) fair value measurements. Other Equity Investments Included in other equity investments classified as Level 3 are reporting entities’ venture capital securities in the Technology, Media and Telecommunications industries. The fair value measurements of these securities include significant unobservable inputs including an enterprise value to revenue multiples and a discount rate to account for liquidity and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple inputs in isolation would have resulted in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount rate would have resulted in a significantly lower (higher) fair value measurement. GMIB Reinsurance Con |
EMPLOYEE BENEFIT PLANS
EMPLOYEE BENEFIT PLANS | 3 Months Ended |
Mar. 31, 2020 | |
Retirement Benefits [Abstract] | |
Employee Benefit Plans | EMPLOYEE BENEFIT PLANS Pension Plans Holdings and Equitable Life Retirement Plans Holdings sponsors the MONY Life Retirement Income Security Plan for Employees and Equitable Life sponsors the AXA Equitable Retirement Plan (the “AXA Equitable Life QP”), both of which are frozen qualified defined benefit plans covering eligible employees and financial professionals. These pension plans are non-contributory, and their benefits are generally based on a cash balance formula and/or, for certain participants, years of service and average earnings over a specified period. Holdings and Equitable Life also sponsor certain nonqualified defined benefit plans, including the AXA Equitable Excess Retirement Plan, that provide retirement benefits in excess of the amount permitted under the tax law for the qualified plans. Holdings has assumed primary liability for both plans. Equitable Life remains secondarily liable for its obligations under the AXA Equitable Life QP and would recognize such liability in the event Holdings does not perform. AB Retirement Plans AB maintains a qualified, non-contributory, defined benefit retirement plan covering current and former employees who were employed by AB in the United States prior to October 2, 2000 (the “AB Plan”). Benefits under the AB Plan are based on years of credited service, average final base salary, and primary Social Security benefits. Net Periodic Pension Expense Components of net periodic pension expense for the Company’s qualified and non-qualified plans were as follows: Three Months Ended March 31, 2020 2019 (in millions) Service cost $ 2 $ 2 Interest cost 16 22 Expected return on assets (37 ) (38 ) Actuarial (gain) loss — — Net amortization 22 20 Net periodic pension expense $ 3 $ 6 |
INCOME TAXES
INCOME TAXES | 3 Months Ended |
Mar. 31, 2020 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES Income tax expense for the three months ended March 31, 2020 and 2019 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Mar. 31, 2020 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | RELATED PARTY TRANSACTIONS The Company did not enter into any new significant transactions with related parties during the three months ended March 31, 2020 . |
EQUITY
EQUITY | 3 Months Ended |
Mar. 31, 2020 | |
Equity [Abstract] | |
EQUITY | EQUITY Dividends to Shareholders Dividends declared per share of each class of stock were as follows for the periods indicated: Three Months Ended March 31, 2020 2019 Dividends declared per share of common stock $ 0.15 $ 0.13 Dividends declared per depositary share (1) $ 0.39 $ — _______________ (1) Represents a 1/1,000th interest in a share of preferred stock. Share Repurchase On November 6, 2019, Holdings’ Board of Directors authorized a $400 million share repurchase program with an expiration date of December 31, 2020. On February 26, 2020, Holdings’ Board of Directors authorized an increase of $600 million to the capacity of this program as well as the extension of the term of the program until March 31, 2021. Under this program, Holdings may, from time to time through March 31, 2021, purchase up to $1.0 billion of its common stock but it is not obligated to purchase any particular number of shares. Repurchases may be effected in the open market, through derivative, accelerated repurchase and other negotiated transactions and through prearranged trading plans complying with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). During the quarter ended March 31, 2020 , the Holdings repurchased 13.7 million shares of its common stock in the open market. As of March 31, 2020 , Holdings had capacity of approximately $395 million remaining in its stock repurchase program. Accumulated Other Comprehensive Income (Loss) AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of March 31, 2020 and 2019 follow: March 31, 2020 2019 (in millions) Unrealized gains (losses) on investments $ 3,272 $ 430 Defined benefit pension plans (955 ) (919 ) Foreign currency translation adjustments (78 ) (63 ) Total accumulated other comprehensive income (loss) 2,239 (552 ) Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest (50 ) (39 ) Accumulated other comprehensive income (loss) attributable to Holdings $ 2,289 $ (513 ) The components of OCI, net of taxes for the three months ended March 31, 2020 and 2019 follow: Three Months Ended March 31, 2020 2019 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the period $ 1,513 $ 1,342 (Gains) losses reclassified into net income (loss) during the period (1) (47 ) 9 Net unrealized gains (losses) on investments 1,466 1,351 Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (32 ) (517 ) Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $382 and $218) 1,434 834 Change in defined benefit plans: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost 28 49 Change in defined benefit plans (net of deferred income tax expense (benefit) of $7 and $12) 28 49 Foreign currency translation adjustments: Foreign currency translation gains (losses) arising during the period (21 ) (1 ) (Gains) losses reclassified into net income (loss) during the period — — Foreign currency translation adjustment (21 ) (1 ) Total other comprehensive income (loss), net of income taxes 1,441 882 Less: Other comprehensive income (loss) attributable to noncontrolling interest (8 ) (1 ) Other comprehensive income (loss) attributable to Holdings $ 1,449 $ 883 _______________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts presented net of income tax expense (benefit) of $(12) million and $2 million for the three months ended March 31, 2020 and 2019 , respectively Investment gains and losses reclassified from AOCI to Net income (loss) primarily consist of realized gains (losses) on sales and credit losses of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to Net income (loss) as related to defined benefit plans primarily consist of amortization of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefits in the consolidated statements of income (loss). Amounts presented in the table above are net of tax. |
REDEEMABLE NONCONTROLLING INTER
REDEEMABLE NONCONTROLLING INTEREST | 3 Months Ended |
Mar. 31, 2020 | |
Noncontrolling Interest [Abstract] | |
REDEEMABLE NONCONTROLLING INTEREST | REDEEMABLE NONCONTROLLING INTEREST The changes in the components of redeemable noncontrolling interests are presented in the table that follows: Three Months Ended March 31, 2020 2019 (in millions) Balance, beginning of period $ 365 $ 38 Net earnings (loss) attributable to redeemable noncontrolling interests (30 ) 12 Purchase/change of redeemable noncontrolling interests (78 ) 157 Balance, end of period $ 257 $ 207 |
COMMITMENTS AND CONTINGENT LIAB
COMMITMENTS AND CONTINGENT LIABILITIES | 3 Months Ended |
Mar. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENT LIABILITIES | COMMITMENTS AND CONTINGENT LIABILITIES Litigation Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of March 31, 2020 , the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $100 million . For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. In August 2015, a lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from Equitable Life, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that Equitable Life implemented the volatility management strategy in violation of applicable law. Plaintiff seeks an award of damages individually and on a classwide basis, and costs and disbursements, including attorneys’ fees, expert witness fees and other costs. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted Equitable Life’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. In April 2018, the United States Court of Appeals for the Second Circuit reversed the trial court’s decision with instructions to remand the case to Connecticut state court. In September 2018, the Second Circuit issued its mandate, following Equitable Life’s notification to the court that it would not file a petition for writ of certiorari. The case was transferred in December 2018 and is pending in Connecticut Superior Court, Judicial District of Stamford. We are vigorously defending this matter. In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life (“UL”) policies subject to Equitable Life’s COI rate increase. In early 2016, Equitable Life raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in Arizona in 2017 and consolidated with the Brach matter. The current consolidated amended class action complaint alleges the following claims: breach of contract; misrepresentations by Equitable Life in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; and violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek: (a) compensatory damages, costs, and, pre- and post-judgment interest; (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class; and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. Five other federal actions challenging the COI rate increase are also pending against Equitable Life and have been coordinated with the Brach action for the purposes of pre-trial activities. They contain allegations similar to those in the Brach action as well as additional allegations for violations of various states’ consumer protection statutes and common law fraud. Three actions are also pending against Equitable Life in New York state court. Equitable Life is vigorously defending each of these matters. Pre-Capitalized Trust Securities (“P-Caps”) In April 2019, pursuant to separate Purchase Agreements among Holdings, Credit Suisse Securities (USA) LLC, as representative of the several initial purchasers, and the Trusts (as defined below), Pine Street Trust I, a Delaware statutory trust (the “2029 Trust”), completed the issuance and sale of 600,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2029 (the “2029 P-Caps”) for an aggregate purchase price of $600 million and Pine Street Trust II, a Delaware statutory trust (the “2049 Trust” and, together with the 2029 Trust, the “Trusts”), completed the issuance and sale of 400,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2049 (the “2049 P-Caps” and, together with the 2029 P-Caps, the “P-Caps”) for an aggregate purchase price of $400 million in each case to qualified institutional buyers in reliance on Rule 144A that are also “qualified purchasers” for purposes of Section 3(c)(7) of the Investment Company Act of 1940, as amended. The P-Caps are an off-balance sheet contingent funding arrangement that, upon Holdings’ election, gives Holdings the right over a ten-year period (in the case of the 2029 Trust) or over a thirty-year period (in the case of the 2049 Trust) to issue senior notes to the Trusts. The Trusts each invested the proceeds from the sale of their P-Caps in separate portfolios of principal and/or interest strips of U.S. Treasury securities. In return, Holdings will pay a semi-annual facility fee to the 2029 Trust and 2049 Trust calculated at a rate of 2.125% and 2.715% per annum, respectively, which will be applied to the unexercised portion of the contingent funding arrangement and Holdings will reimburse the Trusts for certain expenses. The facility fees are recorded in Other operating costs and expenses in the Consolidated Statements of Income (Loss). Obligations under Funding Agreements Federal Home Loan Bank of New York As a member of the FHLBNY, Equitable Life has access to collateralized borrowings. It also may issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require Equitable Life to pledge qualified mortgage-backed assets and/or government securities as collateral. Equitable Life issues short-term funding agreements to the FHLBNY and uses the funds for asset, liability, and cash management purposes. Equitable Life issues long-term funding agreements to the FHLBNY and uses the funds for spread lending purposes. Entering into FHLBNY membership, borrowings and funding agreements requires the ownership of FHLBNY stock and the pledge of assets as collateral. Equitable Life has purchased FHLBNY stock of $315 million and pledged collateral with a carrying value of $9.8 billion , as of March 31, 2020 . Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset/liability and cash management purposes, see “Derivative and offsetting assets and liabilities” included in Note 4 . The table below summarizes the Company’s activity of funding agreements with the FHLBNY. Change in FHLBNY Funding Agreements during the Three Months Ended March 31, 2020 Outstanding Balance at December 31, 2019 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Outstanding Balance at March 31, 2020 (in millions) Short-term funding agreements: Due in one year or less $ 4,608 $ 11,750 $ 11,900 $ 174 $ 4,632 Long-term funding agreements: Due in years two through five 1,646 — — (174 ) 1,472 Due in more than five years 646 — — — 646 Total long-term funding agreements 2,292 — — (174 ) 2,119 Total funding agreements (1) $ 6,900 $ 11,750 $ 11,900 $ — $ 6,750 _____________ (1) The $9 million and $9 million difference between the funding agreements carrying value shown in fair value table for March 31, 2020 and December 31, 2019 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates. Guarantees and Other Commitments The Company provides certain guarantees or commitments to affiliates and others. At March 31, 2020 , these arrangements include commitments by the Company to provide equity financing of $1.1 billion (including $220 million with affiliates) to certain limited partnerships and real estate joint ventures under certain conditions. Management believes the Company will not incur material losses as a result of these commitments. The Company is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, the Company owns single premium annuities issued by previously wholly-owned life insurance subsidiaries. The Company has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly-owned subsidiaries be unable to meet their obligations. Management believes the need for the Company to satisfy those obligations is remote. Holdings had $426 million of commitments under existing mortgage loan agreements at March 31, 2020 . |
BUSINESS SEGMENT INFORMATION
BUSINESS SEGMENT INFORMATION | 3 Months Ended |
Mar. 31, 2020 | |
Segment Reporting [Abstract] | |
BUSINESS SEGMENT INFORMATION | BUSINESS SEGMENT INFORMATION The Company has four reportable segments: Individual Retirement, Group Retirement, Investment Management and Research and Protection Solutions. These segments reflect the manner by which the Company’s chief operating decision maker views and manages the business. A brief description of these segments follows: • The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income. • The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses. • The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels- Institutional, Retail and Private Wealth Management-and distributes its institutional research products and solutions through Bernstein Research Services. • The Protection Solutions segment includes our life insurance and group employee benefits businesses. Our life insurance business offers a variety of variable universal life, universal life and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of dental, vision, life, and short- and long-term disability and other insurance products to small and medium-size businesses across the United States. Measurement Operating earnings (loss) is the financial measure which primarily focuses on the Company’s segments’ results of operations as well as the underlying profitability of the Company’s core business. By excluding items that can be distortive and unpredictable such as investment gains (losses) and investment income (loss) from derivative instruments, the Company believes Operating earnings (loss) by segment enhances the understanding of the Company’s underlying drivers of profitability and trends in the Company’s segments. Operating earnings is calculated by adjusting each segment’s Net income (loss) attributable to Holdings for the following items: • Items related to variable annuity product features, which include: (i) certain changes in the fair value of the derivatives and other securities we use to hedge these features; (ii) the effect of benefit ratio unlock adjustments related to extraordinary economic conditions or events such as COVID-19; and (iii) changes in the fair value of the embedded derivatives reflected within variable annuity products’ net derivative results and the impact of these items on DAC amortization on our SCS product. • Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances; • Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations, and the one-time impact of the settlement of the defined benefit obligation; • Other adjustments, which includes restructuring costs related to severance, lease write-offs related to non-recurring restructuring activities, separation costs and impacts related to COVID-19; and • Income tax expense (benefit) related to the above items and non-recurring tax items, which includes the effect of uncertain tax positions for a given audit period and permanent differences due to the Tax Reform Act. Revenues derived from any customer did not exceed 10% of revenues for the three months ended March 31, 2020 and 2019 . The table below presents Operating earnings (loss) by segment and Corporate and Other and a reconciliation to Net income (loss) attributable to Holdings for the three months ended March 31, 2020 and 2019 , respectively: Three Months Ended March 31, 2020 2019 (in millions) Net income (loss) attributable to Holdings $ 5,410 $ (775 ) Adjustments related to: Variable annuity product features (1) (6,861 ) 1,540 Investment (gains) losses (4 ) 11 Net actuarial (gains) losses related to pension and other postretirement benefit obligations 27 24 Other adjustments (2) (3) 634 40 Income tax expense (benefit) related to above adjustments (4) 1,303 (337 ) Non-recurring tax items 6 6 Non-GAAP Operating Earnings $ 515 $ 509 Three Months Ended March 31, 2020 2019 (in millions) Operating earnings (loss) by segment: Individual Retirement $ 372 $ 370 Group Retirement $ 106 $ 81 Investment Management and Research $ 95 $ 77 Protection Solutions $ 38 $ 49 Corporate and Other (5) $ (96 ) $ (68 ) ______________ (1) Includes COVID Impact on Variable annuity product features due to assumption update of $1.5 billion and other COVID-19 related impacts of $35 million three months ended March 31, 2020 . (2) Includes assumption updates due to COVID-19 of $1.0 billion and other COVID-19 related impacts of $51 million three months ended March 31, 2020 . (3) Include separation costs of $32 million and $24 million for the three months ended March 31, 2020 and 2019 , respectively. (4) Includes income taxes of $(534) million for the above COVID-19 items for the three months ended March 31, 2020 . (5) Includes interest expense and financing fees of $56 million and $52 million for the three months ended March 31, 2020 and 2019 , respectively. Segment revenues is a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to Total revenues by excluding the following items: • Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features; • Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances; • Other adjustments, which includes investment income (loss) from certain derivative instruments, excluding derivative instruments used to hedge risks associated with interest margins on interest sensitive life and annuity contracts and freestanding and embedded derivatives associated with products with GMxB features. The table below presents segment revenues for the three months ended March 31, 2020 and 2019 . Three Months Ended March 31, 2020 2019 (in millions) Segment revenues: Individual Retirement (1) $ 1,481 $ 1,007 Group Retirement (1) 282 251 Investment Management and Research (2) 907 780 Protection Solutions (1) 859 831 Corporate and Other (1) 299 312 Adjustments related to: Variable annuity product features 8,339 (1,478 ) Investment gains (losses), net 4 (11 ) Other adjustments to segment revenues (3) 422 22 Total revenues $ 12,593 $ 1,714 ______________ (1) Includes investment expenses charged by AB of $18 million and $18 million for the three months ended March 31, 2020 and 2019 , respectively, for services provided to the Company. (2) Inter-segment investment management and other fees of $27 million and $25 million for the three months ended March 31, 2020 and 2019 , respectively, are included in segment revenues of the Investment Management and Research segment. (3) Includes assumption updates due to COVID-19 of $46 million and other COVID-19 related impacts of $(51) million for the three months ended March 31, 2020 . The table below presents Total assets by segment as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (in millions) Total assets by segment: Individual Retirement $ 117,299 $ 123,626 Group Retirement 41,194 43,588 Investment Management and Research 11,915 10,170 Protection Solutions 45,266 46,886 Corporate and Other 25,107 25,600 Total assets $ 240,781 $ 249,870 |
EARNINGS PER COMMON SHARE
EARNINGS PER COMMON SHARE | 3 Months Ended |
Mar. 31, 2020 | |
Earnings Per Share [Abstract] | |
EARNINGS PER COMMON SHARE | EARNINGS PER COMMON SHARE Earnings per common share — basic is calculated by dividing Net income (loss) attributable to Holdings’ common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per common share is calculated by dividing the Net income (loss) available to Holdings’ common shareholders by the weighted-average number of common shares outstanding for the period plus the shares representing the dilutive effect of share-based awards. The following table presents the weighted-average shares outstanding and Earnings per common share — basic and diluted: Three Months Ended March 31, 2020 2019 (in millions) Weighted-average common shares outstanding: Weighted-average common shares outstanding — basic 461.0 518.0 Effect of dilutive potential common shares: Employee share awards (1) 2.5 — Weighted-average common shares outstanding — diluted (2) 463.5 518.0 Net income (loss): Net income (loss) $ 5,447 $ (709 ) Less: Net income (loss) attributable to the noncontrolling interest 37 66 Net income (loss) attributable to Holdings 5,410 (775 ) Less: Preferred stock dividends 13 — Net income (loss) available to Holdings’ common shareholders 5,397 (775 ) Earnings per common share: Basic $ 11.71 $ (1.50 ) Diluted $ 11.65 $ (1.50 ) _____________ (1) Calculated using the treasury stock method. (2) Due to net loss for the three months ended March 31, 2019 , approximately 1 million more shares were excluded from the diluted earnings per common share calculation than would have been excluded as being anti-dilutive under the treasury stock method. For the three months ended March 31, 2020 and 2019 , 6.0 million and 5.3 million outstanding stock awards, respectively, were not included in the computation of diluted earnings per share because their effect was anti-dilutive. |
HELD-FOR-SALE
HELD-FOR-SALE | 3 Months Ended |
Mar. 31, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
HELD-FOR-SALE | HELD-FOR-SALE : Assets and liabilities related to the business classified as held-for-sale are separately reported in the Consolidated Balance Sheets beginning in the period in which the business is classified as held-for-sale. U.S. Financial Life Insurance Company and MONY Life Insurance Company of the Americas, Ltd On December 10, 2019, Holdings entered into a definitive agreement to sell U.S. Financial Life Insurance Company (“USFL”) and MONY Life Insurance Company of the Americas, Ltd (“MLICA”), indirect wholly-owned subsidiaries of Holdings. As a result of the agreement, an estimated impairment of $105 million , net of income tax, was recorded during the quarter ended December 31, 2019 and was included in Investment gains (losses), net in the consolidated statements of income (loss). During the quarter ended March 31, 2020, the Company recorded an additional impairment of $39 million , net of income tax. At March 31, 2020 and December 31, 2019 , respectively, USFL and MLICA had total assets of $843 million and $962 million which is reported in Assets held-for-sale and $679 million and $724 million of total liabilities reported in Liabilities held-for-sale. The assets held-for-sale are reported in the Protection Solutions segment. The transaction closed on April 1, 2020. See Note 18 for further detail of the sale. The following table summarizes the components of assets and liabilities held-for-sale on the consolidated balance sheets at March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (in millions) Assets: Fixed maturity securities $ 860 $ 896 Trading securities, at fair value 14 17 Policy loans 20 19 Cash and cash equivalents 41 65 Amounts due from reinsurers 41 43 Deferred policy acquisition costs 31 31 Other assets 18 24 Assets held-for-sale 1,025 1,095 Less: Loss accrual (182 ) (133 ) Total assets held-for-sale $ 843 $ 962 Liabilities: Policyholders’ account balances $ 279 $ 286 Future policy benefits and other policyholders’ liabilities 398 421 Amounts due to reinsurers (2 ) 6 Other liabilities 4 11 Total liabilities held-for-sale $ 679 $ 724 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2020 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | SUBSEQUENT EVENTS U.S. Financial Life Insurance Company and MONY Life Insurance Company of the Americas, Ltd On December 10, 2019, Holdings entered into a definitive agreement to sell USFL and MLICA. Accordingly, the assets and liabilities of USFL and MLICA were reported as “held-for-sale” in the Company’s consolidated balance sheets as of March 31, 2020 and December 31, 2019. In addition, the Company recognized an impairment loss in Investment gains (losses), net in the consolidated statements of income (loss) of $39 million and $105 million , net of income tax, during the quarters ended March 31, 2020 and December 31, 2019, respectively, as further described in Note 17 . This transaction closed on April 1, 2020. COVID-19 Pandemic The Company has evaluated the effects of events subsequent to March 31, 2020 , and through the date of the filing of these unaudited consolidated financial statements with the Securities and Exchange Commission. Subsequent to March 31, 2020 |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Principles of Consolidation | Basis of Presentation and Principles of Consolidation The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature, with the exception of the Company’s update of its interest rate assumption as further described in Assumption Updates and Model Changes. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . The accompanying consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. All significant intercompany transactions and balances have been eliminated in consolidation. The terms “ first quarter 2020 ” and “ first quarter 2019 ” refer to the three months ended March 31, 2020 and 2019 , respectively. |
Adoption of New Accounting Pronouncements and Future Adoption of New Accounting Pronouncements | Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2016-13 : Financial Instruments—Credit Losses (Topic 326), as clarified and amended by ASU 2018-19: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, ASU 2019-04: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU 2019-05: Financial Instruments—Credit Losses (Topic 326) Targeted Transition Relief, ASU 2019-11: Codification Improvements to Topic 326, Financial Instruments—Credit Losses ASU 2016-13 contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. ASU 2019-05 provides entities that have instruments within the scope of Subtopic 326-20 an option to irrevocably elect the fair value option on an instrument-by instrument basis upon adoption of Topic 326. ASU 2018-19, ASU 2019-04 and ASU 2019-11 clarified the codification guidance and did not materially change the standard. On January 1, 2020, the Company adopted the new standard and completed implementation of its updated expected credit loss models, processes and controls related to the identified financial assets that fall within the scope of the new standard. Upon adoption, the Company recorded a cumulative effect adjustment to reduce the opening retained earnings balance by approximately $40 million, on a pre-tax and pre-DAC basis. The adjustment is primarily attributable to an increase in the allowance for credit losses associated with the Company’s commercial and agricultural mortgage loan portfolios and reinsurance. Results for reporting periods beginning after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported in accordance with previously applicable GAAP. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. The Company elected to early adopt during 2019 the removed disclosures relating to transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and valuation processes for Level 3 fair value measurements. The Company adopted the additional disclosures related to Level 3 fair value information on January 1, 2020. ASU 2018-17 : Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The Company adopted this new standard effective for January 1, 2020. Adoption of this standard did not materially impact the Company’s financial position or results of operations. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944); ASU 2019-09: Financial Services - Insurance (Topic 944): Effective Date This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: In November 2019, ASU 2019-09 was issued which modified ASU 2018-12 to be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on the Company’s consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary, update cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in Accumulated other comprehensive income (“AOCI”) or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred policy acquisition costs. For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. For deferred policy acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, as well as clarifying and amending existing guidance. Effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact adopting the guidance will have on the Company’s consolidated financial statements, however the adoption is not expected to materially impact the Company’s financial position, results of operation, or cash flows. ASU2020-04 : Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting The amendments in this ASU provide optional expedients and exceptions to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective as of March 12, 2020 through December 31, 2022. The Company will determine the applicability of the optional expedients and exceptions provided under the ASU as reference rate reform continues to develop. |
Investments | Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in other comprehensive income (“OCI”), net of allowance for credit losses, policy related amounts and deferred income taxes. With the adoption of the new Financial Instruments-Credit Losses standard, changes in credit losses are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, evaluates AFS debt securities that experienced a decline in fair value below amortized cost for credit losses which are evaluated in accordance with the new financial instruments credit losses guidance effective January 1, 2020. Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security has experienced a credit loss. This assessment includes, but is not limited to, consideration of the severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity and continued viability of the issuer. The Company recognizes an allowance for credit losses on AFS debt securities with a corresponding adjustment to earnings rather than a direct write down that reduces the cost basis of the investment, and credit losses are limited to the amount by which the security’s amortized cost basis exceeds its fair value. Any improvements in estimated credit losses on AFS debt securities are recognized immediately in earnings. Management does not use the length of time a security has been in an unrealized loss position as a factor, either by itself or in combination with other factors, to conclude that a credit loss does not exist, as they were permitted to do prior to January 1, 2020. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting allowance is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. Write-offs of AFS debt securities are recorded when all or a portion of a financial asset is deemed uncollectible. Full or partial write-offs are recorded as reductions to the amortized cost basis of the AFS debt security and deducted from the allowance in the period in which the financial assets are deemed uncollectible. The Company elected to reverse accrued interest deemed uncollectible as a reversal of interest income. In instances where the Company collects cash that it has previously written off, the recovery will be recognized through earnings or as a reduction of the amortized cost basis for interest and principal, respectively. Real estate held for the production of income is stated at depreciated cost less allowance for credit losses.Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies, and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag. Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the consolidated statements of income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At March 31, 2020 and December 31, 2019 , the carrying value of COLI was $872 million and $944 million , respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. Cash and securities segregated primarily includes U.S. Treasury Bills segregated by AB in a special reserve bank custody account for the exclusive benefit of its brokerage customers under Rule 15c3-3 of the Exchange Act. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis. Commercial and Agricultural Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and the allowance for credit losses. The Company calculates the allowance for credit losses in accordance with the current expected credit losses (“CECL”) model in order to provide for the risk of credit losses in the lending process. Expected credit losses for loans with similar risk characteristics are estimated on a collective (i.e., pool) basis in order to meet CECL’s risk of loss concept which requires the Company to consider possibilities of loss, even if remote. For collectively evaluated mortgages, the Company estimates the allowance for credit losses based on the amortized cost basis of its mortgages over their expected life using a probability of default (“PD”) / loss given default (“LGD”) model. The PD/LGD model incorporates the Company’s reasonable and supportable forecast of macroeconomic information over a specified period. For periods beyond the reasonable and supportable forecast period, the model reverts to historical loss information. The CECL model is configured to the Company’s specifications and takes into consideration the detailed risk attributes of each discrete loan in the mortgage portfolio which include, but are not limited to the following: • Loan-to-value (“LTV”) ratio - Derived from current loan balance divided by the fair market value of the property. An LTV ratio in excess of 100% indicates an underwater mortgage. • Debt service coverage (“DSC”) ratio - Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0x, then the income from the property does not support the debt. • Occupancy - Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations - The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Other - Any other factors such as maturity, borrower/tenant related issues, payment status, property condition, or current economic conditions may call into question the performance of the loan. For individually evaluated mortgages, the Company continues to recognize an allowance on the present value of expected future cash flows discounted at the loan’s original effective interest rate or on its collateral value. Mortgage loans that do not share similar risk characteristics with other loans in the portfolio are individually evaluated quarterly by the Company’s IUS Committee. The allowance for credit losses on these individually evaluated mortgages is a loan-specific reserve as a result of the loan review process that is recorded based on the present value of expected future cash flows discounted at the loan’s effective interest rate or based on the fair value of the collateral. The individually assessed allowance for mortgage loans can increase or decrease from period to period based on such factors. Individually assessed loans may include, but are not limited to, mortgages that have deteriorated in credit quality such as troubled debt restructurings (“TDR”) and reasonably expected TDRs, mortgages for which foreclosure is probable, and mortgages which have been classified as “potential problem” or “problem” loans within the Company’s IUS Committee processes as described below. Within the IUS process, Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problem mortgages but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being modified. The decision whether to classify a performing mortgage loan as a potential problem involves judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. Individually assessed mortgage loans without provision for losses are mortgage loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on mortgage loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on mortgage loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Mortgage loans are placed on nonaccrual status once management believes the collection of accrued interest is not probable. Once mortgage loans are classified as nonaccrual mortgage loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan has been restructured to where the collection of interest is considered likely. The Company charges off loan balances and accrued interest that are deemed uncollectible. Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses) Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the allowance for credit losses are included in Investment gains (losses), net. Realized and unrealized holding gains (losses) on trading and equity securities are reflected in Net investment income (loss). Unrealized investment gains (losses) on fixed maturities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, as are amounts attributable to certain pension operations, Closed Block’s policyholders’ dividend obligation, insurance liability loss recognition, DAC related to UL policies, investment-type products and participating traditional life policies. Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities classified as AFS and do not reflect any change in fair value of policyholders’ account balances and future policy benefits. |
Accounting and Consolidation of VIEs | Accounting and Consolidation of VIEs For all new investment products and entities developed by the Company (other than Collateralized Debt Obligations (“CDOs”)), the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, the Company then identifies the primary beneficiary of the VIE. If the Company is deemed to be the primary beneficiary of the VIE, then the Company consolidates the entity. Management of the Company reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client assets under management (“AUM”) to determine the entities that the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships. The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate. Consolidated VIEs At March 31, 2020 and December 31, 2019 , the Company consolidated one real estate joint venture for which it was identified as the primary beneficiary under the VIE model. The consolidated entity is jointly owned by Equitable Life and AXA France and holds an investment in a real estate venture. Included in Other invested assets in the Company’s consolidated balance sheets at March 31, 2020 and December 31, 2019 are total assets of $32 million and $32 million , respectively, related to this VIE, primarily resulting from the consolidated presentation of this real estate joint venture as real estate held for sale. Consolidated AB-Sponsored Investment Funds Included in the Company’s consolidated balance sheet at March 31, 2020 and December 31, 2019 are assets of $377 million and $424 million , liabilities of $73 million and $12 million , and redeemable noncontrolling interests of $179 million and $273 million , respectively, associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets at March 31, 2020 and December 31, 2019 are assets of $193 million and $188 million , liabilities of $32 million and $19 million , and redeemable noncontrolling interests of $46 million and $52 million , respectively, from consolidation of AB-sponsored investment funds under the VOE model. The assets of these consolidated funds are presented within Other invested assets and Cash and cash equivalents, and liabilities of these consolidated funds are presented with Other liabilities in the Company’s consolidated balance sheets; ownership interests not held by the Company relating to consolidated VIEs and VOEs are presented either as redeemable or non-redeemable noncontrolling interests, as appropriate. Redeemable noncontrolling interests are presented in mezzanine equity and non-redeemable noncontrolling interests are presented within permanent equity. The Company is not required to provide financial support to these Company-sponsored investment funds, and only the assets of such funds are available to settle each fund’s own liabilities. Non-Consolidated VIEs At March 31, 2020 and December 31, 2019 , respectively, the Company held approximately $1.2 billion and $1.2 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as Other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $151.4 billion and $160.2 billion at March 31, 2020 and December 31, 2019 , respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $1.2 billion and $1.2 billion and approximately $1.1 billion and $1.1 billion of unfunded commitments at March 31, 2020 and December 31, 2019 , respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations. In addition, at March 31, 2020 and December 31, 2019 , Other invested assets includes real estate held for sale of $(5) million and $(5) million , respectively, as related to one non-consolidated real estate joint venture. Non-Consolidated AB-Sponsored Investment Products As of March 31, 2020 and December 31, 2019 , the net assets of investment products sponsored by AB that are non-consolidated VIEs are approximately $80.5 billion and $79.3 billion , respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is its investment of $7 million and $8 million at March 31, 2020 and December 31, 2019 , respectively. The Company has no further commitments to or economic interest in these VIEs. |
SIGNIFICANT ACCOUNTING POLICI_3
SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Accounting Policies [Abstract] | |
Schedule of New Accounting Pronouncements and Changes in Accounting Principles | Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2016-13 : Financial Instruments—Credit Losses (Topic 326), as clarified and amended by ASU 2018-19: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, ASU 2019-04: Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments and ASU 2019-05: Financial Instruments—Credit Losses (Topic 326) Targeted Transition Relief, ASU 2019-11: Codification Improvements to Topic 326, Financial Instruments—Credit Losses ASU 2016-13 contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. ASU 2019-05 provides entities that have instruments within the scope of Subtopic 326-20 an option to irrevocably elect the fair value option on an instrument-by instrument basis upon adoption of Topic 326. ASU 2018-19, ASU 2019-04 and ASU 2019-11 clarified the codification guidance and did not materially change the standard. On January 1, 2020, the Company adopted the new standard and completed implementation of its updated expected credit loss models, processes and controls related to the identified financial assets that fall within the scope of the new standard. Upon adoption, the Company recorded a cumulative effect adjustment to reduce the opening retained earnings balance by approximately $40 million, on a pre-tax and pre-DAC basis. The adjustment is primarily attributable to an increase in the allowance for credit losses associated with the Company’s commercial and agricultural mortgage loan portfolios and reinsurance. Results for reporting periods beginning after January 1, 2020 are presented under ASU 2016-13 while prior period amounts continue to be reported in accordance with previously applicable GAAP. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. The Company elected to early adopt during 2019 the removed disclosures relating to transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and valuation processes for Level 3 fair value measurements. The Company adopted the additional disclosures related to Level 3 fair value information on January 1, 2020. ASU 2018-17 : Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. The Company adopted this new standard effective for January 1, 2020. Adoption of this standard did not materially impact the Company’s financial position or results of operations. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944); ASU 2019-09: Financial Services - Insurance (Topic 944): Effective Date This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: In November 2019, ASU 2019-09 was issued which modified ASU 2018-12 to be effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2021. Early adoption is permitted. The Company is currently evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements, however the adoption of the ASU is expected to have a significant impact on the Company’s consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary, update cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in Accumulated other comprehensive income (“AOCI”) or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred policy acquisition costs. For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented. For deferred policy acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. ASU 2019-12: Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes This ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740, as well as clarifying and amending existing guidance. Effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the impact adopting the guidance will have on the Company’s consolidated financial statements, however the adoption is not expected to materially impact the Company’s financial position, results of operation, or cash flows. ASU2020-04 : Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting The amendments in this ASU provide optional expedients and exceptions to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. This ASU is effective as of March 12, 2020 through December 31, 2022. The Company will determine the applicability of the optional expedients and exceptions provided under the ASU as reference rate reform continues to develop. |
INVESTMENTS (Tables)
INVESTMENTS (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Investments, Debt and Equity Securities [Abstract] | |
Available-for-Sale Fixed Maturities by Classification | The following tables provide information relating to the Company’s fixed maturities classified as AFS. AFS Fixed Maturities by Classification Amortized Cost Allowance for Credit Losses (4) Gross Unrealized Gains Gross Unrealized Losses Fair Value (in millions) March 31, 2020 (5): Fixed Maturities: Corporate (1) $ 47,408 $ 2 $ 1,760 $ 844 $ 48,322 U.S. Treasury, government and agency 14,226 — 4,407 — 18,633 States and political subdivisions 661 — 71 7 725 Foreign governments 483 — 27 12 498 Residential mortgage-backed (2) 170 — 14 — 184 Asset-backed (3) 1,514 — 6 124 1,396 Commercial mortgage-backed 37 — 2 — 39 Redeemable preferred stock 545 — 10 31 524 Total at March 31, 2020 $ 65,044 $ 2 $ 6,297 $ 1,018 $ 70,321 December 31, 2019 (5): Fixed Maturities: Corporate (1) $ 45,900 $ — $ 2,361 $ 62 $ 48,199 U.S. Treasury, government and agency 14,410 — 1,289 305 15,394 States and political subdivisions 638 — 70 3 705 Foreign governments 462 — 35 5 492 Residential mortgage-backed (2) 178 — 13 — 191 Asset-backed (3) 848 — 4 3 849 Redeemable preferred stock 501 — 17 5 513 Total at December 31, 2019 $ 62,937 $ — $ 3,789 $ 383 $ 66,343 ______________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent the allowance for credit losses for 2020 (see Note 2 Significant Accounting Policies – Investments) (5) Excludes amounts reclassified as Held-for-Sale. |
Contractual Maturities of Available-for-Sale Fixed Maturities | The contractual maturities of AFS fixed maturities at March 31, 2020 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of AFS Fixed Maturities Amortized Cost (Less Allowance for Credit Losses) Fair Value (in millions) March 31, 2020 (1) (2): Contractual maturities: Due in one year or less $ 4,680 $ 4,675 Due in years two through five 14,638 14,733 Due in years six through ten 18,606 19,091 Due after ten years 24,852 29,679 Subtotal 62,776 68,178 Amortized Cost (Less Allowance for Credit Losses) Fair Value Residential mortgage-backed 170 184 Asset-backed 1,514 1,396 Commercial-backed 37 39 Redeemable preferred stock 545 524 Total at March 31, 2020 $ 65,042 $ 70,321 ______________ (1) Net amortized cost is equal to amortized cost, less any allowance for credit losses to the extent applicable. (2) Excludes amounts reclassified as Held-for-Sale. |
Proceeds and Gains (Losses) on Sales for Available-for-Sale Fixed Maturities | The following table shows proceeds from sales, gross gains (losses) from sales and credit losses for AFS fixed maturities for the three months ended March 31, 2020 and 2019 : Proceeds from Sales, Gross Gains (Losses) from Sales and Credit Losses for AFS Fixed Maturities Three Months Ended March 31, 2020 2019 (in millions) Proceeds from sales $ 1,820 $ 1,450 Gross gains on sales $ 70 $ 8 Gross losses on sales $ (6 ) $ (18 ) Credit losses (1) $ (2 ) $ — ______________ (1) Commencing with the Company’s adoption of ASU 2016-13 on January 1, 2020 , credit losses on AFS debt securities were recognized as an allowance for credit losses. In 2019 and prior, credit losses on AFS fixed maturities were recognized as OTTI. |
AFS Fixed Maturities - Credit Loss Impairments | The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts. AFS Fixed Maturities - Credit Loss Impairments Three Months Ended March 31, 2020 2019 (in millions) Balance at January 1, $ (21 ) $ (58 ) Previously recognized impairments on securities that matured, paid, prepaid or sold — 32 Recognized impairments on securities impaired to fair value this period (1) — — Credit losses recognized this period on securities for which credit losses were not previously recognized (2 ) — Additional credit losses this period on securities previously impaired — — Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows (for OTTI securities 2019 and prior) — — Balance at March 31, $ (23 ) $ (26 ) ______________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. |
Net Unrealized Gains (Losses) on Available-for-Sale Fixed Maturities | The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which a credit loss has been recognized, and all other: Net Unrealized Gains (Losses) on AFS Fixed Maturities Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2020 $ 3,453 $ (899 ) $ (189 ) $ (497 ) $ 1,868 Net investment gains (losses) arising during the period 1,922 — — — 1,922 Reclassification adjustment: Included in Net income (loss) (62 ) — — — (62 ) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (23 ) — — (23 ) Deferred income taxes — — — (351 ) (351 ) Policyholders’ liabilities — — (165 ) — (165 ) Net unrealized investment gains (losses) excluding credit losses 5,313 (922 ) (354 ) (848 ) 3,189 Net unrealized investment gains (losses) with credit losses (7 ) 1 — 1 (5 ) Balance, March 31, 2020 $ 5,306 $ (921 ) $ (354 ) $ (847 ) $ 3,184 Balance, January 1, 2019 $ (522 ) $ 100 $ (73 ) $ 104 $ (391 ) Net investment gains (losses) arising during the period 1,710 — — — 1,710 Reclassification adjustment: Included in Net income (loss) (1 ) — — — (1 ) Excluded from Net income (loss) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (701 ) — — (701 ) Deferred income taxes — — — (230 ) (230 ) Policyholders’ liabilities — — 85 — 85 Net unrealized investment gains (losses) excluding credit losses 1,187 (601 ) 12 (126 ) 472 Net unrealized investment gains (losses) with credit losses (1) 1 — — — 1 Balance, March 31, 2019 $ 1,188 $ (601 ) $ 12 $ (126 ) $ 473 _____________ (1) Credit losses for 2019 were OTTI losses. |
Continuous Gross Unrealized Losses for Available-for-Sale Fixed Maturities | The following tables disclose the fair values and gross unrealized losses of the 1,723 issues at March 31, 2020 and the 413 issues at December 31, 2019 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) March 31, 2020 (1): Fixed Maturities: Corporate $ 14,516 $ 750 $ 265 $ 90 $ 14,781 $ 840 U.S. Treasury, government and agency — — — — — — States and political subdivisions 188 7 — — 188 7 Foreign governments 127 5 36 8 163 13 Residential mortgage-backed 17 — 10 — 27 — Asset-backed 1,202 116 61 7 1,263 123 Commercial mortgage-backed — — — — — — Redeemable preferred stock 265 25 43 6 308 31 Total at March 31, 2020 $ 16,315 $ 903 $ 415 $ 111 $ 16,730 $ 1,014 December 31, 2019 (1) (2): Fixed Maturities: Corporate $ 2,773 $ 42 $ 373 $ 20 $ 3,146 $ 62 U.S. Treasury, government and agency 4,309 305 2 — 4,311 305 States and political subdivisions 112 3 — — 112 3 Foreign governments 11 — 47 5 58 5 Residential mortgage-backed — — — — — — Asset-backed 319 1 201 2 520 3 Commercial mortgage-backed — — — — — — Redeemable preferred stock 29 — 49 5 78 5 Total at December 31, 2019 $ 7,553 $ 351 $ 672 $ 32 $ 8,225 $ 383 ______________ (1) Excludes amounts reclassified as Held-for-Sale. (2) |
Financing Receivable, Allowance for Credit Loss | The change in the allowance for credit losses for commercial mortgage loans and agricultural mortgage loans during the three months ended March 31, 2020 was as follows: Three Months Ended March 31, 2020 (in millions) Allowance for credit losses on mortgage loans (1): Commercial mortgages: Beginning Balance, January 1, $ (33 ) Current-period provision for expected credit losses (11 ) Write-offs charged against the allowance — Recoveries of amounts previously written off 1 Ending Balance, Net change in allowance $ (10 ) Ending Balance, March 31 $ (43 ) Three Months Ended March 31, 2020 (in millions) Agricultural mortgages: Beginning Balance, January 1, $ (3 ) Current-period provision for expected credit losses — Write-offs charged against the allowance — Recoveries of amounts previously written off — Net change in allowance — Ending Balance, March 31 $ (3 ) Total allowance for credit losses $ (46 ) _______________ (1) |
Financing Receivable Credit Quality Indicators | The following tables summarize the Company’s mortgage loans segregated by risk rating exposure for the three months ended March 31, 2020 . LTV Ratios (1)(3) At March 31, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: 0% - 50% $ — $ — $ 28 $ 324 $ 213 $ 637 $ 1,202 50% - 70% 119 767 1,003 1,072 2,501 2,046 7,508 70% - 90% — 85 209 10 59 391 754 90% plus — — — — — — — Total commercial $ 119 $ 852 $ 1,240 $ 1,406 $ 2,773 $ 3,074 $ 9,464 Agricultural: 0% - 50% $ 30 $ 136 $ 164 $ 171 $ 270 $ 834 $ 1,605 50% - 70% 38 165 187 126 145 420 1,081 70% - 90% — — 3 — — 16 19 90% plus — — — — — — — Total agricultural $ 68 $ 301 $ 354 $ 297 $ 415 $ 1,270 $ 2,705 Total mortgage loans: 0% - 50% $ 30 $ 136 $ 192 $ 495 $ 483 $ 1,471 $ 2,807 50% - 70% 157 932 1,190 1,198 2,646 2,466 8,589 70% - 90% — 85 212 10 59 407 773 90% plus — — — — — — — Total mortgage loans $ 187 $ 1,153 $ 1,594 $ 1,703 $ 3,188 $ 4,344 $ 12,169 Debt Service Coverage Ratios (2)(3) At March 31, 2020 Amortized Cost Basis by Origination Year 2020 2019 2018 2017 2016 Prior Total (in millions) Mortgage loans: Commercial: Greater than 2.0x $ 119 $ 373 $ 680 $ 583 $ 2,242 $ 1,340 $ 5,337 1.8x to 2.0x — 184 48 379 40 451 1,102 1.5x to 1.8x — 242 223 332 491 577 1,865 1.2x to 1.5x — — 207 75 — 590 872 1.0x to 1.2x — 53 82 37 — 116 288 Less than 1.0x — — — — — — — Total commercial $ 119 $ 852 $ 1,240 $ 1,406 $ 2,773 $ 3,074 $ 9,464 Agricultural Greater than 2.0x $ 3 $ 38 $ 41 $ 37 $ 77 $ 189 $ 385 1.8x to 2.0x 7 30 15 17 22 102 193 1.5x to 1.8x 26 39 47 49 62 249 472 1.2x to 1.5x 12 127 150 121 174 413 997 1.0x to 1.2x 17 57 92 72 61 276 575 Less than 1.0x 3 10 9 1 19 41 83 Total agricultural $ 68 $ 301 $ 354 $ 297 $ 415 $ 1,270 $ 2,705 Total mortgage loans Greater than 2.0x $ 122 $ 411 $ 721 $ 620 $ 2,319 $ 1,529 $ 5,722 1.8x to 2.0x 7 214 63 396 62 553 1,295 1.5x to 1.8x 26 281 270 381 553 826 2,337 1.2x to 1.5x 12 127 357 196 174 1,003 1,869 1.0x to 1.2x 17 110 174 109 61 392 863 Less than 1.0x 3 10 9 1 19 41 83 Total mortgage loans $ 187 $ 1,153 $ 1,594 $ 1,703 $ 3,188 $ 4,344 $ 12,169 ______________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (3) Amounts presented at amortized cost basis. The following tables provide information relating to the LTV and DSC ratios for commercial and agricultural mortgage loans at March 31, 2020 and December 31, 2019 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by LTV and DSC Ratios DSC Ratio (2) (3) LTV Ratio (1) (3): Greater than 2.0x 1.8x to 1.5x to 1.2x to 1.0x to Less than Total (in millions) March 31, 2020: Mortgage loans: Commercial: 0% - 50% $ 942 $ 21 $ 214 $ 25 $ — $ — $ 1,202 50% - 70% 4,143 983 1,437 704 241 — 7,508 70% - 90% 252 98 214 143 47 — 754 90% plus — — — — — — — Total commercial $ 5,337 $ 1,102 $ 1,865 $ 872 $ 288 $ — $ 9,464 Agricultural: 0% - 50% $ 304 $ 110 $ 252 $ 558 $ 333 $ 48 $ 1,605 50% - 70% 81 83 220 420 242 35 1,081 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total agricultural $ 385 $ 193 $ 472 $ 997 $ 575 $ 83 $ 2,705 Total mortgage loans: 0% - 50% $ 1,246 $ 131 $ 466 $ 583 $ 333 $ 48 $ 2,807 50% - 70% 4,224 1,066 1,657 1,124 483 35 8,589 70% - 90% 252 98 214 162 47 — 773 90% plus — — — — — — — Total mortgage loans $ 5,722 $ 1,295 $ 2,337 $ 1,869 $ 863 $ 83 $ 12,169 December 31, 2019: Mortgage loans: Commercial: 0% - 50% $ 903 $ 38 $ 214 $ 25 $ — $ — $ 1,180 50% - 70% 4,097 1,195 1,118 795 242 — 7,447 70% - 90% 251 98 214 154 46 — 763 90% plus — — — — — — — Total commercial $ 5,251 $ 1,331 $ 1,546 $ 974 $ 288 $ — $ 9,390 Agricultural: 0% - 50% $ 322 $ 104 $ 241 $ 545 $ 321 $ 50 $ 1,583 50% - 70% 82 87 236 426 251 33 1,115 70% - 90% — — — 19 — — 19 90% plus — — — — — — — Total agricultural $ 404 $ 191 $ 477 $ 990 $ 572 $ 83 $ 2,717 Total mortgage loans: 0% - 50% $ 1,225 $ 142 $ 455 $ 570 $ 321 $ 50 $ 2,763 50% - 70% 4,179 1,282 1,354 1,221 493 33 8,562 70% - 90% 251 98 214 173 46 — 782 90% plus — — — — — — — Total mortgage loans $ 5,655 $ 1,522 $ 2,023 $ 1,964 $ 860 $ 83 $ 12,107 ______________ (1) The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually. (2) The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (3) Amounts presented at amortized cost basis. |
Age Analysis Of Past Due Mortgage Loans | The following table provides information relating to the aging analysis of past-due mortgage loans at March 31, 2020 and December 31, 2019 , respectively. Age Analysis of Past Due Mortgage Loans (1) Accruing Loans Non-accruing Loans Total Loans Non-accruing Loans with No allowance Interest Income on Non-accruing Loans Past Due Current Total 30-59 Days 60-89 Days 90 Days or More Total (in millions) March 31, 2020: Mortgage loans: Commercial $ — $ — $ — $ — $ 9,464 $ 9,464 $ — $ 9,464 $ — $ — Agricultural 7 17 63 87 2,618 2,705 — 2,705 — — Total $ 7 $ 17 $ 63 $ 87 $ 12,082 $ 12,169 $ — $ 12,169 $ — $ — December 31, 2019: Mortgage loans: Commercial $ — $ — $ — $ — $ 9,390 $ 9,390 $ — $ 9,390 $ — $ — Agricultural 57 1 66 124 2,593 2,717 — 2,717 — — Total $ 57 $ 1 $ 66 $ 124 $ 11,983 $ 12,107 $ — $ 12,107 $ — $ — _______________ (1) Amounts presented at amortized cost basis. |
Net Investment Income (Loss) from Trading Securities | The table below shows a breakdown of Net investment income (loss) from trading securities during the three months ended March 31, 2020 and 2019 : Net Investment Income (Loss) from Trading Securities Three Months Ended March 31, 2020 2019 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ (186 ) $ 318 Net investment gains (losses) recognized on securities sold during the period 4 (24 ) Unrealized and realized gains (losses) on trading securities (182 ) 294 Interest and dividend income from trading securities 51 92 Net investment income (loss) from trading securities $ (131 ) $ 386 |
DERIVATIVES (Tables)
DERIVATIVES (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments by Category | The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments. Derivative Instruments by Category At March 31, 2020 Three Months Ended March 31, 2020 Fair Value Notional Amount Derivative Assets Derivative Liabilities Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 6,317 $ 2 $ 5 $ 220 Swaps 12,947 585 124 3,778 Options 30,050 2,547 3,086 (3,851 ) Interest rate contracts: Swaps 22,896 2,475 343 3,578 Futures 26,713 — — 1,988 Swaptions — — — 9 Credit contracts: Credit default swaps 1,507 26 22 (1 ) Other freestanding contracts: Foreign currency contracts 430 9 8 (2 ) Margin — 107 171 — Collateral — 29 3,757 — Embedded derivatives: GMIB reinsurance contracts (3) — 2,823 — 726 GMxB derivative features liability (4) — — 9,727 (1,198 ) SCS, SIO, MSO and IUL indexed features (5) — — (940 ) 4,154 Total derivative instruments $ 100,860 $ 8,603 $ 16,303 Net derivative gains (losses) $ 9,401 ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets. Derivative Instruments by Category At December 31, 2019 Three Months Ended March 31, 2019 Fair Value Notional Amount Derivative Assets Derivative Net Derivative Gains (Losses) (2) (in millions) Derivative instruments: Freestanding derivatives (1): Equity contracts: Futures $ 4,257 $ 1 $ 1 $ (762 ) Swaps 17,156 9 281 (985 ) Options 47,861 5,098 1,752 1,111 Interest rate contracts: Swaps 23,793 468 526 648 Futures 20,901 — — 56 Swaptions 3,201 16 — — Credit contracts: Credit default swaps 1,400 21 6 7 Other freestanding contracts: Foreign currency contracts 559 12 9 10 Margin — 155 — — Collateral — 74 3,016 — Embedded derivatives: GMIB reinsurance contracts (3) 2,139 — 18 GMxB derivative features liability (4) — — 8,432 (408 ) SCS, SIO, MSO and IUL indexed features (5) — — 3,268 (1,325 ) Total derivative instruments $ 119,128 $ 7,993 $ 17,291 Net derivative gains (losses) $ (1,630 ) ______________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). (3) Reported in GMIB reinsurance contract asset in the consolidated balance sheets. (4) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (5) Reported in Policyholders’ account balances in the consolidated balance sheets. |
Offsetting Financial Assets and Liabilities and Derivative Instruments | The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at March 31, 2020 : Offsetting of Financial Assets and Liabilities and Derivative Instruments At March 31, 2020 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount (in millions) Assets: Derivative assets (1) $ 5,779 $ 5,522 $ 257 $ (162 ) $ 95 Other financial assets 1,855 — 1,855 — 1,855 Other invested assets $ 7,634 $ 5,522 $ 2,112 $ (162 ) $ 1,950 Liabilities: Derivative liabilities (2) $ 7,354 $ 5,522 $ 1,832 $ — $ 1,832 Other financial liabilities 3,884 — 3,884 — 3,884 Other liabilities $ 11,238 $ 5,522 $ 5,716 $ — $ 5,716 ______________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Primarily financial instrument sent (held). The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2019 : Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2019 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets Gross Amount not Offset in the Balance Sheets (3) Net Amount (in millions) Assets: Derivative assets (1) $ 5,852 $ 5,466 $ 386 $ (77 ) $ 309 Other financial instruments 2,394 — 2,394 — 2,394 Other invested assets $ 8,246 $ 5,466 $ 2,780 $ (77 ) $ 2,703 Liabilities: Derivative liabilities (2) $ 5,512 $ 5,466 $ 46 $ — $ 46 Other financial liabilities 3,924 — 3,924 — 3,924 Other liabilities $ 9,436 $ 5,466 $ 3,970 $ — $ 3,970 ______________ (1) Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs. (2) Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs. (3) Primarily financial instrument sent (held). |
CLOSED BLOCK (Tables)
CLOSED BLOCK (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Closed Block Disclosure [Abstract] | |
Schedule of Closed Block Assets and Liabilities | Summarized financial information for the Company’s Closed Block is as follows: March 31, 2020 December 31, 2019 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,404 $ 6,478 Policyholder dividend obligation — 2 Other liabilities 76 38 Total Closed Block liabilities 6,480 6,518 Assets Designated to the Closed Block: Fixed maturities available-for-sale, at fair value, net of allowance for credit losses of $0 and $0 (amortized cost of $3,557 and $3,558) 3,684 3,754 Mortgage loans on real estate, net of allowance for credit losses of $4 and $0 1,742 1,759 Policy loans 676 706 Cash and other invested assets 112 82 Other assets 133 145 Total assets designated to the Closed Block 6,347 6,446 March 31, 2020 December 31, 2019 (in millions) Excess of Closed Block liabilities over assets designated to the Closed Block 133 72 Amounts included in accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation: $0 and $(2); and net of income tax: $27 and $41 111 164 Maximum future earnings to be recognized from Closed Block assets and liabilities $ 244 $ 236 |
Closed Block Operations, Net Results | The Company’s Closed Block revenues and expenses were as follows: Three Months Ended March 31, 2020 2019 (in millions) Revenues: Premiums and other income $ 42 $ 48 Net investment income (loss) 66 67 Investment gains (losses), net — (1 ) Total revenues 108 114 Benefits and Other Deductions: Policyholders’ benefits and dividends 103 121 Other operating costs and expenses — 1 Total benefits and other deductions 103 122 Net income (loss), before income taxes 5 (8 ) Income tax (expense) benefit — (1 ) Net income (loss) $ 5 $ (9 ) |
INSURANCE LIABILITIES (Tables)
INSURANCE LIABILITIES (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Insurance [Abstract] | |
Variable Annuity Contracts- GMDB GMIB | The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Three Months Ended March 31, 2020 and 2019 GMDB GMIB Direct Assumed Ceded Direct Assumed Ceded (in millions) Balance at January 1, 2020 4,784 76 (105 ) 4,691 187 (2,139 ) Paid guarantee benefits (111 ) (6 ) 5 (74 ) (1 ) 20 Other changes in reserve 379 2 (11 ) 1,682 33 (704 ) Balance at March 31, 2020 $ 5,052 $ 72 $ (111 ) $ 6,299 $ 219 $ (2,823 ) Balance at January 1, 2019 4,659 82 (113 ) 3,743 184 (1,732 ) Paid guarantee benefits (118 ) (6 ) 4 (56 ) (1 ) 21 Other changes in reserve 129 1 — 55 (1 ) (29 ) Balance at March 31, 2019 $ 4,670 $ 77 $ (109 ) $ 3,742 $ 182 $ (1,740 ) |
Schedule of Net Amount of Risk by Product and Guarantee | Direct Variable Annuity Contracts with GMDB and GMIB Features at March 31, 2020 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,662 $ 92 $ 58 $ 176 $ 14,988 Separate Accounts 40,733 7,887 2,607 27,713 78,940 Total Account Values $ 55,395 $ 7,979 $ 2,665 $ 27,889 $ 93,928 Net Amount at Risk, gross $ 715 $ 877 $ 2,296 $ 22,881 $ 26,769 Net Amount at Risk, net of amounts reinsured $ 715 $ 857 $ 1,647 $ 22,881 $ 26,100 Average attained age of policyholders (in years) 51.1 67.8 74.4 69.6 55.1 Percentage of policyholders over age 70 10.7 % 46.4 % 68.7 % 51.6 % 19.5 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rate) Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 18 $ 228 $ 246 Separate Accounts — — 20,724 29,476 50,200 Total Account Values $ — $ — $ 20,742 $ 29,704 $ 50,446 Net Amount at Risk, gross $ — $ — $ 1,360 $ 17,568 $ 18,928 Net Amount at Risk, net of amounts reinsured $ — $ — $ 425 $ 15,774 $ 16,199 Average attained age of policyholders (in years) N/A N/A 68.9 69.7 69.6 Weighted average years remaining until annuitization N/A N/A 1.6 0.3 0.4 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Assumed Variable Annuity Contracts with GMDB and GMIB Features at March 31, 2020 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions, except age and interest rates) Variable annuity contracts with GMDB features Reinsured Account Values $ 776 $ 4,352 $ 225 $ 946 $ 6,299 Net Amount at Risk assumed $ 13 $ 627 $ 22 $ 263 $ 925 Average attained age of policyholders (in years) 68 73 78 76 73 Percentage of policyholders over age 70 46.3 % 65.2 % 80.7 % 75.8 % 65.0 % Range of contractually specified interest rates (1) N/A N/A 3%-10% 5%-10% 3%-10% Variable annuity contracts with GMIB features Reinsured Account Values $ 744 $ 37 $ 190 $ 956 $ 1,927 Net Amount at Risk assumed $ 2 $ 3 $ 46 $ 445 $ 496 Average attained age of policyholders (in years) 72 74 72 69 71 Percentage of policyholders over age 70 65.1 % 62.8 % 61.5 % 53.8 % 59.1 % Range of contractually specified interest rates N/A N/A 3.3%-6.5% 6%-6% 3.3%-6.5% ______________ (1) In general, for policies with the highest contractual interest rate shown (10%), the rate applied only for the first 10 years after issue, which has now elapsed. |
Schedule of Fair Value of Separate Accounts by Major Category of Investment | Investment in Variable Insurance Trust Mutual Funds March 31, 2020 December 31, 2019 Mutual Fund Type GMDB GMIB GMDB GMIB (in millions) Equity $ 32,913 $ 13,765 $ 42,489 $ 17,941 Fixed income 5,151 2,680 5,263 2,699 Balanced 39,965 33,483 45,871 38,445 Other 911 272 865 263 Total $ 78,940 $ 50,200 $ 94,488 $ 59,348 |
No Lapse Guarantee Liabilities | The change in the fair value of the NLG feature, reflected in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets, is summarized in the table below. Direct Liability (1) Three Months Ended March 31, 2020 2019 (in millions) Balance at January 1, (2) 897 812 Paid guarantee benefits (13 ) (7 ) Other changes in reserves 41 20 Balance at March 31, $ 925 $ 825 ______________ (1) There were no amounts of reinsurance ceded in any period presented. (2) The beginning balance for March 31, 2020 was reduced by $22 million to reflect the balance transferred to Assets held-for-sale at December 31, 2019. |
FAIR VALUE DISCLOSURES (Tables)
FAIR VALUE DISCLOSURES (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Fair Value Disclosures [Abstract] | |
Assets and Liabilities Measured at Fair Value on Recurring Basis | Fair Value Measurements at March 31, 2020 (1) Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, AFS: Corporate (2) $ — $ 47,137 $ 1,185 $ 48,322 U.S. Treasury, government and agency — 18,633 — 18,633 States and political subdivisions — 689 36 725 Foreign governments — 498 — 498 Residential mortgage-backed (3) — 184 — 184 Asset-backed (4) — 1,356 40 1,396 Commercial mortgage-backed — 39 — 39 Redeemable preferred stock 252 272 — 524 Total fixed maturities, AFS 252 68,808 1,261 70,321 Other equity investments 12 — 87 99 Trading securities 438 6,059 37 6,534 Other invested assets: Short-term investments — 142 — 142 Assets of consolidated VIEs/VOEs 98 365 16 479 Swaps — 2,594 — 2,594 Credit default swaps — 4 — 4 Futures (3 ) — — (3 ) Options — (539 ) — (539 ) Swaptions — — — — Total other invested assets 95 2,566 16 2,677 Cash equivalents 9,026 — — 9,026 Segregated securities — 2,013 — 2,013 GMIB reinsurance contracts asset — — 2,823 2,823 Separate Accounts assets (5) 102,853 2,632 — 105,485 Total Assets $ 112,676 $ 82,078 $ 4,224 $ 198,978 Liabilities GMxB derivative features’ liability $ — $ — $ 9,727 $ 9,727 SCS, SIO, MSO and IUL indexed features’ liability — (940 ) — (940 ) Liabilities of consolidated VIEs and VOEs 1 19 — 20 Contingent payment arrangements — — 24 24 Total Liabilities $ 1 $ (921 ) $ 9,751 $ 8,831 ______________ (1) Excludes amounts reclassified as Held-for-Sale. (2) Corporate fixed maturities includes both public and private issues. (3) Includes publicly traded agency pass-through securities and collateralized obligations. (4) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (5) Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At March 31, 2020 , the fair value of such investments was $361 million . Fair Value Measurements at December 31, 2019 (1) Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, AFS: Corporate (2) $ — $ 46,942 $ 1,257 $ 48,199 U.S. Treasury, government and agency — 15,394 — 15,394 States and political subdivisions — 666 39 705 Foreign governments — 492 — 492 Residential mortgage-backed (3) — 191 — 191 Asset-backed (4) — 749 100 849 Commercial mortgage-backed (3) — — — — Redeemable preferred stock 239 274 — 513 Total fixed maturities, AFS 239 64,708 1,396 66,343 Other equity investments 13 — 97 110 Trading securities 500 6,495 36 7,031 Other invested assets: Short-term investments — 490 — 490 Assets of consolidated VIEs/VOEs 132 457 17 606 Swaps — (327 ) — (327 ) Credit default swaps — 15 — 15 Options — 3,346 — 3,346 Swaptions — 16 — 16 Total other invested assets 132 3,997 17 4,146 Cash equivalents 3,497 — — 3,497 Segregated securities — 1,095 — 1,095 GMIB reinsurance contracts asset — — 2,139 2,139 Separate Accounts assets (5) 123,432 2,892 — 126,324 Total Assets $ 127,813 $ 79,187 $ 3,685 $ 210,685 Liabilities GMxB derivative features’ liability $ — $ — $ 8,432 $ 8,432 SCS, SIO, MSO and IUL indexed features’ liability — 3,268 — 3,268 Liabilities of consolidated VIEs and VOEs 1 9 — 10 Contingent payment arrangements — — 23 23 Total Liabilities $ 1 $ 3,277 $ 8,455 $ 11,733 ______________ (1) Excludes amounts reclassified as Held-for-Sale. (2) Corporate fixed maturities includes both public and private issues. (3) Includes publicly traded agency pass-through securities and collateralized obligations. (4) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (5) Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At December 31, 2019 , the fair value of such investments was $356 million . |
Reconciliation of Assets and Liabilities at Level 3 | The tables below present reconciliations for all Level 3 assets and liabilities at March 31, 2020 and 2019 , respectively: Level 3 Instruments - Fair Value Measurements Corporate State and Asset- (in millions) Balance, January 1, 2020 $ 1,257 $ 39 $ 100 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 1 — — Investment gains (losses), net (2 ) — — Subtotal (1 ) — — Other comprehensive income (loss) (61 ) (3 ) (8 ) Purchases 61 — 48 Sales (45 ) — — Transfers into Level 3 (1) — — — Transfers out of Level 3 (1) (26 ) — (100 ) Balance, March 31, 2020 $ 1,185 $ 36 $ 40 Balance, January 1, 2019 $ 1,186 $ 39 $ 519 Total gains and (losses), realized and unrealized, included in: Net income (loss) as: Net investment income (loss) 1 — — Investment gains (losses), net — — — Subtotal 1 — — Other comprehensive income (loss) 9 1 4 Purchases 70 — 11 Sales (34 ) — — Transfers into Level 3 (1) 17 — — Transfers out of Level 3 (1) (69 ) — — Balance, March 31, 2019 $ 1,180 $ 40 $ 534 _____________ (1) Transfers into/out of the Level 3 classification are reflected at beginning of period fair values. Other Equity Investments GMIB Reinsurance Contract Asset Separate Accounts Assets GMxB Derivative Features Liability Contingent Payment Arrangement (in millions) Balance, January 1, 2020 $ 150 $ 2,139 $ — $ (8,432 ) $ (23 ) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net 7 — — — — Net derivative gains (losses), excluding non-performance risk — 955 — (3,884 ) — Non-performance risk (1) — (229 ) — 2,686 — Total realized and unrealized gains (losses) 7 726 — (1,198 ) — Other comprehensive income (loss) (7 ) — — — — Purchases (2) 2 10 — (111 ) — Sales (3) (11 ) (20 ) — 14 — Settlements (4) — — — — — Change in estimate (5) — (32 ) — — — Activity related to consolidated VIEs/VOEs (1 ) — — — (1 ) Transfers into Level 3 (6) — — — — — Transfers out of Level 3 (6) — — — — — Balance, March 31, 2020 $ 140 $ 2,823 $ — $ (9,727 ) $ (24 ) Balance, January 1, 2019 $ 165 $ 1,732 $ 21 $ (5,614 ) $ (7 ) Realized and unrealized gains (losses), included in Net income (loss) as: Investment gains (losses), net — — — — — Net derivative gains (losses), excluding non-performance risk — (11 ) — 63 — Non-performance risk (1) — 29 — (470 ) — Total realized and unrealized gains (losses) — 18 — (407 ) — Other comprehensive income (loss) — — — — — Purchases (2) 2 11 4 (111 ) — Sales (3) — (21 ) — 6 — Settlements (4) — — (1 ) — — Change in estimate — — — — — Activity related to consolidated VIEs/VOEs (1 ) — — — — Transfers into Level 3 (6) — — — — — Transfers out of Level 3 (6) (29 ) — (1 ) — — Balance, March 31, 2019 $ 137 $ 1,740 $ 23 $ (6,126 ) $ (7 ) ______________ (1) The Company’s non-performance risk is recorded through Net derivative gains (losses). (2) For the GMIB reinsurance contract asset, and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) For contingent payment arrangements, it represents payments under the arrangement. (5) For the GMIB reinsurance contract asset, represents a transfer from amounts due from reinsurers. (6) Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values. The table below details changes in unrealized gains (losses) for the three months ended March 31, 2020 and 2019 by category for Level 3 assets and liabilities still held at March 31, 2020 and 2019 , respectively. Change in Unrealized Gains (Losses) for Level 3 Instruments Net Income (Loss) Net Derivative Gains (Losses) OCI (in millions) Held at March 31, 2020: Change in unrealized gains (losses): Fixed maturities, AFS Corporate $ — $ (61 ) State and political subdivisions — (2 ) Asset-backed — (8 ) Total fixed maturities, AFS — (71 ) GMIB reinsurance contracts 726 — GMxB derivative features liability (1,198 ) — Total $ (472 ) $ (71 ) Held at March 31, 2019: Change in unrealized gains (losses): Fixed maturities, AFS Corporate $ — $ 9 State and political subdivisions — 1 Asset-backed — 4 Total fixed maturities, AFS — 14 GMIB reinsurance contracts 18 — GMxB derivative features liability (408 ) — Total $ (390 ) $ 14 |
Quantitative Information About Level 3 Fair Value Measurement | The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at March 31, 2020 and December 31, 2019 , respectively. Quantitative Information about Level 3 Fair Value Measurements at March 31, 2020 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 63 Matrix pricing model Spread over Benchmark 15 - 580 bps 264 bps 1,034 Market comparable EBITDA multiples 3.2x - 31.5x 14.0x Other equity investments 37 Discounted cash flow Earnings multiple 8.0x GMIB reinsurance contract asset 2,823 Discounted cash flow Non-performance risk 144 - 293 bps 233 bps Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (2) Liabilities: GMIBNLG 9,308 Discounted cash flow Non-performance risk 304 bps Assumed GMIB Reinsurance Contracts 218 Discounted cash flow Non-performance risk 201 - 419 bps 357 bps GWBL/GMWB 146 Discounted cash flow Non-performance risk 304 bps GIB 38 Discounted cash flow Non-performance risk 304 bps GMAB 17 Discounted cash flow Non-performance risk 304 bps ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. (2) For Lapses, Withdrawals, and Utilizations the rates were weighted by counts, for Mortality weighted average rates are shown for all ages combined and for Withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2019 Fair Valuation Significant Range Weighted Average (in millions) Assets: Investments: Fixed maturities, AFS: Corporate $ 57 Matrix pricing model Spread over benchmark 65 - 580 bps 184 bps 1,025 Market comparable companies EBITDA multiples 3.3x - 56.7x 14.3x Other equity investments 36 Discounted cash flow Earnings multiple 8.0x GMIB reinsurance contract asset 2,139 Discounted cash flow Non-performance risk 55 - 109 bps Fair Valuation Significant Range Weighted Average Liabilities: GMIBNLG 8,128 Discounted cash flow Non-performance risk 124 bps Assumed GMIB Reinsurance Contracts 186 Discounted cash flow Non-performance risk 61 - 141 bps GWBL/GMWB 109 Discounted cash flow Non-performance risk 124 bps GIB 5 Discounted cash flow Non-performance risk 124 bps GMAB 4 Discounted cash flow Lapse rates 1.0% - 10.0% ______________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. |
Fair Value Disclosure Financial Instruments Not Carried At Fair Value | Note 4 The carrying values and fair values at March 31, 2020 and December 31, 2019 for financial instruments not otherwise disclosed in Note 3 and Note 4 are presented in the table below. Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed Carrying Fair Value Level 1 Level 2 Level 3 Total (in millions) March 31, 2020: Mortgage loans on real estate $ 12,123 $ — $ — $ 12,134 $ 12,134 Policy loans (1) $ 3,720 $ — $ — $ 4,686 $ 4,686 Policyholders’ liabilities: Investment contracts (1) $ 2,089 $ — $ — $ 2,201 $ 2,201 FHLBNY funding agreements $ 6,759 $ — $ 6,835 $ — $ 6,835 Short-term and long-term debt $ 4,217 $ — $ 4,201 $ — $ 4,201 Separate Accounts liabilities $ 7,563 $ — $ — $ 7,563 $ 7,563 December 31, 2019: Mortgage loans on real estate $ 12,107 $ — $ — $ 12,334 $ 12,334 Policy loans (1) $ 3,735 $ — $ — $ 4,707 $ 4,707 Policyholders’ liabilities: Investment contracts (1) $ 2,056 $ — $ — $ 2,167 $ 2,167 FHLBNY funding agreements $ 6,909 $ — $ 6,957 $ — $ 6,957 Short-term and long-term debt $ 4,111 $ — $ 4,476 $ — $ 4,476 Separate Accounts liabilities $ 9,041 $ — $ — $ 9,041 $ 9,041 ______________ (1) |
EMPLOYEE BENEFIT PLANS (Tables)
EMPLOYEE BENEFIT PLANS (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Retirement Benefits [Abstract] | |
Components of certain benefit costs | Components of net periodic pension expense for the Company’s qualified and non-qualified plans were as follows: Three Months Ended March 31, 2020 2019 (in millions) Service cost $ 2 $ 2 Interest cost 16 22 Expected return on assets (37 ) (38 ) Actuarial (gain) loss — — Net amortization 22 20 Net periodic pension expense $ 3 $ 6 |
EQUITY (Tables)
EQUITY (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Equity [Abstract] | |
Dividends Declared | Dividends declared per share of each class of stock were as follows for the periods indicated: Three Months Ended March 31, 2020 2019 Dividends declared per share of common stock $ 0.15 $ 0.13 Dividends declared per depositary share (1) $ 0.39 $ — _______________ (1) Represents a 1/1,000th interest in a share of preferred stock. |
Schedule of Accumulated Other Comprehensive Income (Loss) | AOCI represents cumulative gains (losses) on items that are not reflected in Net income (loss). The balances as of March 31, 2020 and 2019 follow: March 31, 2020 2019 (in millions) Unrealized gains (losses) on investments $ 3,272 $ 430 Defined benefit pension plans (955 ) (919 ) Foreign currency translation adjustments (78 ) (63 ) Total accumulated other comprehensive income (loss) 2,239 (552 ) Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest (50 ) (39 ) Accumulated other comprehensive income (loss) attributable to Holdings $ 2,289 $ (513 ) |
Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes | The components of OCI, net of taxes for the three months ended March 31, 2020 and 2019 follow: Three Months Ended March 31, 2020 2019 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the period $ 1,513 $ 1,342 (Gains) losses reclassified into net income (loss) during the period (1) (47 ) 9 Net unrealized gains (losses) on investments 1,466 1,351 Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other (32 ) (517 ) Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $382 and $218) 1,434 834 Change in defined benefit plans: Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost 28 49 Change in defined benefit plans (net of deferred income tax expense (benefit) of $7 and $12) 28 49 Foreign currency translation adjustments: Foreign currency translation gains (losses) arising during the period (21 ) (1 ) (Gains) losses reclassified into net income (loss) during the period — — Foreign currency translation adjustment (21 ) (1 ) Total other comprehensive income (loss), net of income taxes 1,441 882 Less: Other comprehensive income (loss) attributable to noncontrolling interest (8 ) (1 ) Other comprehensive income (loss) attributable to Holdings $ 1,449 $ 883 _______________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts presented net of income tax expense (benefit) of $(12) million and $2 million for the three months ended March 31, 2020 and 2019 , respectively |
REDEEMABLE NONCONTROLLING INT_2
REDEEMABLE NONCONTROLLING INTEREST (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Noncontrolling Interest [Abstract] | |
Redeemable Noncontrolling Interest | The changes in the components of redeemable noncontrolling interests are presented in the table that follows: Three Months Ended March 31, 2020 2019 (in millions) Balance, beginning of period $ 365 $ 38 Net earnings (loss) attributable to redeemable noncontrolling interests (30 ) 12 Purchase/change of redeemable noncontrolling interests (78 ) 157 Balance, end of period $ 257 $ 207 |
COMMITMENTS AND CONTINGENT LI_2
COMMITMENTS AND CONTINGENT LIABILITIES (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Activity of Funding Agreements with FHLBNY | Change in FHLBNY Funding Agreements during the Three Months Ended March 31, 2020 Outstanding Balance at December 31, 2019 Issued During the Period Repaid During the Period Long-term Agreements Maturing Within One Year Outstanding Balance at March 31, 2020 (in millions) Short-term funding agreements: Due in one year or less $ 4,608 $ 11,750 $ 11,900 $ 174 $ 4,632 Long-term funding agreements: Due in years two through five 1,646 — — (174 ) 1,472 Due in more than five years 646 — — — 646 Total long-term funding agreements 2,292 — — (174 ) 2,119 Total funding agreements (1) $ 6,900 $ 11,750 $ 11,900 $ — $ 6,750 _____________ (1) The $9 million and $9 million difference between the funding agreements carrying value shown in fair value table for March 31, 2020 and December 31, 2019 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates. |
BUSINESS SEGMENT INFORMATION (T
BUSINESS SEGMENT INFORMATION (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information, by Segment | The table below presents Operating earnings (loss) by segment and Corporate and Other and a reconciliation to Net income (loss) attributable to Holdings for the three months ended March 31, 2020 and 2019 , respectively: Three Months Ended March 31, 2020 2019 (in millions) Net income (loss) attributable to Holdings $ 5,410 $ (775 ) Adjustments related to: Variable annuity product features (1) (6,861 ) 1,540 Investment (gains) losses (4 ) 11 Net actuarial (gains) losses related to pension and other postretirement benefit obligations 27 24 Other adjustments (2) (3) 634 40 Income tax expense (benefit) related to above adjustments (4) 1,303 (337 ) Non-recurring tax items 6 6 Non-GAAP Operating Earnings $ 515 $ 509 Three Months Ended March 31, 2020 2019 (in millions) Operating earnings (loss) by segment: Individual Retirement $ 372 $ 370 Group Retirement $ 106 $ 81 Investment Management and Research $ 95 $ 77 Protection Solutions $ 38 $ 49 Corporate and Other (5) $ (96 ) $ (68 ) ______________ (1) Includes COVID Impact on Variable annuity product features due to assumption update of $1.5 billion and other COVID-19 related impacts of $35 million three months ended March 31, 2020 . (2) Includes assumption updates due to COVID-19 of $1.0 billion and other COVID-19 related impacts of $51 million three months ended March 31, 2020 . (3) Include separation costs of $32 million and $24 million for the three months ended March 31, 2020 and 2019 , respectively. (4) Includes income taxes of $(534) million for the above COVID-19 items for the three months ended March 31, 2020 . (5) Includes interest expense and financing fees of $56 million and $52 million for the three months ended March 31, 2020 and 2019 , respectively. Segment revenues is a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to Total revenues by excluding the following items: • Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features; • Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances; • Other adjustments, which includes investment income (loss) from certain derivative instruments, excluding derivative instruments used to hedge risks associated with interest margins on interest sensitive life and annuity contracts and freestanding and embedded derivatives associated with products with GMxB features. The table below presents segment revenues for the three months ended March 31, 2020 and 2019 . Three Months Ended March 31, 2020 2019 (in millions) Segment revenues: Individual Retirement (1) $ 1,481 $ 1,007 Group Retirement (1) 282 251 Investment Management and Research (2) 907 780 Protection Solutions (1) 859 831 Corporate and Other (1) 299 312 Adjustments related to: Variable annuity product features 8,339 (1,478 ) Investment gains (losses), net 4 (11 ) Other adjustments to segment revenues (3) 422 22 Total revenues $ 12,593 $ 1,714 ______________ (1) Includes investment expenses charged by AB of $18 million and $18 million for the three months ended March 31, 2020 and 2019 , respectively, for services provided to the Company. (2) Inter-segment investment management and other fees of $27 million and $25 million for the three months ended March 31, 2020 and 2019 , respectively, are included in segment revenues of the Investment Management and Research segment. (3) Includes assumption updates due to COVID-19 of $46 million and other COVID-19 related impacts of $(51) million for the three months ended March 31, 2020 . The table below presents Total assets by segment as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (in millions) Total assets by segment: Individual Retirement $ 117,299 $ 123,626 Group Retirement 41,194 43,588 Investment Management and Research 11,915 10,170 Protection Solutions 45,266 46,886 Corporate and Other 25,107 25,600 Total assets $ 240,781 $ 249,870 |
EARNINGS PER COMMON SHARE (Tabl
EARNINGS PER COMMON SHARE (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table presents the weighted-average shares outstanding and Earnings per common share — basic and diluted: Three Months Ended March 31, 2020 2019 (in millions) Weighted-average common shares outstanding: Weighted-average common shares outstanding — basic 461.0 518.0 Effect of dilutive potential common shares: Employee share awards (1) 2.5 — Weighted-average common shares outstanding — diluted (2) 463.5 518.0 Net income (loss): Net income (loss) $ 5,447 $ (709 ) Less: Net income (loss) attributable to the noncontrolling interest 37 66 Net income (loss) attributable to Holdings 5,410 (775 ) Less: Preferred stock dividends 13 — Net income (loss) available to Holdings’ common shareholders 5,397 (775 ) Earnings per common share: Basic $ 11.71 $ (1.50 ) Diluted $ 11.65 $ (1.50 ) _____________ (1) Calculated using the treasury stock method. (2) Due to net loss for the three months ended March 31, 2019 , approximately 1 million more shares were excluded from the diluted earnings per common share calculation than would have been excluded as being anti-dilutive under the treasury stock method. |
HELD-FOR-SALE (Tables)
HELD-FOR-SALE (Tables) | 3 Months Ended |
Mar. 31, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Assets And Liabilities Held-for-sale | The following table summarizes the components of assets and liabilities held-for-sale on the consolidated balance sheets at March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 (in millions) Assets: Fixed maturity securities $ 860 $ 896 Trading securities, at fair value 14 17 Policy loans 20 19 Cash and cash equivalents 41 65 Amounts due from reinsurers 41 43 Deferred policy acquisition costs 31 31 Other assets 18 24 Assets held-for-sale 1,025 1,095 Less: Loss accrual (182 ) (133 ) Total assets held-for-sale $ 843 $ 962 Liabilities: Policyholders’ account balances $ 279 $ 286 Future policy benefits and other policyholders’ liabilities 398 421 Amounts due to reinsurers (2 ) 6 Other liabilities 4 11 Total liabilities held-for-sale $ 679 $ 724 |
ORGANIZATION - Narrative (Detai
ORGANIZATION - Narrative (Details) - segment | 3 Months Ended | 12 Months Ended |
Mar. 31, 2020 | Dec. 31, 2019 | |
Organization Basis Of Presentation [Line Items] | ||
Number of reportable segments | 4 | |
Alliance Bernstein | ||
Organization Basis Of Presentation [Line Items] | ||
Economic interest | 65.00% | 65.00% |
SIGNIFICANT ACCOUNTING POLICI_4
SIGNIFICANT ACCOUNTING POLICIES - Adoption of New Accounting Pronouncements (Details) $ in Millions | Jan. 01, 2020USD ($) |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Cumulative effect of new accounting principle in period of adoption | $ (30) |
Accounting Standards Update 2016-13 | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Cumulative effect of new accounting principle in period of adoption | $ 40 |
SIGNIFICANT ACCOUNTING POLICI_5
SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2020 | Jan. 01, 2020 | Dec. 31, 2019 | |
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||
Life insurance, corporate or bank owned, amount | $ 872 | $ 944 | |
Cumulative effect of new accounting principle in period of adoption | $ (30) | ||
Accounting Standards Update 2016-13 | |||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||
Cumulative effect of new accounting principle in period of adoption | 40 | ||
Retained Earnings | |||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||
Cumulative effect of new accounting principle in period of adoption | $ (30) | ||
Equity real estate | Minimum | |||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||
Property, plant and equipment, useful life | 40 years | ||
Equity real estate | Maximum | |||
Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||
Property, plant and equipment, useful life | 50 years |
SIGNIFICANT ACCOUNTING POLICI_6
SIGNIFICANT ACCOUNTING POLICIES - Variable Interest Entities (Details) $ in Millions | 3 Months Ended | |||
Mar. 31, 2020USD ($)joint_venture | Mar. 31, 2019USD ($) | Dec. 31, 2019USD ($)joint_venture | ||
Variable Interest Entity [Line Items] | ||||
Assets | $ 240,781 | $ 249,870 | ||
Liabilities | 218,884 | 234,379 | ||
Redeemable non-controlling interest | [1],[2] | $ 257 | $ 365 | |
Variable Interest Entity, Primary Beneficiary | ||||
Variable Interest Entity [Line Items] | ||||
Number of consolidated real estate joint ventures | joint_venture | 1 | 1 | ||
Assets | $ 32 | $ 32 | ||
Number of nonconsolidated real estate joint ventures | joint_venture | 1 | |||
Operating income (loss) | $ (5) | $ (5) | ||
Variable Interest Entity, Not Primary Beneficiary | ||||
Variable Interest Entity [Line Items] | ||||
Assets | 1,200 | 1,200 | ||
Variable interest entity, nonconsolidated net assets | 151,400 | 160,200 | ||
Variable interest entity, maximum loss exposure | 1,200 | 1,200 | ||
Variable interest entity, unfunded commitments | 1,100 | 1,100 | ||
AB-Sponsored Investment Funds | ||||
Variable Interest Entity [Line Items] | ||||
Variable interest entity, nonconsolidated net assets | 80,500 | 79,300 | ||
Variable interest entity, maximum loss exposure | 7 | 8 | ||
AB-Sponsored Investment Funds | Variable Interest Entity, Primary Beneficiary | ||||
Variable Interest Entity [Line Items] | ||||
Assets | 377 | 424 | ||
Liabilities | 73 | 12 | ||
Redeemable non-controlling interest | 179 | 273 | ||
AB-Sponsored Investment Funds | VOE Consolidation Model | ||||
Variable Interest Entity [Line Items] | ||||
Assets | 193 | 188 | ||
Liabilities | 32 | 19 | ||
Redeemable non-controlling interest | $ 46 | $ 52 | ||
[1] | See Note 13 for details of Redeemable noncontrolling interest. | |||
[2] | See Note 2 for details of balances with variable interest entities. |
SIGNIFICANT ACCOUNTING POLICI_7
SIGNIFICANT ACCOUNTING POLICIES - Assumption Updates and Model Changes (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2020 | Sep. 30, 2019 | Mar. 31, 2019 | |
Change in Accounting Estimate [Line Items] | |||
Policyholders’ benefits | $ 2,788,000,000 | $ 880,000,000 | |
Policy charges and fee income | 991,000,000 | 931,000,000 | |
Interest credited to policyholders’ account balances | 317,000,000 | 304,000,000 | |
Earnings (loss) from operations, before income taxes | 6,887,000,000 | (924,000,000) | |
Net income (loss) | 5,447,000,000 | $ (709,000,000) | |
Long-term Lapses, Partial Withdrawal Rates and Election Assumptions Updates | |||
Change in Accounting Estimate [Line Items] | |||
Policyholders’ benefits | 1,400,000,000 | ||
Amortization of deferred policy acquisition costs, net | 1,100,000,000 | ||
Policy charges and fee income | 46,000,000 | ||
Interest credited to policyholders’ account balances | $ (6,000,000) | ||
Earnings (loss) from operations, before income taxes | (2,500,000,000) | ||
Net income (loss) | (1,900,000,000) | ||
5-year Historical Average Over A 10-year Period | |||
Change in Accounting Estimate [Line Items] | |||
Interest rate assumptions | $ 0.0225 |
INVESTMENTS - Narrative (Detail
INVESTMENTS - Narrative (Details) | 3 Months Ended | |
Mar. 31, 2020USD ($)security | Dec. 31, 2019USD ($)security | |
Net Investment Income [Line Items] | ||
Number of positions in unrealized loss position | security | 1,723 | 413 |
Debt securities exposure in single issuer greater than stated percentage of total investments | 0.60% | |
Amortized cost | $ 65,042,000,000 | |
Unrealized loss on available for sale securities | 217,000,000 | |
Gross unrealized losses | 111,000,000 | $ 32,000,000 |
Allowance for credit loss | 46,000,000 | |
Separate account equity investment carrying value | 46,000,000 | 58,000,000 |
Corporate | ||
Net Investment Income [Line Items] | ||
Exposure in single issuer of total investments | $ 286,000,000 | $ 309,000,000 |
Debt securities exposure in single issuer of total investments, percentage | 1.30% | 2.00% |
Gross unrealized losses | $ 90,000,000 | $ 20,000,000 |
Fixed maturities | ||
Net Investment Income [Line Items] | ||
Accrued investment income receivable | 498,000,000 | |
Accrued interest, written off | 1,000,000 | |
Amortized cost | 65,044,000,000 | 62,937,000,000 |
Commercial Real Estate and Agricultural Real Estate Portfolio Segment | ||
Net Investment Income [Line Items] | ||
Accrued investment income receivable | 28,000,000 | 32,000,000 |
Accrued interest, written off | 0 | |
Individually Assessed Mortgage Loans | ||
Net Investment Income [Line Items] | ||
Mortgage loans foreclosure probable | 0 | |
Allowance for credit loss | 0 | |
Commercial Real Estate Portfolio Segment | ||
Net Investment Income [Line Items] | ||
Allowance for credit loss | 43,000,000 | 33,000,000 |
Non-accruing Loans | 0 | 0 |
Fair Value, Measurements, Recurring | ||
Net Investment Income [Line Items] | ||
Trading securities, at fair value | 6,534,000,000 | 7,031,000,000 |
Other Than Investment Grade | External Credit Rating, Non Investment Grade | Fixed maturities | ||
Net Investment Income [Line Items] | ||
Available-for-sale securities, amortized cost basis other than investment grade | $ 1,700,000,000 | $ 1,400,000,000 |
Percentage of available for sale securities | 2.60% | 2.30% |
Unrealized loss on available for sale securities | $ 21,000,000 |
INVESTMENTS - Available-for-sal
INVESTMENTS - Available-for-sale Securities (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | $ 65,044 | $ 62,937 | |
Allowance for Credit Losses | 2 | 0 | |
Gross Unrealized Gains | 6,297 | 3,789 | |
Gross Unrealized Losses | 1,018 | 383 | |
Fixed maturities available for sale, at fair value | 70,321 | 66,343 | |
Amortized Cost | |||
Due in one year or less | 4,680 | ||
Due in years two through five | 14,638 | ||
Due in years six through ten | 18,606 | ||
Due after ten years | 24,852 | ||
Subtotal | 62,776 | ||
Amortized cost | 65,042 | ||
Fair Value | |||
Due in one year or less | 4,675 | ||
Due in years two through five | 14,733 | ||
Due in years six through ten | 19,091 | ||
Due after ten years | 29,679 | ||
Subtotal | 68,178 | ||
Fair Value | 70,321 | ||
Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Abstract] | |||
Proceeds from sales | 1,820 | $ 1,450 | |
Gross gains on sales | 70 | 8 | |
Gross losses on sales | (6) | (18) | |
Total OTTI | (2) | 0 | |
Fixed Maturities - Credit Loss Impairments | |||
Balances, beginning of period | (21) | (58) | |
Previously recognized impairments on securities that matured, paid, prepaid or sold | 0 | 32 | |
Recognized impairments on securities impaired to fair value this period | 0 | 0 | |
Impairments recognized this period on securities not previously impaired | (2) | 0 | |
Additional impairments this period on securities previously impaired | 0 | 0 | |
Increases due to passage of time on previously recorded credit losses | 0 | 0 | |
Accretion of previously recognized impairments due to increases in expected cash flows | 0 | 0 | |
Balances, end of period | (23) | $ (26) | |
Corporate | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 47,408 | 45,900 | |
Allowance for Credit Losses | 2 | 0 | |
Gross Unrealized Gains | 1,760 | 2,361 | |
Gross Unrealized Losses | 844 | 62 | |
Fixed maturities available for sale, at fair value | 48,322 | 48,199 | |
U.S. Treasury, government and agency | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 14,226 | 14,410 | |
Allowance for Credit Losses | 0 | 0 | |
Gross Unrealized Gains | 4,407 | 1,289 | |
Gross Unrealized Losses | 0 | 305 | |
Fixed maturities available for sale, at fair value | 18,633 | 15,394 | |
States and political subdivisions | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 661 | 638 | |
Allowance for Credit Losses | 0 | 0 | |
Gross Unrealized Gains | 71 | 70 | |
Gross Unrealized Losses | 7 | 3 | |
Fixed maturities available for sale, at fair value | 725 | 705 | |
Foreign governments | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 483 | 462 | |
Allowance for Credit Losses | 0 | 0 | |
Gross Unrealized Gains | 27 | 35 | |
Gross Unrealized Losses | 12 | 5 | |
Fixed maturities available for sale, at fair value | 498 | 492 | |
Residential mortgage-backed | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 170 | 178 | |
Allowance for Credit Losses | 0 | 0 | |
Gross Unrealized Gains | 14 | 13 | |
Gross Unrealized Losses | 0 | 0 | |
Fixed maturities available for sale, at fair value | 184 | 191 | |
Amortized Cost | |||
Without single maturity date | 170 | ||
Fair Value | |||
Without single maturity date | 184 | ||
Asset-backed | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 1,514 | 848 | |
Allowance for Credit Losses | 0 | 0 | |
Gross Unrealized Gains | 6 | 4 | |
Gross Unrealized Losses | 124 | 3 | |
Fixed maturities available for sale, at fair value | 1,396 | 849 | |
Amortized Cost | |||
Without single maturity date | 1,514 | ||
Fair Value | |||
Without single maturity date | 1,396 | ||
Commercial mortgage-backed | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 37 | ||
Allowance for Credit Losses | 0 | ||
Gross Unrealized Gains | 2 | ||
Gross Unrealized Losses | 0 | ||
Fixed maturities available for sale, at fair value | 39 | ||
Amortized Cost | |||
Without single maturity date | 37 | ||
Fair Value | |||
Without single maturity date | 39 | ||
Redeemable preferred stock | |||
Debt Securities, Available-for-sale [Line Items] | |||
Amortized Cost | 545 | 501 | |
Allowance for Credit Losses | 0 | 0 | |
Gross Unrealized Gains | 10 | 17 | |
Gross Unrealized Losses | 31 | 5 | |
Fixed maturities available for sale, at fair value | 524 | $ 513 | |
Amortized Cost | |||
Without single maturity date | 545 | ||
Fair Value | |||
Without single maturity date | $ 524 |
INVESTMENTS - Net Unrealized In
INVESTMENTS - Net Unrealized Investments (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Beginning of year | $ 15,126 | $ 15,432 |
Deferred income taxes | (382) | (218) |
End of year | 21,640 | 14,682 |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Net Unrealized Gains (Losses) on Investments | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Beginning of year | 3,453 | (522) |
Net investment gains (losses) arising during the period | 1,922 | 1,710 |
Included in Net income (loss) | (62) | (1) |
Excluded from Net earnings (loss) | 0 | 0 |
Net unrealized investment gains (losses) excluding OTTI losses | 5,313 | 1,187 |
Net unrealized investment gains (losses) with OTTI losses | (7) | 1 |
End of year | 5,306 | 1,188 |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | DAC | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Beginning of year | (899) | 100 |
DAC | (23) | (701) |
Net unrealized investment gains (losses) excluding OTTI losses | (922) | (601) |
End of year | (921) | (601) |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Policyholders’ Liabilities | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Beginning of year | (189) | (73) |
Policyholders liabilities | (165) | 85 |
Net unrealized investment gains (losses) excluding OTTI losses | (354) | 12 |
End of year | (354) | 12 |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Deferred Income Tax Asset (Liability) | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Beginning of year | (497) | 104 |
Deferred income taxes | (351) | (230) |
Net unrealized investment gains (losses) excluding OTTI losses | (848) | (126) |
End of year | (847) | (126) |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Beginning of year | 1,868 | (391) |
Net investment gains (losses) arising during the period | 1,922 | 1,710 |
Included in Net income (loss) | (62) | (1) |
Excluded from Net earnings (loss) | 0 | 0 |
DAC | (23) | (701) |
Deferred income taxes | (351) | (230) |
Policyholders liabilities | (165) | 85 |
Net unrealized investment gains (losses) excluding OTTI losses | 3,189 | 472 |
Net unrealized investment gains (losses) with OTTI losses | (5) | 1 |
End of year | 3,184 | 473 |
Fixed maturities | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | DAC | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Net unrealized investment gains (losses) with OTTI losses | 1 | 0 |
Fixed maturities | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Policyholders’ Liabilities | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Net unrealized investment gains (losses) with OTTI losses | 0 | 0 |
Fixed maturities | AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent | Unrealized Investment Gains Losses All Other | Deferred Income Tax Asset (Liability) | ||
Debt Securities, Available-for-sale, Net Unrealized Investments [Roll Forward] | ||
Net unrealized investment gains (losses) with OTTI losses | $ 1 | $ 0 |
INVESTMENTS - Fixed Maturities
INVESTMENTS - Fixed Maturities Available-for-sale (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | $ 16,315 | $ 7,553 |
Less than 12 Months, Gross unrealized Losses | 903 | 351 |
12 Months or Longer, Fair Value | 415 | 672 |
12 Months or Longer, Gross unrealized Losses | 111 | 32 |
Total Fair Value | 16,730 | 8,225 |
Total Gross unrealized losses | 1,014 | 383 |
Corporate | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 14,516 | 2,773 |
Less than 12 Months, Gross unrealized Losses | 750 | 42 |
12 Months or Longer, Fair Value | 265 | 373 |
12 Months or Longer, Gross unrealized Losses | 90 | 20 |
Total Fair Value | 14,781 | 3,146 |
Total Gross unrealized losses | 840 | 62 |
U.S. Treasury, government and agency | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 0 | 4,309 |
Less than 12 Months, Gross unrealized Losses | 0 | 305 |
12 Months or Longer, Fair Value | 0 | 2 |
12 Months or Longer, Gross unrealized Losses | 0 | 0 |
Total Fair Value | 0 | 4,311 |
Total Gross unrealized losses | 0 | 305 |
States and political subdivisions | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 188 | 112 |
Less than 12 Months, Gross unrealized Losses | 7 | 3 |
12 Months or Longer, Fair Value | 0 | 0 |
12 Months or Longer, Gross unrealized Losses | 0 | 0 |
Total Fair Value | 188 | 112 |
Total Gross unrealized losses | 7 | 3 |
Foreign governments | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 127 | 11 |
Less than 12 Months, Gross unrealized Losses | 5 | 0 |
12 Months or Longer, Fair Value | 36 | 47 |
12 Months or Longer, Gross unrealized Losses | 8 | 5 |
Total Fair Value | 163 | 58 |
Total Gross unrealized losses | 13 | 5 |
Residential mortgage-backed | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 17 | 0 |
Less than 12 Months, Gross unrealized Losses | 0 | 0 |
12 Months or Longer, Fair Value | 10 | 0 |
12 Months or Longer, Gross unrealized Losses | 0 | 0 |
Total Fair Value | 27 | 0 |
Total Gross unrealized losses | 0 | 0 |
Asset-backed | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 1,202 | 319 |
Less than 12 Months, Gross unrealized Losses | 116 | 1 |
12 Months or Longer, Fair Value | 61 | 201 |
12 Months or Longer, Gross unrealized Losses | 7 | 2 |
Total Fair Value | 1,263 | 520 |
Total Gross unrealized losses | 123 | 3 |
Commercial mortgage-backed | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 0 | 0 |
Less than 12 Months, Gross unrealized Losses | 0 | 0 |
12 Months or Longer, Fair Value | 0 | 0 |
12 Months or Longer, Gross unrealized Losses | 0 | 0 |
Total Fair Value | 0 | 0 |
Total Gross unrealized losses | 0 | 0 |
Redeemable preferred stock | ||
Available For Sale Securities Continuous Unrealized Loss Position [Line Items] | ||
Less than Twelve Months, Fair Value | 265 | 29 |
Less than 12 Months, Gross unrealized Losses | 25 | 0 |
12 Months or Longer, Fair Value | 43 | 49 |
12 Months or Longer, Gross unrealized Losses | 6 | 5 |
Total Fair Value | 308 | 78 |
Total Gross unrealized losses | $ 31 | $ 5 |
INVESTMENTS - Mortgage Loans (D
INVESTMENTS - Mortgage Loans (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2020USD ($) | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Ending balance | $ (46) |
Commercial Real Estate Portfolio Segment | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Beginning balance | (33) |
Current-period provision for expected credit losses | (11) |
Write-offs charged against the allowance | 0 |
Recoveries of amounts previously written off | 1 |
Net change in allowance | (10) |
Ending balance | (43) |
Agricultural Real Estate Portfolio Segment | |
Financing Receivable, Allowance for Credit Loss [Roll Forward] | |
Beginning balance | (3) |
Current-period provision for expected credit losses | 0 |
Write-offs charged against the allowance | 0 |
Recoveries of amounts previously written off | 0 |
Net change in allowance | 0 |
Ending balance | $ (3) |
INVESTMENTS - Credit Quality (D
INVESTMENTS - Credit Quality (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | ||
Mar. 31, 2020 | Dec. 31, 2019 | Mar. 31, 2020 | Dec. 31, 2019 | |
Commercial Mortgage Loans | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | $ 119 | |||
2019 | 852 | |||
2018 | 1,240 | |||
2017 | 1,406 | |||
2016 | 2,773 | |||
Prior | 3,074 | |||
Total | $ 9,464 | $ 9,390 | 9,464 | $ 9,390 |
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 0 | 0 | ||
Current | 9,464 | 9,390 | ||
Total | 9,464 | 9,390 | ||
Non-accruing Loans | 0 | 0 | ||
Total | 9,464 | 9,390 | ||
Non-accruing Loans with No allowance | 0 | 0 | ||
Interest Income on Non-accruing Loans | 0 | 0 | ||
Commercial Mortgage Loans | 30-59 Days | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 0 | 0 | ||
Commercial Mortgage Loans | 60-89 Days | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 0 | 0 | ||
Commercial Mortgage Loans | 90 Days Or Greater | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 0 | 0 | ||
Commercial Mortgage Loans | Greater than 2.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 119 | |||
2019 | 373 | |||
2018 | 680 | |||
2017 | 583 | |||
2016 | 2,242 | |||
Prior | 1,340 | |||
Total | 5,337 | 5,337 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 5,337 | 5,251 | ||
Total | 5,337 | |||
Commercial Mortgage Loans | 1.8x to 2.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 184 | |||
2018 | 48 | |||
2017 | 379 | |||
2016 | 40 | |||
Prior | 451 | |||
Total | 1,102 | 1,102 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,102 | 1,331 | ||
Total | 1,102 | |||
Commercial Mortgage Loans | 1.5x to 1.8x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 242 | |||
2018 | 223 | |||
2017 | 332 | |||
2016 | 491 | |||
Prior | 577 | |||
Total | 1,865 | 1,865 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,865 | 1,546 | ||
Total | 1,865 | |||
Commercial Mortgage Loans | 1.2x to 1.5x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 0 | |||
2018 | 207 | |||
2017 | 75 | |||
2016 | 0 | |||
Prior | 590 | |||
Total | 872 | 872 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 872 | 974 | ||
Total | 872 | |||
Commercial Mortgage Loans | 1.0x to 1.2x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 53 | |||
2018 | 82 | |||
2017 | 37 | |||
2016 | 0 | |||
Prior | 116 | |||
Total | 288 | 288 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 288 | 288 | ||
Total | 288 | |||
Commercial Mortgage Loans | Less than 1.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 0 | |||
2018 | 0 | |||
2017 | 0 | |||
2016 | 0 | |||
Prior | 0 | |||
Total | 0 | 0 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total | 0 | |||
Commercial Mortgage Loans | 0% - 50% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 0 | |||
2018 | 28 | |||
2017 | 324 | |||
2016 | 213 | |||
Prior | 637 | |||
Total | 1,202 | 1,202 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,202 | 1,180 | ||
Total | 1,202 | |||
Commercial Mortgage Loans | 0% - 50% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 942 | 903 | ||
Commercial Mortgage Loans | 0% - 50% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 21 | 38 | ||
Commercial Mortgage Loans | 0% - 50% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 214 | 214 | ||
Commercial Mortgage Loans | 0% - 50% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 25 | 25 | ||
Commercial Mortgage Loans | 0% - 50% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 0% - 50% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 50% - 70% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 119 | |||
2019 | 767 | |||
2018 | 1,003 | |||
2017 | 1,072 | |||
2016 | 2,501 | |||
Prior | 2,046 | |||
Total | 7,508 | 7,508 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 7,508 | 7,447 | ||
Total | 7,508 | |||
Commercial Mortgage Loans | 50% - 70% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 4,143 | 4,097 | ||
Commercial Mortgage Loans | 50% - 70% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 983 | 1,195 | ||
Commercial Mortgage Loans | 50% - 70% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,437 | 1,118 | ||
Commercial Mortgage Loans | 50% - 70% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 704 | 795 | ||
Commercial Mortgage Loans | 50% - 70% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 241 | 242 | ||
Commercial Mortgage Loans | 50% - 70% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 70% - 90% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 85 | |||
2018 | 209 | |||
2017 | 10 | |||
2016 | 59 | |||
Prior | 391 | |||
Total | 754 | 754 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 754 | 763 | ||
Total | 754 | |||
Commercial Mortgage Loans | 70% - 90% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 252 | 251 | ||
Commercial Mortgage Loans | 70% - 90% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 98 | 98 | ||
Commercial Mortgage Loans | 70% - 90% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 214 | 214 | ||
Commercial Mortgage Loans | 70% - 90% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 143 | 154 | ||
Commercial Mortgage Loans | 70% - 90% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 47 | 46 | ||
Commercial Mortgage Loans | 70% - 90% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 90% plus | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 0 | |||
2018 | 0 | |||
2017 | 0 | |||
2016 | 0 | |||
Prior | 0 | |||
Total | 0 | 0 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total | 0 | |||
Commercial Mortgage Loans | 90% plus | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 90% plus | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 90% plus | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 90% plus | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 90% plus | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Commercial Mortgage Loans | 90% plus | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 68 | |||
2019 | 301 | |||
2018 | 354 | |||
2017 | 297 | |||
2016 | 415 | |||
Prior | 1,270 | |||
Total | 2,705 | 2,717 | 2,705 | 2,717 |
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 87 | 124 | ||
Current | 2,618 | 2,593 | ||
Total | 2,705 | 2,717 | ||
Non-accruing Loans | 0 | 0 | ||
Total | 2,705 | 2,717 | ||
Non-accruing Loans with No allowance | 0 | 0 | ||
Interest Income on Non-accruing Loans | 0 | 0 | ||
Agricultural Mortgage Loans | 30-59 Days | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 7 | 57 | ||
Agricultural Mortgage Loans | 60-89 Days | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 17 | 1 | ||
Agricultural Mortgage Loans | 90 Days Or Greater | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 63 | 66 | ||
Agricultural Mortgage Loans | Greater than 2.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 3 | |||
2019 | 38 | |||
2018 | 41 | |||
2017 | 37 | |||
2016 | 77 | |||
Prior | 189 | |||
Total | 385 | 385 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 385 | 404 | ||
Total | 385 | |||
Agricultural Mortgage Loans | 1.8x to 2.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 7 | |||
2019 | 30 | |||
2018 | 15 | |||
2017 | 17 | |||
2016 | 22 | |||
Prior | 102 | |||
Total | 193 | 193 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 193 | 191 | ||
Total | 193 | |||
Agricultural Mortgage Loans | 1.5x to 1.8x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 26 | |||
2019 | 39 | |||
2018 | 47 | |||
2017 | 49 | |||
2016 | 62 | |||
Prior | 249 | |||
Total | 472 | 472 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 472 | 477 | ||
Total | 472 | |||
Agricultural Mortgage Loans | 1.2x to 1.5x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 12 | |||
2019 | 127 | |||
2018 | 150 | |||
2017 | 121 | |||
2016 | 174 | |||
Prior | 413 | |||
Total | 997 | 997 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 997 | 990 | ||
Total | 997 | |||
Agricultural Mortgage Loans | 1.0x to 1.2x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 17 | |||
2019 | 57 | |||
2018 | 92 | |||
2017 | 72 | |||
2016 | 61 | |||
Prior | 276 | |||
Total | 575 | 575 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 575 | 572 | ||
Total | 575 | |||
Agricultural Mortgage Loans | Less than 1.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 3 | |||
2019 | 10 | |||
2018 | 9 | |||
2017 | 1 | |||
2016 | 19 | |||
Prior | 41 | |||
Total | 83 | 83 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 83 | 83 | ||
Total | 83 | |||
Agricultural Mortgage Loans | 0% - 50% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 30 | |||
2019 | 136 | |||
2018 | 164 | |||
2017 | 171 | |||
2016 | 270 | |||
Prior | 834 | |||
Total | 1,605 | 1,605 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,605 | 1,583 | ||
Total | 1,605 | |||
Agricultural Mortgage Loans | 0% - 50% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 304 | 322 | ||
Agricultural Mortgage Loans | 0% - 50% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 110 | 104 | ||
Agricultural Mortgage Loans | 0% - 50% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 252 | 241 | ||
Agricultural Mortgage Loans | 0% - 50% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 558 | 545 | ||
Agricultural Mortgage Loans | 0% - 50% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 333 | 321 | ||
Agricultural Mortgage Loans | 0% - 50% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 48 | 50 | ||
Agricultural Mortgage Loans | 50% - 70% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 38 | |||
2019 | 165 | |||
2018 | 187 | |||
2017 | 126 | |||
2016 | 145 | |||
Prior | 420 | |||
Total | 1,081 | 1,081 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,081 | 1,115 | ||
Total | 1,081 | |||
Agricultural Mortgage Loans | 50% - 70% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 81 | 82 | ||
Agricultural Mortgage Loans | 50% - 70% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 83 | 87 | ||
Agricultural Mortgage Loans | 50% - 70% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 220 | 236 | ||
Agricultural Mortgage Loans | 50% - 70% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 420 | 426 | ||
Agricultural Mortgage Loans | 50% - 70% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 242 | 251 | ||
Agricultural Mortgage Loans | 50% - 70% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 35 | 33 | ||
Agricultural Mortgage Loans | 70% - 90% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 0 | |||
2018 | 3 | |||
2017 | 0 | |||
2016 | 0 | |||
Prior | 16 | |||
Total | 19 | 19 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 19 | 19 | ||
Total | 19 | |||
Agricultural Mortgage Loans | 70% - 90% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 70% - 90% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 70% - 90% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 70% - 90% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 19 | 19 | ||
Agricultural Mortgage Loans | 70% - 90% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 70% - 90% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 90% plus | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 0 | |||
2018 | 0 | |||
2017 | 0 | |||
2016 | 0 | |||
Prior | 0 | |||
Total | 0 | 0 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total | 0 | |||
Agricultural Mortgage Loans | 90% plus | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 90% plus | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 90% plus | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 90% plus | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 90% plus | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Agricultural Mortgage Loans | 90% plus | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total Mortgages Loan | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 187 | |||
2019 | 1,153 | |||
2018 | 1,594 | |||
2017 | 1,703 | |||
2016 | 3,188 | |||
Prior | 4,344 | |||
Total | 12,169 | 12,107 | 12,169 | 12,107 |
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 87 | 124 | ||
Current | 12,082 | 11,983 | ||
Total | 12,169 | 12,107 | ||
Non-accruing Loans | 0 | 0 | ||
Total | 12,169 | 12,107 | ||
Non-accruing Loans with No allowance | 0 | 0 | ||
Interest Income on Non-accruing Loans | 0 | $ 0 | ||
Total Mortgages Loan | 30-59 Days | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 7 | 57 | ||
Total Mortgages Loan | 60-89 Days | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 17 | 1 | ||
Total Mortgages Loan | 90 Days Or Greater | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total Past Due | 63 | 66 | ||
Total Mortgages Loan | Greater than 2.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 122 | |||
2019 | 411 | |||
2018 | 721 | |||
2017 | 620 | |||
2016 | 2,319 | |||
Prior | 1,529 | |||
Total | 5,722 | 5,722 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 5,722 | 5,655 | ||
Total | 5,722 | |||
Total Mortgages Loan | 1.8x to 2.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 7 | |||
2019 | 214 | |||
2018 | 63 | |||
2017 | 396 | |||
2016 | 62 | |||
Prior | 553 | |||
Total | 1,295 | 1,295 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,295 | 1,522 | ||
Total | 1,295 | |||
Total Mortgages Loan | 1.5x to 1.8x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 26 | |||
2019 | 281 | |||
2018 | 270 | |||
2017 | 381 | |||
2016 | 553 | |||
Prior | 826 | |||
Total | 2,337 | 2,337 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 2,337 | 2,023 | ||
Total | 2,337 | |||
Total Mortgages Loan | 1.2x to 1.5x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 12 | |||
2019 | 127 | |||
2018 | 357 | |||
2017 | 196 | |||
2016 | 174 | |||
Prior | 1,003 | |||
Total | 1,869 | 1,869 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,869 | 1,964 | ||
Total | 1,869 | |||
Total Mortgages Loan | 1.0x to 1.2x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 17 | |||
2019 | 110 | |||
2018 | 174 | |||
2017 | 109 | |||
2016 | 61 | |||
Prior | 392 | |||
Total | 863 | 863 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 863 | 860 | ||
Total | 863 | |||
Total Mortgages Loan | Less than 1.0x | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 3 | |||
2019 | 10 | |||
2018 | 9 | |||
2017 | 1 | |||
2016 | 19 | |||
Prior | 41 | |||
Total | 83 | 83 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 83 | 83 | ||
Total | 83 | |||
Total Mortgages Loan | 0% - 50% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 30 | |||
2019 | 136 | |||
2018 | 192 | |||
2017 | 495 | |||
2016 | 483 | |||
Prior | 1,471 | |||
Total | 2,807 | 2,807 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 2,807 | 2,763 | ||
Total | 2,807 | |||
Total Mortgages Loan | 0% - 50% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,246 | 1,225 | ||
Total Mortgages Loan | 0% - 50% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 131 | 142 | ||
Total Mortgages Loan | 0% - 50% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 466 | 455 | ||
Total Mortgages Loan | 0% - 50% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 583 | 570 | ||
Total Mortgages Loan | 0% - 50% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 333 | 321 | ||
Total Mortgages Loan | 0% - 50% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 48 | 50 | ||
Total Mortgages Loan | 50% - 70% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 157 | |||
2019 | 932 | |||
2018 | 1,190 | |||
2017 | 1,198 | |||
2016 | 2,646 | |||
Prior | 2,466 | |||
Total | 8,589 | 8,589 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 8,589 | 8,562 | ||
Total | 8,589 | |||
Total Mortgages Loan | 50% - 70% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 4,224 | 4,179 | ||
Total Mortgages Loan | 50% - 70% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,066 | 1,282 | ||
Total Mortgages Loan | 50% - 70% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,657 | 1,354 | ||
Total Mortgages Loan | 50% - 70% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 1,124 | 1,221 | ||
Total Mortgages Loan | 50% - 70% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 483 | 493 | ||
Total Mortgages Loan | 50% - 70% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 35 | 33 | ||
Total Mortgages Loan | 70% - 90% | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 85 | |||
2018 | 212 | |||
2017 | 10 | |||
2016 | 59 | |||
Prior | 407 | |||
Total | 773 | 773 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 773 | 782 | ||
Total | 773 | |||
Total Mortgages Loan | 70% - 90% | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 252 | 251 | ||
Total Mortgages Loan | 70% - 90% | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 98 | 98 | ||
Total Mortgages Loan | 70% - 90% | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 214 | 214 | ||
Total Mortgages Loan | 70% - 90% | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 162 | 173 | ||
Total Mortgages Loan | 70% - 90% | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 47 | 46 | ||
Total Mortgages Loan | 70% - 90% | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total Mortgages Loan | 90% plus | ||||
Financing Receivable, before Allowance for Credit Loss [Abstract] | ||||
2020 | 0 | |||
2019 | 0 | |||
2018 | 0 | |||
2017 | 0 | |||
2016 | 0 | |||
Prior | 0 | |||
Total | 0 | 0 | ||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total | $ 0 | |||
Total Mortgages Loan | 90% plus | Greater than 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total Mortgages Loan | 90% plus | 1.8x to 2.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total Mortgages Loan | 90% plus | 1.5x to 1.8x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total Mortgages Loan | 90% plus | 1.2x to 1.5x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total Mortgages Loan | 90% plus | 1.0x to 1.2x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | 0 | 0 | ||
Total Mortgages Loan | 90% plus | Less than 1.0x | ||||
Age Analysis of Past Due Mortgage Loan | ||||
Total | $ 0 | $ 0 |
INVESTMENTS - Trading Securitie
INVESTMENTS - Trading Securities (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Investments, Debt and Equity Securities [Abstract] | ||
Net investment gains (losses) recognized during the period on securities held at the end of the period | $ (186) | $ 318 |
Net investment gains (losses) recognized on securities sold during the period | 4 | (24) |
Unrealized and realized gains (losses) on trading securities | (182) | 294 |
Interest and dividend income from trading securities | 51 | 92 |
Net investment income (loss) from trading securities | $ (131) | $ 386 |
DERIVATIVES - Derivatives by Ca
DERIVATIVES - Derivatives by Category (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
Derivatives, Fair Value [Line Items] | |||
Notional Amount | $ 100,860 | $ 119,128 | |
Asset Derivatives | 8,603 | 7,993 | |
Liability Derivatives | 16,303 | 17,291 | |
Gains (Losses) Reported In Earnings (Loss) | 9,401 | $ (1,630) | |
Futures | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 6,317 | 4,257 | |
Asset Derivatives | 2 | 1 | |
Liability Derivatives | 5 | 1 | |
Gains (Losses) Reported In Earnings (Loss) | 220 | (762) | |
Swaps | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 12,947 | 17,156 | |
Asset Derivatives | 585 | 9 | |
Liability Derivatives | 124 | 281 | |
Gains (Losses) Reported In Earnings (Loss) | 3,778 | (985) | |
Options | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 30,050 | 47,861 | |
Asset Derivatives | 2,547 | 5,098 | |
Liability Derivatives | 3,086 | 1,752 | |
Gains (Losses) Reported In Earnings (Loss) | (3,851) | 1,111 | |
Swaps | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 22,896 | 23,793 | |
Asset Derivatives | 2,475 | 468 | |
Liability Derivatives | 343 | 526 | |
Gains (Losses) Reported In Earnings (Loss) | 3,578 | 648 | |
Futures | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 26,713 | 20,901 | |
Asset Derivatives | 0 | 0 | |
Liability Derivatives | 0 | 0 | |
Gains (Losses) Reported In Earnings (Loss) | 1,988 | 56 | |
Swaptions | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 3,201 | |
Asset Derivatives | 0 | 16 | |
Liability Derivatives | 0 | 0 | |
Gains (Losses) Reported In Earnings (Loss) | 9 | 0 | |
Credit default swaps | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 1,507 | 1,400 | |
Asset Derivatives | 26 | 21 | |
Liability Derivatives | 22 | 6 | |
Gains (Losses) Reported In Earnings (Loss) | (1) | 7 | |
Foreign currency contracts | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 430 | 559 | |
Asset Derivatives | 9 | 12 | |
Liability Derivatives | 8 | 9 | |
Gains (Losses) Reported In Earnings (Loss) | (2) | 10 | |
Margin | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Asset Derivatives | 107 | 155 | |
Liability Derivatives | 171 | 0 | |
Gains (Losses) Reported In Earnings (Loss) | 0 | 0 | |
Collateral | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Asset Derivatives | 29 | 74 | |
Liability Derivatives | 3,757 | 3,016 | |
Gains (Losses) Reported In Earnings (Loss) | 0 | 0 | |
GMIB Reinsurance Contracts | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | ||
Asset Derivatives | 2,823 | 2,139 | |
Liability Derivatives | 0 | 0 | |
Gains (Losses) Reported In Earnings (Loss) | 726 | 18 | |
GMxB Derivative Features’ Liability | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Asset Derivatives | 0 | 0 | |
Liability Derivatives | 9,727 | 8,432 | |
Gains (Losses) Reported In Earnings (Loss) | (1,198) | (408) | |
SCS, SIO, MSO and IUL Indexed Features | |||
Derivatives, Fair Value [Line Items] | |||
Notional Amount | 0 | 0 | |
Asset Derivatives | 0 | 0 | |
Liability Derivatives | (940) | $ 3,268 | |
Gains (Losses) Reported In Earnings (Loss) | $ 4,154 | $ (1,325) |
DERIVATIVES - Narrative (Detail
DERIVATIVES - Narrative (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Derivative [Line Items] | ||
Cash and securities collateral for derivative contract | $ 3,800 | $ 3,000 |
Cash and securities collateral | 29 | 74 |
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices | ||
Derivative [Line Items] | ||
Initial margin requirement | 466 | 252 |
Us Treasury Notes Ultra Long Bonds And Euro Dollar | ||
Derivative [Line Items] | ||
Initial margin requirement | 651 | 166 |
Euro Stoxx, FTSE100, EAFE And Topix Indices | ||
Derivative [Line Items] | ||
Initial margin requirement | $ 159 | $ 60 |
DERIVATIVES - Offsetting of Fin
DERIVATIVES - Offsetting of Financial Assets and Liabilities and Derivative Instruments (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Total derivatives | ||
Assets | ||
Gross Amount Recognized | $ 5,779 | $ 5,852 |
Gross Amount Recognized | 5,522 | 5,466 |
Net Amount Presented in the Balance Sheets | 257 | 386 |
Gross Amount not Offset in the Balance Sheets | (162) | (77) |
Net Amount | 95 | 309 |
Liabilities | ||
Gross Amount Recognized | 7,354 | 5,512 |
Gross Amount Offset in the Balance Sheets | 5,522 | 5,466 |
Net Amount Presented in the Balance Sheets | 1,832 | 46 |
Gross Amount not Offset in the Balance Sheets | 0 | 0 |
Net Amount | 1,832 | 46 |
Other financial instruments | ||
Assets | ||
Gross Amount Recognized | 1,855 | 2,394 |
Gross Amount Recognized | 0 | 0 |
Net Amount Presented in the Balance Sheets | 1,855 | 2,394 |
Gross Amount not Offset in the Balance Sheets | 0 | 0 |
Net Amount | 1,855 | 2,394 |
Other invested assets | ||
Assets | ||
Gross Amount Recognized | 7,634 | 8,246 |
Gross Amount Recognized | 5,522 | 5,466 |
Net Amount Presented in the Balance Sheets | 2,112 | 2,780 |
Gross Amount not Offset in the Balance Sheets | (162) | (77) |
Net Amount | 1,950 | 2,703 |
Other financial liabilities | ||
Liabilities | ||
Gross Amount Recognized | 3,884 | 3,924 |
Gross Amount Offset in the Balance Sheets | 0 | 0 |
Net Amount Presented in the Balance Sheets | 3,884 | 3,924 |
Gross Amount not Offset in the Balance Sheets | 0 | 0 |
Net Amount | 3,884 | 3,924 |
Other liabilities | ||
Liabilities | ||
Gross Amount Recognized | 11,238 | 9,436 |
Gross Amount Offset in the Balance Sheets | 5,522 | 5,466 |
Net Amount Presented in the Balance Sheets | 5,716 | 3,970 |
Gross Amount not Offset in the Balance Sheets | 0 | 0 |
Net Amount | $ 5,716 | $ 3,970 |
GOODWILL - Narrative (Details)
GOODWILL - Narrative (Details) - USD ($) $ in Billions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2020 | Dec. 31, 2019 | |
Alliance Bernstein | Investment Management | ||
Goodwill [Line Items] | ||
Amortization of intangible assets | $ 4.6 | $ 4.6 |
CLOSED BLOCK - Closed Block Sum
CLOSED BLOCK - Closed Block Summarized Financial Information (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Closed Block Liabilities: | ||
Future policy benefits, policyholders’ account balances and other | $ 6,404 | $ 6,478 |
Policyholder dividend obligation | 0 | 2 |
Other liabilities | 76 | 38 |
Total Closed Block liabilities | 6,480 | 6,518 |
Assets Designated to the Closed Block: | ||
Fixed maturities available-for-sale, at fair value, net of allowance for credit losses of $0 and $0 (amortized cost of $3,557 and $3,558) | 3,684 | 3,754 |
Mortgage loans on real estate, net of allowance for credit losses of $4 and $0 | 1,742 | 1,759 |
Policy loans | 676 | 706 |
Cash and other invested assets | 112 | 82 |
Other assets | 133 | 145 |
Total assets designated to the Closed Block | 6,347 | 6,446 |
Excess of Closed Block liabilities over assets designated to the Closed Block | 133 | 72 |
Amounts included in accumulated other comprehensive income (loss): | ||
Net unrealized investment gains (losses), net of policyholders’ dividend obligation: $0 and $(2); and net of income tax: $27 and $41 | 111 | 164 |
Maximum future earnings to be recognized from Closed Block assets and liabilities | 244 | 236 |
Fixed maturities available-for-sale, allowance for credit losses | 0 | 0 |
Fixed maturity available for sale, amortized cost | 3,557 | 3,558 |
Mortgage loans, credit losses | 4 | 0 |
Policyholder dividend obligation | 0 | (2) |
Closed block operations, income taxes | $ 27 | $ 41 |
CLOSED BLOCK - Closed Block Rev
CLOSED BLOCK - Closed Block Revenues and Expenses (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Revenues: | ||
Premiums and other income | $ 42 | $ 48 |
Net investment income (loss) | 66 | 67 |
Investment gains (losses), net | 0 | (1) |
Total revenues | 108 | 114 |
Benefits and Other Deductions: | ||
Policyholders’ benefits and dividends | 103 | 121 |
Other operating costs and expenses | 0 | 1 |
Total benefits and other deductions | 103 | 122 |
Net income (loss), before income taxes | 5 | (8) |
Income tax (expense) benefit | 0 | (1) |
Net income (loss) | $ 5 | $ (9) |
INSURANCE LIABILITIES - Rollfor
INSURANCE LIABILITIES - Rollforward of Liability and Reinsurance Ceded (Details) - USD ($) $ in Millions | 3 Months Ended | |||
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | Dec. 31, 2018 | |
GMDB Direct | ||||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | ||||
Opening Balance | $ 5,052 | $ 4,670 | $ 4,784 | $ 4,659 |
Paid guarantee benefits | (111) | (118) | ||
Other changes in reserves | 379 | 129 | ||
Closing Balance | 5,052 | 4,670 | 4,784 | 4,659 |
GMDB Assumed | ||||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | ||||
Opening Balance | 72 | 77 | 76 | 82 |
Paid guarantee benefits | (6) | (6) | ||
Other changes in reserves | 2 | 1 | ||
Closing Balance | 72 | 77 | 76 | 82 |
GMDB | ||||
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward] | ||||
Opening Balance | (105) | (113) | ||
Paid guarantee benefits | 5 | 4 | ||
Other changes in reserve | (11) | 0 | ||
Ending Balance | (111) | (109) | ||
GMIB Direct | ||||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | ||||
Opening Balance | 6,299 | 3,742 | 4,691 | 3,743 |
Paid guarantee benefits | (74) | (56) | ||
Other changes in reserves | 1,682 | 55 | ||
Closing Balance | 6,299 | 3,742 | 4,691 | 3,743 |
GMIB Assumed | ||||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | ||||
Opening Balance | 219 | 182 | 187 | 184 |
Paid guarantee benefits | (1) | (1) | ||
Other changes in reserves | 33 | (1) | ||
Closing Balance | 219 | 182 | $ 187 | $ 184 |
GMIB Ceded | ||||
Guaranteed Minimum Death Benefit Reinsurance Ceded [Roll Forward] | ||||
Opening Balance | (2,139) | (1,732) | ||
Paid guarantee benefits | 20 | 21 | ||
Other changes in reserve | (704) | (29) | ||
Ending Balance | $ (2,823) | $ (1,740) |
INSURANCE LIABILITIES - Variabl
INSURANCE LIABILITIES - Variable Annuity Contracts with GMDB and GMIB Features and Buybacks (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Dec. 31, 2019 | |
GMDB | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Separate Accounts | $ 78,940 | $ 94,488 |
GMDB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | 14,988 | |
Separate Accounts | 78,940 | |
Net Amount At Risk By Product And Guarantee, Account Value | 93,928 | |
Net Amount at Risk, gross | 26,769 | |
Net Amount at Risk, net of amounts reinsured | $ 26,100 | |
Average attained age of contractholders (in years) | 55 years 1 month 6 days | |
Percentage of policyholders over age 70 | 19.50% | |
GMDB | Direct Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
GMDB | Direct Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.50% | |
GMDB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 6,299 | |
Net Amount at Risk, gross | $ 925 | |
Average attained age of contractholders (in years) | 73 years | |
Percentage of policyholders over age 70 | 65.00% | |
GMDB | Deferred Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
GMDB | Deferred Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 10.00% | |
GMIB | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Separate Accounts | $ 50,200 | $ 59,348 |
GMIB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | 246 | |
Separate Accounts | 50,200 | |
Net Amount At Risk By Product And Guarantee, Account Value | 50,446 | |
Net Amount at Risk, gross | 18,928 | |
Net Amount at Risk, net of amounts reinsured | $ 16,199 | |
Average attained age of contractholders (in years) | 69 years 7 months 6 days | |
Weighted average years remaining until annuitization (in years) | 4 months 24 days | |
GMIB | Direct Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
GMIB | Direct Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.50% | |
GMIB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 1,927 | |
Net Amount at Risk, gross | $ 496 | |
Average attained age of contractholders (in years) | 71 years | |
Percentage of policyholders over age 70 | 59.10% | |
GMIB | Deferred Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.30% | |
GMIB | Deferred Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.50% | |
Return of Premium | GMDB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 14,662 | |
Separate Accounts | 40,733 | |
Net Amount At Risk By Product And Guarantee, Account Value | 55,395 | |
Net Amount at Risk, gross | 715 | |
Net Amount at Risk, net of amounts reinsured | $ 715 | |
Average attained age of contractholders (in years) | 51 years 1 month 6 days | |
Percentage of policyholders over age 70 | 10.70% | |
Return of Premium | GMDB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 776 | |
Net Amount at Risk, gross | $ 13 | |
Average attained age of contractholders (in years) | 68 years | |
Percentage of policyholders over age 70 | 46.30% | |
Return of Premium | GMIB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 0 | |
Separate Accounts | 0 | |
Net Amount At Risk By Product And Guarantee, Account Value | 0 | |
Net Amount at Risk, gross | 0 | |
Net Amount at Risk, net of amounts reinsured | 0 | |
Return of Premium | GMIB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | 744 | |
Net Amount at Risk, gross | $ 2 | |
Average attained age of contractholders (in years) | 72 years | |
Percentage of policyholders over age 70 | 65.10% | |
Ratchet | GMDB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 92 | |
Separate Accounts | 7,887 | |
Net Amount At Risk By Product And Guarantee, Account Value | 7,979 | |
Net Amount at Risk, gross | 877 | |
Net Amount at Risk, net of amounts reinsured | $ 857 | |
Average attained age of contractholders (in years) | 67 years 9 months 18 days | |
Percentage of policyholders over age 70 | 46.40% | |
Ratchet | GMDB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 4,352 | |
Net Amount at Risk, gross | $ 627 | |
Average attained age of contractholders (in years) | 73 years | |
Percentage of policyholders over age 70 | 65.20% | |
Ratchet | GMIB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 0 | |
Separate Accounts | 0 | |
Net Amount At Risk By Product And Guarantee, Account Value | 0 | |
Net Amount at Risk, gross | 0 | |
Net Amount at Risk, net of amounts reinsured | 0 | |
Ratchet | GMIB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | 37 | |
Net Amount at Risk, gross | $ 3 | |
Average attained age of contractholders (in years) | 74 years | |
Percentage of policyholders over age 70 | 62.80% | |
Roll-Up | GMDB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 58 | |
Separate Accounts | 2,607 | |
Net Amount At Risk By Product And Guarantee, Account Value | 2,665 | |
Net Amount at Risk, gross | 2,296 | |
Net Amount at Risk, net of amounts reinsured | $ 1,647 | |
Average attained age of contractholders (in years) | 74 years 4 months 24 days | |
Percentage of policyholders over age 70 | 68.70% | |
Roll-Up | GMDB | Direct Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
Roll-Up | GMDB | Direct Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.00% | |
Roll-Up | GMDB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 225 | |
Net Amount at Risk, gross | $ 22 | |
Average attained age of contractholders (in years) | 78 years | |
Percentage of policyholders over age 70 | 80.70% | |
Roll-Up | GMDB | Deferred Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
Roll-Up | GMDB | Deferred Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 10.00% | |
Roll-Up | GMIB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 18 | |
Separate Accounts | 20,724 | |
Net Amount At Risk By Product And Guarantee, Account Value | 20,742 | |
Net Amount at Risk, gross | 1,360 | |
Net Amount at Risk, net of amounts reinsured | $ 425 | |
Average attained age of contractholders (in years) | 68 years 10 months 25 days | |
Weighted average years remaining until annuitization (in years) | 1 year 7 months 6 days | |
Roll-Up | GMIB | Direct Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
Roll-Up | GMIB | Direct Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.00% | |
Roll-Up | GMIB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 190 | |
Net Amount at Risk, gross | $ 46 | |
Average attained age of contractholders (in years) | 72 years | |
Percentage of policyholders over age 70 | 61.50% | |
Roll-Up | GMIB | Deferred Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.30% | |
Roll-Up | GMIB | Deferred Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.50% | |
Combo | GMDB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 176 | |
Separate Accounts | 27,713 | |
Net Amount At Risk By Product And Guarantee, Account Value | 27,889 | |
Net Amount at Risk, gross | 22,881 | |
Net Amount at Risk, net of amounts reinsured | $ 22,881 | |
Average attained age of contractholders (in years) | 69 years 7 months 6 days | |
Percentage of policyholders over age 70 | 51.60% | |
Combo | GMDB | Direct Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
Combo | GMDB | Direct Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.50% | |
Combo | GMDB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 946 | |
Net Amount at Risk, gross | $ 263 | |
Average attained age of contractholders (in years) | 76 years | |
Percentage of policyholders over age 70 | 75.80% | |
Combo | GMDB | Deferred Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 5.00% | |
Combo | GMDB | Deferred Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 10.00% | |
Combo | GMIB | Direct Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 228 | |
Separate Accounts | 29,476 | |
Net Amount At Risk By Product And Guarantee, Account Value | 29,704 | |
Net Amount at Risk, gross | 17,568 | |
Net Amount at Risk, net of amounts reinsured | $ 15,774 | |
Average attained age of contractholders (in years) | 69 years 8 months 12 days | |
Weighted average years remaining until annuitization (in years) | 3 months 19 days | |
Combo | GMIB | Direct Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 3.00% | |
Combo | GMIB | Direct Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.50% | |
Combo | GMIB | Deferred Variable Annuity | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
General Account | $ 956 | |
Net Amount at Risk, gross | $ 445 | |
Average attained age of contractholders (in years) | 69 years | |
Percentage of policyholders over age 70 | 53.80% | |
Combo | GMIB | Deferred Variable Annuity | Minimum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.00% | |
Combo | GMIB | Deferred Variable Annuity | Maximum | ||
Net Amount at Risk by Product and Guarantee [Line Items] | ||
Range of contractually specified interest rates (as a percent) | 6.00% |
INSURANCE LIABILITIES - Separat
INSURANCE LIABILITIES - Separate Account Investments, Hedging Programs and Variable and Interest-Sensitive Live Insurance Policies (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
GMDB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | $ 78,940 | $ 94,488 | |
GMIB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 50,200 | 59,348 | |
Direct Liabilities For Guarantees | |||
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward] | |||
Opening Balance | 897 | $ 812 | |
Paid guarantee benefits | (13) | (7) | |
Other changes in reserves | 41 | 20 | |
Closing Balance | 925 | $ 825 | |
Adjustment to Assets held-for-sale | 22 | ||
Equity | GMDB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 32,913 | 42,489 | |
Equity | GMIB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 13,765 | 17,941 | |
Fixed income | GMDB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 5,151 | 5,263 | |
Fixed income | GMIB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 2,680 | 2,699 | |
Balanced | GMDB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 39,965 | 45,871 | |
Balanced | GMIB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 33,483 | 38,445 | |
Other | GMDB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | 911 | 865 | |
Other | GMIB | |||
Liabilities for Guarantees on Long-Duration Contracts [Line Items] | |||
Separate Accounts | $ 272 | $ 263 |
FAIR VALUE DISCLOSURES - Assets
FAIR VALUE DISCLOSURES - Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Investments: | ||
Fixed maturities available for sale, at fair value | $ 70,321 | $ 66,343 |
U.S. Treasury, government and agency | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 18,633 | 15,394 |
States and political subdivisions | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 725 | 705 |
Foreign governments | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 498 | 492 |
Residential mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 184 | 191 |
Asset-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 1,396 | 849 |
Commercial mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 39 | |
Redeemable preferred stock | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 524 | 513 |
Fair Value, Measurements, Recurring | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 70,321 | 66,343 |
Other equity investments | 99 | 110 |
Trading securities, at fair value | 6,534 | 7,031 |
Other invested assets: | 2,677 | 4,146 |
Cash equivalents | 9,026 | 3,497 |
Segregated securities | 2,013 | 1,095 |
GMIB reinsurance contracts asset | 2,823 | 2,139 |
Separate Accounts assets | 105,485 | 126,324 |
Total Assets | 198,978 | 210,685 |
Liabilities: | ||
Contingent payment arrangements | 24 | 23 |
Total Liabilities | 8,831 | 11,733 |
Fair Value, Measurements, Recurring | Corporate | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 48,322 | 48,199 |
Fair Value, Measurements, Recurring | U.S. Treasury, government and agency | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 18,633 | 15,394 |
Fair Value, Measurements, Recurring | States and political subdivisions | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 725 | 705 |
Fair Value, Measurements, Recurring | Foreign governments | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 498 | 492 |
Fair Value, Measurements, Recurring | Residential mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 184 | 191 |
Fair Value, Measurements, Recurring | Asset-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 1,396 | 849 |
Fair Value, Measurements, Recurring | Commercial mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 39 | 0 |
Fair Value, Measurements, Recurring | Redeemable preferred stock | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 524 | 513 |
Fair Value, Measurements, Recurring | Short-term investments | ||
Investments: | ||
Other invested assets: | 142 | 490 |
Fair Value, Measurements, Recurring | Assets of consolidated VIEs/VOEs | ||
Investments: | ||
Other invested assets: | 479 | 606 |
Fair Value, Measurements, Recurring | Swap | ||
Investments: | ||
Other invested assets: | 2,594 | (327) |
Fair Value, Measurements, Recurring | Credit default swaps | ||
Investments: | ||
Other invested assets: | 4 | 15 |
Fair Value, Measurements, Recurring | Future | ||
Investments: | ||
Other invested assets: | (3) | |
Fair Value, Measurements, Recurring | Options Held | ||
Investments: | ||
Other invested assets: | (539) | 3,346 |
Fair Value, Measurements, Recurring | Swaption | ||
Investments: | ||
Other invested assets: | 0 | 16 |
Fair Value, Measurements, Recurring | Guaranteed Minimum Withdrawal Benefit | ||
Liabilities: | ||
Guarantees | 9,727 | 8,432 |
Fair Value, Measurements, Recurring | SCS, SIO, MSO and IUL indexed features liability | ||
Liabilities: | ||
Guarantees | (940) | 3,268 |
Fair Value, Measurements, Recurring | Level 1 | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 252 | 239 |
Other equity investments | 12 | 13 |
Trading securities, at fair value | 438 | 500 |
Other invested assets: | 95 | 132 |
Cash equivalents | 9,026 | 3,497 |
Segregated securities | 0 | 0 |
GMIB reinsurance contracts asset | 0 | 0 |
Separate Accounts assets | 102,853 | 123,432 |
Total Assets | 112,676 | 127,813 |
Liabilities: | ||
Contingent payment arrangements | 0 | 0 |
Total Liabilities | 1 | 1 |
Fair Value, Measurements, Recurring | Level 1 | Corporate | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury, government and agency | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | States and political subdivisions | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Foreign governments | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Residential mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Asset-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Commercial mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Redeemable preferred stock | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 252 | 239 |
Fair Value, Measurements, Recurring | Level 1 | Short-term investments | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Assets of consolidated VIEs/VOEs | ||
Investments: | ||
Other invested assets: | 98 | 132 |
Fair Value, Measurements, Recurring | Level 1 | Swap | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Credit default swaps | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Future | ||
Investments: | ||
Other invested assets: | (3) | |
Fair Value, Measurements, Recurring | Level 1 | Options Held | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Swaption | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | Guaranteed Minimum Withdrawal Benefit | ||
Liabilities: | ||
Guarantees | 0 | 0 |
Fair Value, Measurements, Recurring | Level 1 | SCS, SIO, MSO and IUL indexed features liability | ||
Liabilities: | ||
Guarantees | 0 | 0 |
Fair Value, Measurements, Recurring | Level 2 | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 68,808 | 64,708 |
Other equity investments | 0 | 0 |
Trading securities, at fair value | 6,059 | 6,495 |
Other invested assets: | 2,566 | 3,997 |
Cash equivalents | 0 | 0 |
Segregated securities | 2,013 | 1,095 |
GMIB reinsurance contracts asset | 0 | 0 |
Separate Accounts assets | 2,632 | 2,892 |
Total Assets | 82,078 | 79,187 |
Liabilities: | ||
Contingent payment arrangements | 0 | 0 |
Total Liabilities | (921) | 3,277 |
Fair Value, Measurements, Recurring | Level 2 | Corporate | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 47,137 | 46,942 |
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury, government and agency | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 18,633 | 15,394 |
Fair Value, Measurements, Recurring | Level 2 | States and political subdivisions | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 689 | 666 |
Fair Value, Measurements, Recurring | Level 2 | Foreign governments | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 498 | 492 |
Fair Value, Measurements, Recurring | Level 2 | Residential mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 184 | 191 |
Fair Value, Measurements, Recurring | Level 2 | Asset-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 1,356 | 749 |
Fair Value, Measurements, Recurring | Level 2 | Commercial mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 39 | 0 |
Fair Value, Measurements, Recurring | Level 2 | Redeemable preferred stock | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 272 | 274 |
Fair Value, Measurements, Recurring | Level 2 | Short-term investments | ||
Investments: | ||
Other invested assets: | 142 | 490 |
Fair Value, Measurements, Recurring | Level 2 | Assets of consolidated VIEs/VOEs | ||
Investments: | ||
Other invested assets: | 365 | 457 |
Fair Value, Measurements, Recurring | Level 2 | Swap | ||
Investments: | ||
Other invested assets: | 2,594 | (327) |
Fair Value, Measurements, Recurring | Level 2 | Credit default swaps | ||
Investments: | ||
Other invested assets: | 4 | 15 |
Fair Value, Measurements, Recurring | Level 2 | Future | ||
Investments: | ||
Other invested assets: | 0 | |
Fair Value, Measurements, Recurring | Level 2 | Options Held | ||
Investments: | ||
Other invested assets: | (539) | 3,346 |
Fair Value, Measurements, Recurring | Level 2 | Swaption | ||
Investments: | ||
Other invested assets: | 0 | 16 |
Fair Value, Measurements, Recurring | Level 2 | Guaranteed Minimum Withdrawal Benefit | ||
Liabilities: | ||
Guarantees | 0 | 0 |
Fair Value, Measurements, Recurring | Level 2 | SCS, SIO, MSO and IUL indexed features liability | ||
Liabilities: | ||
Guarantees | (940) | 3,268 |
Fair Value, Measurements, Recurring | Level 3 | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 1,261 | 1,396 |
Other equity investments | 87 | 97 |
Trading securities, at fair value | 37 | 36 |
Other invested assets: | 16 | 17 |
Cash equivalents | 0 | 0 |
Segregated securities | 0 | 0 |
GMIB reinsurance contracts asset | 2,823 | 2,139 |
Separate Accounts assets | 0 | 0 |
Total Assets | 4,224 | 3,685 |
Liabilities: | ||
Contingent payment arrangements | 24 | 23 |
Total Liabilities | 9,751 | 8,455 |
Fair Value, Measurements, Recurring | Level 3 | Corporate | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 1,185 | 1,257 |
Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury, government and agency | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | States and political subdivisions | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 36 | 39 |
Fair Value, Measurements, Recurring | Level 3 | Foreign governments | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Residential mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Asset-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 40 | 100 |
Fair Value, Measurements, Recurring | Level 3 | Commercial mortgage-backed | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Redeemable preferred stock | ||
Investments: | ||
Fixed maturities available for sale, at fair value | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Short-term investments | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Assets of consolidated VIEs/VOEs | ||
Investments: | ||
Other invested assets: | 16 | 17 |
Fair Value, Measurements, Recurring | Level 3 | Swap | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Credit default swaps | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Future | ||
Investments: | ||
Other invested assets: | 0 | |
Fair Value, Measurements, Recurring | Level 3 | Options Held | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Swaption | ||
Investments: | ||
Other invested assets: | 0 | 0 |
Fair Value, Measurements, Recurring | Level 3 | Guaranteed Minimum Withdrawal Benefit | ||
Liabilities: | ||
Guarantees | 9,727 | 8,432 |
Fair Value, Measurements, Recurring | Level 3 | SCS, SIO, MSO and IUL indexed features liability | ||
Liabilities: | ||
Guarantees | 0 | 0 |
Fair Value, Measurements, Recurring | NAV | ||
Investments: | ||
Separate Accounts assets | 361 | 356 |
Variable Interest Entity, Primary Beneficiary | Fair Value, Measurements, Recurring | ||
Liabilities: | ||
Guarantees | 20 | 10 |
Variable Interest Entity, Primary Beneficiary | Fair Value, Measurements, Recurring | Level 1 | ||
Liabilities: | ||
Guarantees | 1 | 1 |
Variable Interest Entity, Primary Beneficiary | Fair Value, Measurements, Recurring | Level 2 | ||
Liabilities: | ||
Guarantees | 19 | 9 |
Variable Interest Entity, Primary Beneficiary | Fair Value, Measurements, Recurring | Level 3 | ||
Liabilities: | ||
Guarantees | $ 0 | $ 0 |
FAIR VALUE DISCLOSURES - Narrat
FAIR VALUE DISCLOSURES - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Fair value adjustments on GMIB asset | $ 381 | $ 110 | |
Fair value adjustments on GMIB liability | 74 | 25 | |
AFS fixed maturities transferred from Level 3 to Level 2 | 126 | $ 69 | |
AFS fixed maturities transferred from Level 3 to Level 2 | $ 0 | $ 17 | |
Fair value measurement with unobservable inputs reconciliation recurring basis asset transfers percentage | 0.60% | 0.60% | |
Nonrecurring | Level 3 | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Investments, fair value disclosure | $ 267 | 428 | |
Fair Value, Measurements, Recurring | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Separate Accounts assets | 105,485 | 126,324 | |
Business combination, contingent consideration, liability | 24 | 23 | |
Fair Value, Measurements, Recurring | Level 3 | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Separate Accounts assets | 0 | 0 | |
Business combination, contingent consideration, liability | 24 | $ 23 | |
AB 2019 Acquisition | Level 3 | Alliance Bernstein | Long-term revenue growth rate | Minimum | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Contingent payment arrangement, measurement input | 0.70% | ||
AB 2019 Acquisition | Level 3 | Alliance Bernstein | Long-term revenue growth rate | Maximum | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Contingent payment arrangement, measurement input | 2.50% | ||
AB 2019 Acquisition | Level 3 | Alliance Bernstein | Discount rate | Minimum | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Contingent payment arrangement, measurement input | 10.40% | ||
AB 2019 Acquisition | Level 3 | Alliance Bernstein | Risk Free Interest Rate | Minimum | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Contingent payment arrangement, measurement input | 3.50% | ||
AB 2019 Acquisition | Level 3 | Alliance Bernstein | Market price risk adjustment rate | Minimum | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Contingent payment arrangement, measurement input | 6.90% | ||
AB 2016 Acquisition | Level 3 | Alliance Bernstein | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Business combination, contingent consideration, liability | 24 | $ 23 | |
AB 2016 Acquisition | Level 3 | Alliance Bernstein | Long-term revenue growth rate | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Contingent payment arrangement, measurement input | 50.00% | ||
AB 2016 Acquisition | Level 3 | Alliance Bernstein | Discount rate | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Contingent payment arrangement, measurement input | 3.00% | ||
Contingent Payment Arrangement | Level 3 | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
AFS fixed maturities transferred from Level 3 to Level 2 | 0 | $ 0 | |
AFS fixed maturities transferred from Level 3 to Level 2 | 0 | 0 | |
Purchases | 0 | 0 | |
Change in estimate | $ 0 | $ 0 | |
Contingent Payment Arrangement | Level 3 | Alliance Bernstein | |||
Fair Value Inputs Assets Quantitative Information 1 [Line Items] | |||
Purchases | $ 17 | ||
Change in estimate | $ 3 |
FAIR VALUE DISCLOSURES - Fair V
FAIR VALUE DISCLOSURES - Fair Value Measurement Reconciliation for All Levels (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2019 | |
Total gains (losses), realized and unrealized, included in: | |||
Investment gains (losses), net | $ 65 | $ (11) | |
Transfers into level 3 | 0 | 17 | |
Transfers into level 3 | (126) | (69) | |
Corporate | |||
Total gains (losses), realized and unrealized, included in: | |||
OCI | (61) | 9 | |
Corporate | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | 1,257 | 1,186 | $ 1,186 |
Net investment income (loss) | 1 | 1 | |
Investment gains (losses), net | (2) | 0 | |
Total realized and unrealized gains (losses) | (1) | 1 | |
OCI | (61) | 9 | |
Purchases | 61 | 70 | |
Actual return on plan assets — Sales/Settlements | (45) | (34) | |
Transfers into level 3 | 0 | 17 | |
Transfers into level 3 | (26) | (69) | |
Ending Balance | 1,185 | 1,180 | 1,257 |
States and political subdivisions | |||
Total gains (losses), realized and unrealized, included in: | |||
OCI | (2) | 1 | |
States and political subdivisions | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | 39 | 39 | 39 |
Net investment income (loss) | 0 | 0 | |
Investment gains (losses), net | 0 | 0 | |
Total realized and unrealized gains (losses) | 0 | 0 | |
OCI | (3) | 1 | |
Purchases | 0 | 0 | |
Actual return on plan assets — Sales/Settlements | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Ending Balance | 36 | 40 | 39 |
Asset-backed | |||
Total gains (losses), realized and unrealized, included in: | |||
OCI | (8) | 4 | |
Asset-backed | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | 100 | 519 | 519 |
Net investment income (loss) | 0 | 0 | |
Investment gains (losses), net | 0 | 0 | |
Total realized and unrealized gains (losses) | 0 | 0 | |
OCI | (8) | 4 | |
Purchases | 48 | 11 | |
Actual return on plan assets — Sales/Settlements | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Transfers into level 3 | (100) | 0 | |
Ending Balance | 40 | 534 | 100 |
Other equity investments | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | 150 | 165 | 165 |
Investment gains (losses), net | 7 | 0 | |
Net derivative gains (losses), excluding non-performance risk | 0 | 0 | |
Nonperformance risk | 0 | 0 | |
Total realized and unrealized gains (losses) | 7 | 0 | |
OCI | (7) | 0 | |
Purchases | 2 | 2 | |
Actual return on plan assets — Sales/Settlements | (11) | 0 | |
Settlements | 0 | 0 | |
Change in estimate | 0 | 0 | |
Activity related to consolidated VIEs/VOEs | (1) | (1) | |
Transfers into level 3 | 0 | 0 | |
Transfers into level 3 | 0 | (29) | |
Ending Balance | 140 | 137 | 150 |
GMIB Reinsurance Contract Asset | |||
Total gains (losses), realized and unrealized, included in: | |||
OCI | 0 | 0 | |
GMIB Reinsurance Contract Asset | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | 2,139 | 1,732 | 1,732 |
Investment gains (losses), net | 0 | 0 | |
Net derivative gains (losses), excluding non-performance risk | 955 | (11) | |
Nonperformance risk | (229) | 29 | |
Total realized and unrealized gains (losses) | 726 | 18 | |
OCI | 0 | 0 | |
Purchases | 10 | 11 | |
Actual return on plan assets — Sales/Settlements | (20) | (21) | |
Settlements | 0 | 0 | |
Change in estimate | (32) | 0 | |
Activity related to consolidated VIEs/VOEs | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Ending Balance | 2,823 | 1,740 | 2,139 |
Separate Accounts Assets | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | 0 | 21 | 21 |
Investment gains (losses), net | 0 | 0 | |
Net derivative gains (losses), excluding non-performance risk | 0 | 0 | |
Nonperformance risk | 0 | 0 | |
Total realized and unrealized gains (losses) | 0 | 0 | |
OCI | 0 | 0 | |
Purchases | 0 | 4 | |
Actual return on plan assets — Sales/Settlements | 0 | 0 | |
Settlements | 0 | (1) | |
Change in estimate | 0 | 0 | |
Activity related to consolidated VIEs/VOEs | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Transfers into level 3 | 0 | (1) | |
Ending Balance | 0 | 23 | 0 |
GMxB Derivative Features Liability | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | (8,432) | (5,614) | (5,614) |
Investment gains (losses), net | 0 | 0 | |
Net derivative gains (losses), excluding non-performance risk | (3,884) | 63 | |
Nonperformance risk | 2,686 | (470) | |
Total realized and unrealized gains (losses) | (1,198) | (407) | |
OCI | 0 | 0 | |
Purchases | (111) | (111) | |
Actual return on plan assets — Sales/Settlements | 14 | 6 | |
Settlements | 0 | 0 | |
Change in estimate | 0 | 0 | |
Activity related to consolidated VIEs/VOEs | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Ending Balance | (9,727) | (6,126) | (8,432) |
Contingent Payment Arrangement | Level 3 | |||
Total gains (losses), realized and unrealized, included in: | |||
Beginning Balance | (23) | (7) | (7) |
Investment gains (losses), net | 0 | 0 | |
Net derivative gains (losses), excluding non-performance risk | 0 | 0 | |
Nonperformance risk | 0 | 0 | |
Total realized and unrealized gains (losses) | 0 | 0 | |
OCI | 0 | 0 | |
Purchases | 0 | 0 | |
Actual return on plan assets — Sales/Settlements | 0 | 0 | |
Settlements | 0 | 0 | |
Change in estimate | 0 | 0 | |
Activity related to consolidated VIEs/VOEs | (1) | 0 | |
Transfers into level 3 | 0 | 0 | |
Transfers into level 3 | 0 | 0 | |
Ending Balance | $ (24) | $ (7) | $ (23) |
FAIR VALUE DISCLOSURES - Unreal
FAIR VALUE DISCLOSURES - Unrealized Gains (Losses) for Level 3 Instruments (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Level 3 Assets And Liabilities Held | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Net Derivative Gains (Losses) | $ (472) | $ (390) |
OCI | (71) | 14 |
Corporate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Net Derivative Gains (Losses) | 0 | 0 |
OCI | (61) | 9 |
States and political subdivisions | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Net Derivative Gains (Losses) | 0 | 0 |
OCI | (2) | 1 |
Asset-backed | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Net Derivative Gains (Losses) | 0 | 0 |
OCI | (8) | 4 |
Fixed maturities, AFS | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Net Derivative Gains (Losses) | 0 | 0 |
OCI | (71) | 14 |
GMIB Reinsurance Contract Asset | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Net Derivative Gains (Losses) | 726 | 18 |
OCI | 0 | 0 |
GMxB derivative features liability | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Net Derivative Gains (Losses) | (1,198) | (408) |
OCI | $ 0 | $ 0 |
FAIR VALUE DISCLOSURES - Quanti
FAIR VALUE DISCLOSURES - Quantitative Information about Level 3 (Details) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2020USD ($) | Dec. 31, 2019USD ($) | |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Asset, fair value | $ 8,603 | $ 7,993 |
Corporate | Level 3 | Matrix pricing model | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Fair Value Unobservable Inputs | $ 63 | $ 57 |
Corporate | Level 3 | Matrix pricing model | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Spread over Benchmark | 0.0015 | 0.0065 |
Corporate | Level 3 | Matrix pricing model | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Spread over Benchmark | 0.0580 | 0.058 |
Corporate | Level 3 | Matrix pricing model | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Spread over Benchmark | 0.0264 | 0.0184 |
Corporate | Level 3 | Market comparable companies | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Fair Value Unobservable Inputs | $ 1,034 | $ 1,025 |
Corporate | EBITDA Multiple | Level 3 | Market comparable companies | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 3.2 | 3.3 |
Corporate | EBITDA Multiple | Level 3 | Market comparable companies | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 31.5 | 56.7 |
Corporate | EBITDA Multiple | Level 3 | Market comparable companies | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 14 | 14.3 |
Corporate | Discount rate | Level 3 | Market comparable companies | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 0.060 | 0.039 |
Corporate | Discount rate | Level 3 | Market comparable companies | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 0.252 | 0.165 |
Corporate | Discount rate | Level 3 | Market comparable companies | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 0.101 | 0.100 |
Corporate | Cash Flow Multiples | Level 3 | Market comparable companies | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 0.8 | 1.8 |
Corporate | Cash Flow Multiples | Level 3 | Market comparable companies | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 25.8 | 18 |
Corporate | Cash Flow Multiples | Level 3 | Market comparable companies | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 11.1 | 10.7 |
Other equity investments | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Fair Value Unobservable Inputs | $ 37 | $ 36 |
Fair value inputs, discount period | 11 years | 11 years |
Other equity investments | Discount rate | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 0.1 | |
Other equity investments | Earnings Multiple | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 8 | 8 |
Other equity investments | Discount factor | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Equity securities, measurement input | 0.1 | |
GMIB reinsurance contracts | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Asset, fair value | $ 2,823 | $ 2,139 |
GMIB reinsurance contracts | Non-performance risk | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0144 | 0.0055 |
GMIB reinsurance contracts | Non-performance risk | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0293 | 0.0109 |
GMIB reinsurance contracts | Non-performance risk | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0233 | |
GMIB reinsurance contracts | Lapse rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.008 | 0.008 |
GMIB reinsurance contracts | Lapse rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.10 | 0.10 |
GMIB reinsurance contracts | Lapse rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0156 | |
GMIB reinsurance contracts | Withdrawal rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0 | 0 |
GMIB reinsurance contracts | Withdrawal rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.08 | 0.08 |
GMIB reinsurance contracts | Withdrawal rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0119 | |
GMIB reinsurance contracts | Utilization Rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0 | 0 |
GMIB reinsurance contracts | Utilization Rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.49 | 0.49 |
GMIB reinsurance contracts | Utilization Rate | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0659 | |
GMIB reinsurance contracts | Volatility rates - Equity | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.20 | 0.09 |
GMIB reinsurance contracts | Volatility rates - Equity | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.370 | 0.30 |
GMIB reinsurance contracts | Volatility rates - Equity | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.27 | |
GMIB reinsurance contracts | Mortality rate | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0271 | |
GMIBNLG | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Liability, fair value | $ 9,308 | $ 8,128 |
GMIBNLG | Non-performance risk | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0304 | 0.0124 |
GMIBNLG | Lapse rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.008 | 0.008 |
GMIBNLG | Lapse rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.199 | 0.199 |
GMIBNLG | Lapse rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0275 | |
GMIBNLG | Withdrawal rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.003 | 0.003 |
GMIBNLG | Withdrawal rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.11 | 0.11 |
GMIBNLG | Withdrawal rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0121 | |
GMIBNLG | Annuitization | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0 | 0 |
GMIBNLG | Annuitization | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 1 | 1 |
GMIBNLG | Annuitization | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0646 | |
GMIBNLG | Mortality rate | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0134 | |
Assumed GMIB Reinsurance Contracts | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Liability, fair value | $ 218 | $ 186 |
Assumed GMIB Reinsurance Contracts | Non-performance risk | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0201 | 0.0061 |
Assumed GMIB Reinsurance Contracts | Non-performance risk | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0419 | 0.0141 |
Assumed GMIB Reinsurance Contracts | Non-performance risk | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0375 | |
Assumed GMIB Reinsurance Contracts | Lapse rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.011 | 0.011 |
Assumed GMIB Reinsurance Contracts | Lapse rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.111 | 0.111 |
Assumed GMIB Reinsurance Contracts | Lapse rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0156 | |
Assumed GMIB Reinsurance Contracts | Withdrawal rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.006 | 0.006 |
Assumed GMIB Reinsurance Contracts | Withdrawal rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.222 | 0.222 |
Assumed GMIB Reinsurance Contracts | Withdrawal rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.011 | 0.011 |
Assumed GMIB Reinsurance Contracts | Withdrawal rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 1 | 1 |
Assumed GMIB Reinsurance Contracts | Withdrawal rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0119 | |
Assumed GMIB Reinsurance Contracts | Utilization Rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0 | 0 |
Assumed GMIB Reinsurance Contracts | Utilization Rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.3 | 0.3 |
Assumed GMIB Reinsurance Contracts | Utilization Rate | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0659 | |
Assumed GMIB Reinsurance Contracts | Volatility rates - Equity | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.20 | 0.09 |
Assumed GMIB Reinsurance Contracts | Volatility rates - Equity | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.37 | 0.30 |
Assumed GMIB Reinsurance Contracts | Volatility rates - Equity | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.27 | |
GWBL/GMWB | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Liability, fair value | $ 146 | $ 109 |
GWBL/GMWB | Non-performance risk | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0304 | 0.0124 |
GWBL/GMWB | Lapse rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.008 | 0.008 |
GWBL/GMWB | Lapse rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.10 | 0.010 |
GWBL/GMWB | Lapse rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0175 | |
GWBL/GMWB | Withdrawal rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0 | 0 |
GWBL/GMWB | Withdrawal rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.07 | 0.070 |
GWBL/GMWB | Withdrawal rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0119 | |
GWBL/GMWB | Utilization Rate | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 1 | 1 |
GWBL/GMWB | Volatility rates - Equity | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.20 | 0.09 |
GWBL/GMWB | Volatility rates - Equity | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.37 | 0.30 |
GWBL/GMWB | Volatility rates - Equity | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.27 | |
GIB | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Liability, fair value | $ 38 | $ 5 |
GIB | Non-performance risk | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.000304 | 0.0124 |
GIB | Lapse rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.012 | 0.012 |
GIB | Lapse rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.199 | 0.199 |
GIB | Lapse rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0175 | |
GIB | Withdrawal rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0 | 0 |
GIB | Withdrawal rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.08 | 0.080 |
GIB | Withdrawal rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0119 | |
GIB | Utilization Rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0 | 0 |
GIB | Utilization Rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 1 | 1 |
GIB | Utilization Rate | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0659 | |
GIB | Volatility rates - Equity | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.20 | 0.09 |
GIB | Volatility rates - Equity | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.370 | 0.30 |
GIB | Volatility rates - Equity | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.27 | |
GMAB | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Liability, fair value | $ 17 | $ 4 |
GMAB | Non-performance risk | Level 3 | Discounted cash flow | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.000304 | |
GMAB | Lapse rates | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.01 | 0.01 |
GMAB | Lapse rates | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.10 | 0.10 |
GMAB | Lapse rates | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0175 | |
GMAB | Volatility rates - Equity | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.20 | 0.09 |
GMAB | Volatility rates - Equity | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.37 | 0.30 |
GMAB | Volatility rates - Equity | Level 3 | Discounted cash flow | Weighted Average | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.27 | |
Ages 0 - 40 | GMIB reinsurance contracts | Mortality rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0001 | 0.0001 |
Ages 0 - 40 | GMIB reinsurance contracts | Mortality rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0018 | 0.0018 |
Ages 0 - 40 | GMIBNLG | Mortality rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0001 | 0.0001 |
Ages 0 - 40 | GMIBNLG | Mortality rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0019 | 0.0019 |
Ages 41 - 60 | GMIB reinsurance contracts | Mortality rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0007 | 0.0007 |
Ages 41 - 60 | GMIB reinsurance contracts | Mortality rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0054 | 0.0054 |
Ages 41 - 60 | GMIBNLG | Mortality rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0006 | 0.0006 |
Ages 41 - 60 | GMIBNLG | Mortality rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0053 | 0.0053 |
Ages 61 - 115 | GMIB reinsurance contracts | Mortality rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.0042 | 0.0042 |
Ages 61 - 115 | GMIB reinsurance contracts | Mortality rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing asset, measurement input | 0.4220 | 0.4220 |
Ages 61 - 115 | GMIBNLG | Mortality rate | Level 3 | Discounted cash flow | Minimum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.0041 | 0.0041 |
Ages 61 - 115 | GMIBNLG | Mortality rate | Level 3 | Discounted cash flow | Maximum | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Servicing liability, measurement input | 0.4139 | 0.4139 |
FAIR VALUE DISCLOSURES - Carryi
FAIR VALUE DISCLOSURES - Carrying Values and Fair Values of Financial Instruments (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Consolidated Amounts [Abstract] | ||
Mortgage loans on real estate | $ 12,123 | $ 12,107 |
Policy loans | 3,720 | 3,735 |
Policyholders liabilities: Investment contracts | 55,810 | 58,879 |
Separate Accounts liabilities | 106,128 | 126,910 |
Carrying Value | ||
Consolidated Amounts [Abstract] | ||
Mortgage loans on real estate | 12,123 | 12,107 |
Policy loans | 3,720 | 3,735 |
Policyholders liabilities: Investment contracts | 2,089 | 2,056 |
Funding Agreements | 6,759 | 6,909 |
Short-term debt | 4,217 | 4,111 |
Separate Accounts liabilities | 7,563 | 9,041 |
Measured at Fair Value | ||
Consolidated Amounts [Abstract] | ||
Mortgage loans on real estate | 12,134 | 12,334 |
Policy loans | 4,686 | 4,707 |
Policyholders liabilities: Investment contracts | 2,201 | 2,167 |
Funding Agreements | 6,835 | 6,957 |
Short-term debt | 4,201 | 4,476 |
Separate Accounts liabilities | 7,563 | 9,041 |
Measured at Fair Value | Level 1 | ||
Consolidated Amounts [Abstract] | ||
Mortgage loans on real estate | 0 | 0 |
Policy loans | 0 | 0 |
Policyholders liabilities: Investment contracts | 0 | 0 |
Funding Agreements | 0 | 0 |
Short-term debt | 0 | 0 |
Separate Accounts liabilities | 0 | 0 |
Measured at Fair Value | Level 2 | ||
Consolidated Amounts [Abstract] | ||
Mortgage loans on real estate | 0 | 0 |
Policy loans | 0 | 0 |
Policyholders liabilities: Investment contracts | 0 | 0 |
Funding Agreements | 6,835 | 6,957 |
Short-term debt | 4,201 | 4,476 |
Separate Accounts liabilities | 0 | 0 |
Measured at Fair Value | Level 3 | ||
Consolidated Amounts [Abstract] | ||
Mortgage loans on real estate | 12,134 | 12,334 |
Policy loans | 4,686 | 4,707 |
Policyholders liabilities: Investment contracts | 2,201 | 2,167 |
Funding Agreements | 0 | 0 |
Short-term debt | 0 | 0 |
Separate Accounts liabilities | $ 7,563 | $ 9,041 |
EMPLOYEE BENEFIT PLANS - Compon
EMPLOYEE BENEFIT PLANS - Components of Certain Benefit Costs (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Net periodic pension expense | $ 3 | $ 6 |
Net Periodic Pension Expense | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | 2 | 2 |
Interest cost | 16 | 22 |
Expected return on assets | (37) | (38) |
Actuarial (gain) loss | 0 | 0 |
Net amortization | $ 22 | $ 20 |
EQUITY - Dividends Declared (De
EQUITY - Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Equity [Abstract] | ||
Dividends declared per share of common stock | $ 0.15 | $ 0.13 |
Dividends declared per depositary share | $ 0.39 | $ 0 |
Dividends declared per depositary share (1) | $ 0 | $ 0 |
EQUITY - Narrative (Details)
EQUITY - Narrative (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2020 | Feb. 26, 2020 | Nov. 06, 2019 | |
Equity [Abstract] | |||
Share repurchase plan, authorized amount | $ 600,000,000 | $ 400,000,000 | |
Stock repurchase program, number of shares authorized to be repurchased | 1,000,000,000 | ||
Shares repurchased (in shares) | 13,700,000 | ||
Stock repurchase program, remaining authorized repurchase amount | $ 395,000,000 |
EQUITY - Cumulative Gains (Loss
EQUITY - Cumulative Gains (Losses) (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Equity [Abstract] | ||
Unrealized gains (losses) on investments | $ 3,272 | $ 430 |
Defined benefit pension plans | (955) | (919) |
Foreign currency translation adjustments | (78) | (63) |
Total accumulated other comprehensive income (loss) | 2,239 | (552) |
Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest | (50) | (39) |
Accumulated other comprehensive income (loss) attributable to Holdings | $ 2,289 | $ (513) |
EQUITY - Components of OCI, Net
EQUITY - Components of OCI, Net of Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | Dec. 31, 2017 | |
Equity [Abstract] | |||
Net unrealized gains (losses) arising during the period | $ 1,513 | $ 1,342 | |
(Gains) losses reclassified into net income (loss) during the period | (47) | 9 | |
Net unrealized gains (losses) on investments | 1,466 | 1,351 | |
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other | (32) | (517) | |
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $382 and $218) | 1,434 | 834 | |
Change in defined benefit plans: | |||
Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost | 28 | 49 | |
Change in defined benefit plans (net of deferred income tax expense (benefit) of $7 and $12) | 28 | 49 | |
Foreign currency translation adjustments: | |||
Foreign currency translation gains (losses) arising during the period | (21) | (1) | |
(Gains) losses reclassified into net income (loss) during the period | 0 | 0 | |
Foreign currency translation adjustment | (21) | (1) | |
Total other comprehensive income (loss), net of income taxes | 1,441 | 882 | $ (1,177) |
Less: Other comprehensive income (loss) attributable to noncontrolling interest | (8) | (1) | |
Other comprehensive income (loss) attributable to Holdings | 1,449 | 883 | |
Reclassification adjustment | (12) | 2 | |
AFS Securities, OCI, tax | 382 | 218 | |
Defined benefit plan, OCI, tax | $ 7 | $ 12 |
REDEEMABLE NONCONTROLLING INT_3
REDEEMABLE NONCONTROLLING INTEREST - Summary of Redeemable Noncontrolling Interest (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2020 | Mar. 31, 2019 | ||
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] | |||
Balance, beginning of period | [1],[2] | $ 365 | |
Net earnings (loss) attributable to redeemable noncontrolling interests | 37 | $ 66 | |
Balance, end of period | [1],[2] | 257 | |
Redeemable Noncontrolling Interest | |||
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] | |||
Balance, beginning of period | 365 | 38 | |
Net earnings (loss) attributable to redeemable noncontrolling interests | (30) | 12 | |
Purchase/change of redeemable noncontrolling interests | (78) | 157 | |
Balance, end of period | $ 257 | $ 207 | |
[1] | See Note 13 for details of Redeemable noncontrolling interest. | ||
[2] | See Note 2 for details of balances with variable interest entities. |
COMMITMENTS AND CONTINGENT LI_3
COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details) - USD ($) shares in Millions, $ in Millions | 1 Months Ended | ||
Apr. 30, 2019 | Mar. 31, 2020 | Feb. 29, 2016 | |
Loss Contingencies [Line Items] | |||
Unaccrued amounts of reasonably possible range of losses | $ 100 | ||
Federal home loan bank stock | 315 | ||
Carrying value of collateral pledged for federal home loan bank | 9,800 | ||
AXA | |||
Loss Contingencies [Line Items] | |||
Commitments by the Company to provide equity financing | 1,100 | ||
Face amount of mortgage loans | 426 | ||
Affiliated Entity | AXA | |||
Loss Contingencies [Line Items] | |||
Commitments by the Company to provide equity financing | $ 220 | ||
Brach Family Foundation Litigation | |||
Loss Contingencies [Line Items] | |||
Liability for future policy benefits, face value of policy | $ 1 | ||
Pre-Capitalized Trust Securities, Redeemable February 15, 2049 | |||
Loss Contingencies [Line Items] | |||
Shares issued (in shares) | 0.6 | ||
Proceeds from offering | $ 600 | ||
Sale of stock, semi-annual facility fee, rate | 2.125% | ||
Pre-Capitalized Trust Securities, Redeemable February 15, 2029 | |||
Loss Contingencies [Line Items] | |||
Shares issued (in shares) | 0.4 | ||
Proceeds from offering | $ 400 | ||
Sale of stock, semi-annual facility fee, rate | 2.715% |
COMMITMENTS AND CONTINGENT LI_4
COMMITMENTS AND CONTINGENT LIABILITIES - Funding Agreements (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Dec. 31, 2019 | |
Debt Instrument [Line Items] | ||
Outstanding balance at end of period | $ 6,750 | $ 6,900 |
Issued during the period | 11,750 | |
Repaid during the period | 11,900 | |
Long-term Agreements Maturing Within One Year | 0 | |
Difference related to remaining amortization | 9 | 9 |
Federal Home Loan Bank of New York Short-Term Funding Agreements Maturing in Less than One Year | ||
Debt Instrument [Line Items] | ||
Outstanding balance at end of period | 4,632 | 4,608 |
Issued during the period | 11,750 | |
Repaid during the period | 11,900 | |
Long-term Agreements Maturing Within One Year | 174 | |
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing Between Two and Five Years | ||
Debt Instrument [Line Items] | ||
Outstanding balance at end of period | 1,472 | 1,646 |
Issued during the period | 0 | |
Repaid during the period | 0 | |
Long-term Agreements Maturing Within One Year | (174) | |
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Greater than Five Years | ||
Debt Instrument [Line Items] | ||
Outstanding balance at end of period | 646 | 646 |
Issued during the period | 0 | |
Repaid during the period | 0 | |
Long-term Agreements Maturing Within One Year | 0 | |
Federal Home Loan Bank of New York Long-Term Funding Agreements | ||
Debt Instrument [Line Items] | ||
Outstanding balance at end of period | 2,119 | $ 2,292 |
Issued during the period | 0 | |
Repaid during the period | 0 | |
Long-term Agreements Maturing Within One Year | $ (174) |
BUSINESS SEGMENT INFORMATION -
BUSINESS SEGMENT INFORMATION - Narrative (Details) | 3 Months Ended |
Mar. 31, 2020segment | |
Segment Reporting [Abstract] | |
Number of reportable segments | 4 |
BUSINESS SEGMENT INFORMATION _2
BUSINESS SEGMENT INFORMATION - Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Segment Reporting Information [Line Items] | ||
Net income (loss) | $ 5,410 | $ (775) |
Adjustments related to: | ||
Non-GAAP Operating Earnings | 515 | 509 |
Interest expense | 52 | 56 |
Adjustments | ||
Segment Reporting Information [Line Items] | ||
Net income (loss) | 5,410 | (775) |
Adjustments related to: | ||
Variable annuity product features | (6,861) | 1,540 |
Investment (gains) losses | (4) | 11 |
Net actuarial (gains) losses related to pension and other postretirement benefit obligations | 27 | 24 |
Other adjustments | 634 | 40 |
Income tax expense (benefit) related to above adjustments | 1,303 | (337) |
Non-recurring tax items | 6 | 6 |
COVID Impact on VA product feature due to assumption updates | 1,500 | |
Other COVID-19 impact | 35 | |
Assumption updates due to COVID-19 | 1,000 | |
Other COVID-19 impact | 51 | |
Separation costs | 32 | 24 |
COVID-19 impact on taxes | (534) | |
Operating Segments | Individual Retirement | ||
Adjustments related to: | ||
Non-GAAP Operating Earnings | 372 | 370 |
Operating Segments | Group Retirement | ||
Adjustments related to: | ||
Non-GAAP Operating Earnings | 106 | 81 |
Operating Segments | Investment Management and Research | ||
Adjustments related to: | ||
Non-GAAP Operating Earnings | 95 | 77 |
Operating Segments | Protection Solutions | ||
Adjustments related to: | ||
Non-GAAP Operating Earnings | 38 | 49 |
Corporate and Other | ||
Adjustments related to: | ||
Non-GAAP Operating Earnings | (96) | (68) |
Interest expense | $ 56 | $ 52 |
BUSINESS SEGMENT INFORMATION _3
BUSINESS SEGMENT INFORMATION - Reconciliation of Revenue from Segments to Consolidated (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Segment Reporting Information [Line Items] | ||
Total revenues | $ 12,593 | $ 1,714 |
Operating Segments | Individual Retirement | ||
Segment Reporting Information [Line Items] | ||
Total revenues | 1,481 | 1,007 |
Operating Segments | Group Retirement | ||
Segment Reporting Information [Line Items] | ||
Total revenues | 282 | 251 |
Operating Segments | Investment Management and Research | ||
Segment Reporting Information [Line Items] | ||
Total revenues | 907 | 780 |
Operating Segments | Protection Solutions | ||
Segment Reporting Information [Line Items] | ||
Total revenues | 859 | 831 |
Corporate and Other | ||
Segment Reporting Information [Line Items] | ||
Total revenues | 299 | 312 |
Adjustments | ||
Adjustments related to: | ||
Variable annuity product features | 8,339 | (1,478) |
Investment (gains) losses | (4) | 11 |
Other adjustments to segment revenues | 422 | 22 |
Assumption updates due to COVID-19 | 46 | |
Other COVID-19 related impact | (51) | |
Intersegment Eliminations | ||
Adjustments related to: | ||
Investment expenses | 18 | 18 |
Investment management and other fees | Intersegment Eliminations | ||
Adjustments related to: | ||
Revenues | $ 27 | $ 25 |
BUSINESS SEGMENT INFORMATION _4
BUSINESS SEGMENT INFORMATION - Reconciliation of Assets from Segment to Consolidated (Details) - USD ($) $ in Millions | Mar. 31, 2020 | Dec. 31, 2019 |
Segment Reporting Information [Line Items] | ||
Total assets | $ 240,781 | $ 249,870 |
Operating Segments | Individual Retirement | ||
Segment Reporting Information [Line Items] | ||
Total assets | 117,299 | 123,626 |
Operating Segments | Group Retirement | ||
Segment Reporting Information [Line Items] | ||
Total assets | 41,194 | 43,588 |
Operating Segments | Investment Management and Research | ||
Segment Reporting Information [Line Items] | ||
Total assets | 11,915 | 10,170 |
Operating Segments | Protection Solutions | ||
Segment Reporting Information [Line Items] | ||
Total assets | 45,266 | 46,886 |
Corporate and Other | ||
Segment Reporting Information [Line Items] | ||
Total assets | $ 25,107 | $ 25,600 |
EARNINGS PER COMMON SHARE - Bas
EARNINGS PER COMMON SHARE - Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Earnings Per Share [Abstract] | ||
Weighted average number of shares outstanding - basic (in shares) | 461 | 518 |
Effect of dilutive securities common shares, employee stock awards (in shares) | 2.5 | 0 |
Weighted average common shares outstanding - diluted (in shares) | 463.5 | 518 |
Net income (loss) | $ 5,447,000 | $ (709,000) |
Less: Net income (loss) attributable to the noncontrolling interest | 37,000 | 66,000 |
Net income (loss) attributable to Holdings | 5,410,000 | (775,000) |
Less: Preferred stock dividends | 13,000 | 0 |
Net income (loss) available to Holdings’ common shareholders | $ 5,397,000 | $ (775,000) |
Net income (loss) attributable to Holdings per common share: | ||
Basic (in usd per share) | $ 11.71 | $ (1.50) |
Diluted (in usd per share) | $ 11.65 | $ (1.50) |
Effect of dilutive securities (in shares) | 1 |
EARNINGS PER COMMON SHARE - Nar
EARNINGS PER COMMON SHARE - Narrative (Details) - shares shares in Millions | 3 Months Ended | |
Mar. 31, 2020 | Mar. 31, 2019 | |
Earnings Per Share [Abstract] | ||
Antidilutive securities (in shares) | 6 | 5.3 |
HELD-FOR-SALE (Details)
HELD-FOR-SALE (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Dec. 31, 2019 | |
Assets: | ||
Assets held-for-sale | $ 843 | $ 962 |
Liabilities: | ||
Total liabilities held-for-sale | 679 | 724 |
U.S. Financial Life Insurance Company and MONY Life Insurance Company of the Americas, Ltd | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Investment impairment | (39) | (105) |
Assets: | ||
Fixed maturity securities | 860 | 896 |
Trading securities, at fair value | 14 | 17 |
Policy loans | 20 | 19 |
Cash and cash equivalents | 41 | 65 |
Amounts due from reinsurers | 41 | 43 |
Deferred policy acquisition costs | 31 | 31 |
Other assets | 18 | 24 |
Assets held-for-sale | 1,025 | 1,095 |
Less: Loss accrual | (182) | (133) |
Total assets held-for-sale | 843 | 962 |
Liabilities: | ||
Policyholders’ account balances | 279 | 286 |
Future policy benefits and other policyholders’ liabilities | 398 | 421 |
Amounts due to reinsurers | (2) | 6 |
Other liabilities | 4 | 11 |
Total liabilities held-for-sale | $ 679 | $ 724 |
SUBSEQUENT EVENTS - Narrative (
SUBSEQUENT EVENTS - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2020 | Dec. 31, 2019 | |
U.S. Financial Life Insurance Company and MONY Life Insurance Company of the Americas, Ltd | ||
Subsequent Event [Line Items] | ||
Investment impairment | $ (39) | $ (105) |
Uncategorized Items - eqh1q2020
Label | Element | Value |
Parent [Member] | ||
Cumulative Effect of New Accounting Principle in Period of Adoption | us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | $ (30,000,000) |